Subject index  by unknown
JACC February 1999 613A 
Subject Index 
Ablation-catheter 
A Randomized Prospective Study of 8mm Versus 
4ram Tip Electrodes for Radiofrequency Current 
Ablation of Atrial Flutter 1084 150°116A 
A Single Left Atrial Radiofrequency Ablation 
Lesion Reduces Atrial Defibrillation Thresholds 
in Sheep 1233-179o 159A 
Ablation of Stow/Slow Atrioventricular Nodal 
Reentrant Tachycardia: Evidence for Multiple 
Slow Pathways 906-2..166A 
Accuracy of Geometric Localization Using 
Noncontact Multielectrode Mapping Array in 
the Right Atrium II 14-146°123A 
Alterations of Heart Rate Variability At~er 
Radiofrequency Catheter Ablation of Focal 
Atrial Fibrillation 1175-187•144A 
Anatomic Observations Following Transcatheter 
Radiofrequency Ablation of Accessory 
Pathways in Young Patients 1210-158°533A 
Anatomy and Dimensions of the Inferior Right 
Atrial Isthmus in Patients With and Without 
History of Common Atrial Flutter 890-1 •164A 
Arrangement of the Atrial Muscle Fibers in the 
Inferior Right Atrial Isthmus: Its Role in Atrial 
Flutter t202-153• 147A 
Atypical Patterns of Reentry in Patients With 
Atrioventricular Nodal Tachycardia 906-4, 
166A 
Bezold-Jarisch-Like Reflex During Radiofrequency 
Ablation of the Pulmonary Vein in Patients With 
Paroxysmal Focal Atrial Fibrillation 1053 156,~ 
I l iA  
Can Extensive Right Atrial Ablation in Atrial 
Fibrillation Patients Decrease Atrial 
Defibrillation Thresholds? 1233-178° 158A 
Catheter Ablation for Refractory Multiple 
Morphologic VT: Values of Nonfluoroseopic 
Electroanatomical Mapping 8 t 6-3 * 122A 
Catheter Ablation of Left Atrial Tract (Marshall) 
From the Coronary Sinus 838-4° 137A 
Catheter Ablation of Organized Atrial Dysrhythmias 
Associated With Atrial Fibrillation: 
Transtelephonic Monitoring May Guide Patient 
Selection 1022-157•105A 
Circle Maps of Respiratory Sinus Arrhythmia 
Patterns: A New Method to Differentiate 
Cardiac Denervation From Vagal Modulations 
After AV Node Modification 1146-185 • 135A 
Clinical Characteristics and Ablation of Left Side 
Atrial Flutter 1084-148°116A 
Comparison of 8-ram Tip and Irrigated Tip Catheters 
for Radiofrequency Ablation of Ventricular 
Myocardium 1172-149°140A 
Comparison of Activation Patterns During Sinus 
Rhythm and Ventricular Tachycardia n
Postinfaretion Patients Using a Noncontact 
Mapping System 816-6•123A 
Concealed Entrainment in Radiofrequency Catheter 
Ablation of Atypical Atrial Flutter in Patients 
Without Prior Cardiac Surgery 1084-146•116A 
Criteria for a Complete and Transmural Anterior 
Line in Primary Right Atrial Ablation for 
Idiopathic Atrial Fibrillation 838-2° 136A 
Dilated Pulmonary' Veins in Focal Atrial Fibrillation 
Originating From Pulmonary Veins 1053-154• 
I10A 
Dynamic Patterns of High and Low Frequency Atrial 
Activation Potentials Recorded at the Posterior 
Input to the AV Node Using a Split-Tip 
Electrode Catheter and a Long Stabilizing 
Sheath 906-3•166A 
Effect of Right Atrial Isthmus Ablation on the 
Occurrence of Atrial Fibrillation: Observations 
in Four Patient Groups Having Type l Atrial 
Flutter With or Without Associated Atrial 
Fibrillation 1084-152- II7A 
Electrical Isolation of the Left Atrium Using Right 
Atrial Radiofrequency Catheter Ablation: 
Description of a New q'echnique 1203 147• 
149A 
Electrophysiologic Mechanism of Focal Atrial 
Fibrillation Originating From Pulmonary Veins 
1053-155o I l IA  
Evolution of Right Pulmonary Vein Lumen 
Narrowing Alter Right Atrial Linear 
Radiofrequeocy Ablation 838-6•137A 
Identification of a Gap in Linear Radiofrequency 
Lesions in Humans Using a Noncontact 
Mapping Catheter I I 14-150 •124A 
Identification of Left Atrial Tract (Marshall) 
Potential From Left PuMmonary Vein 1053-152• 
110A 
Influence of Atrial Flutter Ablation on Interatrial 
Septum and Lett Atrial Depolarization 890-6- 
165A 
Influence of Right or Left Atrial Linear Lesions on 
Heart Rate Response in Canine Pacing Model of 
Atrial Fibrillation 1052-146°108A 
Initial Experience With the Noncontact Mapping 
Guided Radioffequency Ablation of Atrial 
Flutter 887 6•164A 
lntracardiac Echocardiographic Quantification of 
Changes in Wall Thickness and Ventricular 
Function Associated With Radiofrequency 
Ablation in Chronic Myocardial Infarction 
1172-150,, 14OA 
lntracardiac Echocardiography and Temperature 
Decay fi)r the Guidance of Radiofi'equency 
Catheter Ablation 887-3• 163A 
lntracardiac, Phased-Array Ultrasound Imaging of 
Cardiac Structures and Devices: First 
Application of High Resolution Vector hnaging 
Within the Heart 887- I • 163A 
ls the Right Atrium Essential to Initiate and Sustain 
Idiopathic Atrial Fibrillation? 820-2•127A 
Linear Lesions/'or Control of Unmappable 
Ventricular Tachycardia in Ischemic and 
Nonischemic Cardiomyopathy 816~o122A 
Localization of Accessory Pathways Based on 
Change in Ventriculoatrial Interval During 
Entrainment of Orthodromie Reentrant 
Tachycardia 906- I - 166A 
Microcatheter Ablation Technique in Paroxysmal 
Atrial Fibrillation: Results of Clinical 
Follow-Up in a Pilot Study 1203-150QI50A 
Microwave Radiometric Thermometry as a New 
Method of Measuring Temperature atDepth 
1172-147° 139A 
Noninducibility of Atrial Fibrillation After Complete 
Right Atrial Compartmentalization Does Not 
Predict Symptomatic Improvement 1203-148o 
150A 
Nonsurgical Septal Reduction Therapy for 
Hypertrophic Obstructive Cardiomyopathy: 
One-Year Follow-Up 1142-103°502A 
Novel Model of Arterial Calcification by Direct 
Intramural Hydroxyapatite Injection 1130-39• 
64A 
Optical Coherence Tomography of Cardiac 
Radiofrequency Catheter Ablation 887-2" 163A 
Predictive Accuracy of RR Interval Distribution 
Pattern for the Assessment of Dual AVN 
Physiology in Patients With Chronic Atrial 
Fibrillation 1231-147 • 156A 
Primary Ablation of Atrial Fibrillation: Impact nf 
Completeness ofRight Atrial Ablation Lines on 
Symptomatic Outcome 838 1 * 136A 
Progressive Isthmus Delay During Atrial Flutter 
Ablation: The Critical Importance of 
Isthmus-Spanning Electrodes for Distinguishing 
Conduction Delay From Block 1084-149 • 
II6A 
Pulmonary Vein Electrophysiology in Patients With 
Left Side Focal Atrial Fibrillation 1053-157• 
I l iA  
Quantitative Effects of Functional Bundle Branch 
Block in Patients With A-V Reentry 1231-151 • 
157A 
Radiofrequency Catheter Ablation of Common and 
Reverse Common Atrial Flutter: A New 
Algorithm to Determine Complete Isthmus 
Conduction Block 890-4•165A 
Right Atrial Mural Swelling and Its Effect on 
Adjacent Great Vessels From Linear 
Radiofi'equency Ablation for Atrial Fibrillation 
838-5 • 137A 
Right Versus Left Atrial Modification: Which 
Atrium Should Be Targeted First for Control of 
Fibrillation? 1203-146•149A 
Risk of Development ol Delayed AV Block After 
Slow Pathway Modification in Patients With 
Atrioventrieular Nodal Reentrant Tachycardia 
and Preexisting Prolonged AH Interval 
1231-146o 156A 
Selective Pulmonary Vein Angiography Improves 
Accuracy of Catheterization a d Mapping in 
Patients With Paroxysmal Focal Atrial 
Fibrillation 1053-153• IIOA 
Should Complete Reversal of the Depolarization 
Sequence in the Right Lateral Atrium During 
Coronary Sinus Pacing Be an Endpoint of 
Catheter Ablation in Common Atrial Flutter':' 
890-3 °165A 
Surgery for Atrial Fibrillation Using lntraoperative 
Radiofi'equeney Catheter Ablation: Results at 
One Year in Mitral Patients 1203-151 •150A 
The Clinical Usefulness of Multielectrode Basket 
Catheter in Mapping and Ablation of Type 1 
Atrial Flutter 1114-149,,123A 
The Comparative Effect of Catheter Ablation. 
Atennlol. and Placebo in Treating Patients With 
Symptomatic Premature Ventricular Contraction 
1172 148•139A 
The Value of Epicardial Mapping of Veutricular 
Tachycardia From the Coronary Venous System: 
A Prospective Multicenter Study 816-1 • 121A 
Thermometry Predicts Electrode Orientation During 
Ablation of Ventricular Myocardium With a 
New Dual Thermocouple 8-ram Tip Catheter 
816-2 • 122A 
Three-Dimensional Nonfluoroscopic 
Electroanatomical Mapping of the Right Atrium 
During Coronary Sinus Pacing: Comparison of 
Patients With and Without Atrial Flutter 
I 114-148 • 123A 
Usefulness of Unipolar Electrograms to Confirm 
Isthmus Block After Radiofrequency Ablation 
of Typical Atrial Flutter 1084-151 • 117A 
Accessory pathways 
An Epidemiology Study of Patients With 
Wolff-Parkinson-White Pattern 1231-150- 
157A 
Accessory pathways, ablation 
Anatomic Observations Following Transcatheter 
Radiofrequency Ablation of Accessory 
Pathways in Young Patients 121fl-158•533A 
Quantitative Effects of Functional Bundle Branch 
Block in Patients With A-V Reentry 1231-151 • 
157A 
KEY: Abstract itle. Session-abstract number • page number 
614A SUBJECT INDEX JACC February 1999 
ACE inhibitor 
Angiotensin Converting Enzyme 1 (ACE) 
Insertion/Deletion Polymorphism in Chilean 
Nonnotensive Population: Effect on Plasma 
ACE Activity. Left Ventricutar Mass in Cardiac 
Fibrogenesis 1136-112•273A 
Angiotensin Converting Enzyme Inhibition 
Improves Endothelial Dysfunction in Chronic 
Cigarette Smokers 1044-1 I 1 •235A 
Angiotensin-Converting Enzyme (ACE) Gene 
Polymorphism Does Not Account fur the 
Variable Level of ACE Inhibition fACE-I) 
Observed in Heart Failure During Chronic ACE 
Inhibition Therapy 881-6•215A 
Angiotensin-Converting Enzyme Inhibitors Rest*re 
Hepatocyte Growth Factor Production in 
Patients With Congestive Heart Failure 856-6o 
20"/A 
Aortic Energetics Are Improved After Enalaprilat 
Administration i Hypertensive Patients 
1223-73 q.306A 
Aspirin and Angiotensin Converting Enzyme 
lnhibitors in 445 Patients With Moderate 
Congestive Heart Failure 881-4,214A 
Bradykinin Is a Potent Dose-Dependent Stimulus for 
Release of Tissue Plasminogen Activator (tPA) 
in the Human Forearm Circulation 9l 1-3o319A 
Cardiac Production of Nitric Oxide Increases Due to 
Chronic Treatment With an 
Angiotensin-Converting Enzyme Inhibitor. 
Cilazapril. in Patients With Essential 
Hypertension 1165-120o285A 
Cardiac. Renal. and Endocrine Effects of 
Three-Month Treatment ofChronic Heart 
Failure With the Vasopeptidase Inhibitor. 
Omapatrilat 1110-17• 185A 
Comparative Effects of Losartan and Captopril on 
Myocardial Infarct Size in Arrhythmias in a Rat 
Model of lschemia nd Reperfusion 1155-140• 
366A 
Contribution of Bradykinin to the Vasodilator 
Effects of Enalapril and Losartan in Patients 
With Heart Failure 1044-112°235A 
Critical Event Pathways for Progression of Heart 
Failure and Mortality: Insights From the ATLAS 
Study 1228-8 •212A 
Does Tissue Affinity Affect the Vascular Protection 
Induced by Angiotensin Converting Enzyme 
lnhibitors? 1072-22. 240A 
Early Versus Later Use of ACE lnhibitors in Acute 
Myocardial Infarction: A Meta-Analysis 
1213-195 •390A 
Effect of Ramipril Treatment on the Risk of Fatal 
Reinfarcfion in Patients With Acute Myocardial 
Infarction Complicated by Heart Failure 858-6• 
380A 
Effects of Angiotensin II Blockade on 
Cardiomyocyte Apoptosis During Remodeling 
of Reperfused Myocardial Infarction in Dogs 
1153-138o364A 
Endothelium-Dependent Response in 
Hypercholesterolemic Coronary Artery Disease 
Patients Under the Effects of Simvastatin and 
Enalapril, Either Separately or Combined 
1135-68,271A 
Evidence for a Potential Adverse Interaction 
Between Aspirin and Angiotensin Converting 
Enzyme lnfiibitors After Percutaneous Coronary 
Angioplasty: The EPILOG Trial 896-5 o397A 
High Dose ACE Inhibitor Strategy ls More Effective 
Than Low Dose in Diabetic Patients With 
Congestive Heart Failure 825-3• 188A 
Importance of ECG -ST Elevation in Patients With 
Acute Myocardial Infarction Treated With 
ACE-lnhibitors 1095-200. 347A 
Long-Term Effects of the ACE Inhibitor, Ramipril, 
on Atherosclerosis inPatients With Coroua~' 
Heart Disease or Other Occlusive Arte[ial 
Disease: Final Results From the PART-2 Trial 
899-4,b 316A 
Long-Tema Ramipril Treatment Prevents Nitrate 
Tolerance by an Antioxidant Mechanism 
1133-78 • 269A 
Plasma Aldosterone Levels Do Not Predict Degree 
of Angiotensin-Converting-Enzyme Inhibition 
in Heart Failure Patients 881-5o214A 
Prognostic Role of the Early Prescription of 
ACE-lnhibitors and Beta-Blockers in Early 
Hospital Survivor; of Acute Myocardial 
Infarction: One-Year Results From the 
Nationwide French USIK Study 1033-198° 
332A 
Quinapril Restores Endothelial Dysfunction in 
Patients With Essential Hyperlension Through 
Independent Meclmnisms on Plasma Bradykinin 
Increases and Blood Pressure Reductions 836-6 
• 276A 
The Detrimental Effect of Combined Aspirin and 
Angiotensin Converting Enzyme Inhibitor 
Therapy on Readmission Rates in Heart Failure 
881-3°214A 
Treatment With ACE-Inhibitors and Prognosis After 
Acute Myocardial Infarction in Diabetic Patients 
1033-195.331A 
Vascular Reactivity to Angiotensin It in Heart 




Angiotensth Converting Enzyme Inhibition 
Improves Endothelial Dysfunction in Chronic 
Cigarette Smokers 1044-11 ,235A 
Beneficial Effects of Troglitazone on Endothelial 
DysfnnctionofCoronary A tery 1220-27• 
301A 
Can Magnesium Sulf~ae Suppress 
Acetylcholine-lnduced Coronary Spasm iu 
Paficnts Witfi Vasospastic Angina? 1042-72• 
233A 
Coronary Artery Constriction: A Mechanism for 
lschemic Nuclear Perfusion Defects 897-5• 
483A 
Coronary Endothelial Dysfunction Predicts 
Progression of All*graft Vasculopathy After 
Heart Transplantation 1111-7°187A 
Coronary Endothelial Function and Angiotensin 
Converting Enzyme Polymorphism: The 
Intervention Cardiology Risk Stratification 
Study (1CARIS) 883-3,312A 
In Vivo Human Coronary Vasomotor Response to 
the Selective B I Kinin Receptor Agonist 
Des-Arg9-Bradykinin 1013-69o 225A 
Muscarinic and Bradykinin Receptor Function in the 
Human Coronary Circulation: What Predicts 
Physiologic Coronary Vasomotion? 1162-20o 
279A 
Serum Cholesterol Level and Vasomotor Responses 
of Coronary Stenoses to Acetylcholine in 
Patients With Stable Angina 1 lql-25•289A 
The Genetic Control of Coronary Vasomotor Tone: 
Role of Angiotensin Converting Enzyme Gene 
Polymoq~hism 883-4*312A 
Vasoconstriction in Primary Pulmonary 
Hypertension by Potassium Channel Blockade 
899-5 °316A 
Acquired immunodeficiency syndrome 
Lipid and Lipoproteiu Abnormalities With lndinavir 
in Human hnmunodeficiency Virus lnlection 
1194-115 •293A 
Adenosine 
Attenuation Corrected Thallium Scinligraphy 
Accarately Predicts the lnvasively Measured 
Fractional [::low Reserve 802-2o417A 
Beneficial Effects of Adenosine Adjtmct o Primary 
Angioplasty in Acute Myocardial Infarction 
1184-171 •376A 
Cardioprotective Effects of Adenosine Transport 
Inhibition During Reversible Ischemia in 
Patients With Coronary Artery Disease 1099-94 
• 53A 
Effect of Aging on Nitrous Oxide-Mediated 
Amiadrenergic Actions of Adenosine in the Rat 
Heart In Vivo 913-3ol67A 
Efficacy of lntracoronary Adenosine 5'-Triphosphate 
(ATP) for Coronary and Fractional Flow 
Reserve (CFR. FFR) 864-3•89A 
Electrophysiologic and Antiarrhythmic Effects of 
KB 130 015. A New Thyroid Hormone Receptor 
Blocker. in the Mammalian Heart 1143-146• 
130A 
Fate of Negative Adenosine SPECT Perfusion 
Images 1239-124•479A 
HMG-CoA Reductase Pravastatin Restored the 
lntarct Size-Limiting Effect of [schemic 
Preconditioning Blunted by 
Hypercholesterolemia 1211-166.386A 
Improved Washout Profiles With an 
Aden*sine/Exercise Protocol in Thallium-201 
Myocardial Peffusion lmaging 1029-36°410A 
Influence of Preoperative Internal Mammary Artery 
Flow Reserve and Postoperative Flow at Rest on 
Functional Graft-Assessment After Minimal 
Invasive Bypass Surgery 1025-62o403A 
Intracoronary Administration of ATP Combined 
With Direct PTCA Reduces the Size of 
Myocardial Infarction?: Cooperative Osaka 
Adenosine Trial for Acute Myocardial Infarction 
(COAT) 1184-169•376A 
IV Versus IC Adenosine for Fractional Flow Reserve 
(FFR): The "Early FORECAST" Study 
1219-47 °99A 
Lower Re-PTCA Rates After Balloon Angioplasty 
Alone: ls Optional Stent Implantation a 
Practicable Method to Avoid the Placement of 
Stents and Therefore for ln-Stent Restenosis? 
1157-43 • 72A 
Outcome of Patients With Vasodilator-lnduced ST
Depression and Normal SPECT Pecfusion 
Imaging 1151-126•448A 
Physiologic Doses of Intravenous Testosterone 
hnprove Exercise and Aden,sine-Induced 
Myocardial Perfusion Defects in Elderly Men 
With Coronary Artery Disease 1091-108•426A 
Quantification of Myocardial Perfusion During Left 
Ventricular Remodelling: A Noncontrast Agent 
Nuclear Magnetic Reasonance (NMR) Imaging 
Technique 849-6 • 372A 
Sal~zty of lntracoronary l~)ppler Measurement Using 
Intracoronary FloWire: Experience With 892 
Cases 1071-49o 46A 
Specificity of the Stress Electrocardiogrum During 
Adenosine Myocardial Perfusion Imaging in 
Patients Taking Digoxin 1017-190•542A 
The Acute Administration of 17 b-Estradiol 
Decreases the Size of Adenosine-lnduced 
Myocardial Perfusion Defects in 
Postmenopausal Women With Coronary Disease 
1091-I06•425A 
The Transition From Compensated Pressure 
Overload Hypertrophy IsCharacterized by an 
Increase in the Interstitial Norepinephrine to
Adenosine Concentration Ratio 1227-18•210A 
Aging 
Age-Dependency ofTemporal Indices of Normal 
Left Ventricular Systolic and Diastolic Function 
Obtained From Color Kinesis Images 1180-33o 
457A 
Aging, a Cardiow~scular Risk Factor, Markedly 
Increases Expression of Endothelin- I In Vivo 
Independent ofBlood Pressure and 
Endothelin-One Clearance 1013-71 •225A 
Cardiovascular Effects of Aging: Interrelationships 
of Aortic, Left Ventricular, and Left Atrial 
Function I 113-101 o499A 
Comparisons of Long-Term Effects of Quinalapril 
Versus Nifedipine Therapy in Patients With 
Moderate to Severe Chronic Aortic 
Regurgitation 1150-104o445A 
Diastolic Filling Pattern Predicts 10-Year Mortality 
in the Elderly Independent ofLeft Ventricular 
Hypertrophy and Age 1113-103°500A 
Disparate Effects of Improving Exercise Capacity 
and Quality of Life Following Cardiac 
Rehabilitation i Young and Elderly Coronary 
Patients 1171-100,505A 
Do Elderly Patients Who Undergo Coronary 
Revascularization After Myocardial Infarction 
Benefit From Beta Blocker Therapy'? 878-4o 
512A 
Do tile "100-Top Hospitals" Differ in Clinical and 
Financial Performance for the Treatment of 
Acute Myocardial Infarction? 1021-88o491A 
KEY: Abstract itle. Session-abstract number * page number 
JACC February 1999 SUBJECT INDEX 615A 
Does Age Affect the Accuracy of Coronary Calcium 
for Predicting Coronary Events? 1059-83. 
415A 
Does Preinfarction Angina-lnduced Protection 
Against Myocardial Infarction in Elderly 
Patients? 878-5.512A 
Early Outcome in Elderly Patients With Acute 
Myocardial Infarction: The 60-Minute 
Myocardial Infarction Project 832-2•356A 
Effect of Aging on Nitrous Oxide-Mediated 
Antiadrenergic Actions of Adenosine in the Rat 
Heart In Vivo 913-3.167A 
Effects of Aging on the Left Ventricle in 
Hypertension: Influence of Gender 1076-115 • 
246A 
Enhanced Endothelium-Dependent Vasodilation i  
Older Endurance Trained Men I 113-100.499A 
Estrogen Supplementation Causes Increased Aortic 
Valvular Thickening and Aortic Stenosis in a 
Menopausal Rabbit Model 1139-194°553A 
Evaluation of ACC/AHA Guidelines for Exercise 
Electrocardiography in Patients Older Than 65 
Years 1198-192.560A 
Hyperglycemia, but Not Hyperinsulineamia, 
Increases the Risk of Premature Death in 
Patients With Coronary Artery Disease 1220-28 
•301A 
Improvement i  Treatment Quality Indicators for 
Elderly Patients With Acute Myocardial 
Infarction: The Cooperative Cardiovascular 
Project in Maryland and the District of 
Columbia 835-5 • 266A 
In-Hospital Mortality of Elderly Patients Following 
Acute Myocardial Infarction 878-2•512A 
Irbesartan Reduces QT Dispersion in Hypertensives 
872-4 • 299A 
Long-Term Effect of Hypertension on Cardiac and 
Neurobehavioral Function in Elderly Subjects 
1136-115 *273A 
Myocyte Apoptosis Precedes Changes in Cardiac 
Tissue Material Properties in the Senescent 
Fischer Rat I 113-99o499A 
NonQ Wave Myocardial Infarction Is Not 
Independently Associated With Higher 
Long-Term Mortality or Reinfarction in the 
Elderly When Compared With Q Wave 
Myocardial Infarction 878-1 •511A 
Oncogenic Ras Induces Premature Senescence in
Primary Vascular Endothelial Cells: In Vitro 
Model for Cardiovascular Aging 1195-76* 
294A 
Predictors of Incident Congestive Heart Failure in 
the Elderly: Relative Influence of Age. Gender. 
Race. and Biological Characteristics 1081-7• 
180A 
Success and Complication Rates During Diagnostic 
Angiography and Coronary Interventions in
Octogenarians: A Single Center Experience in 
Preselected High-Risk Patients 1021-87 ° 491A 
The Influence of Age and Gender on the 
Histopathology ofPatients With Hyperlrophic 
Cardiomyopathy 1229-86-509A 
Utilization of an Artificial Neural Network for 
Mortality Risk Adjustment in The Cooperative 
Cardiovascular P oject 1501-1-6A 
Alcohol 
Changes in Mesenteric Vascular Reactivity and 
Blood Pressure During Chronic Alcohol 
Ingestion and Withdrawal 1223-69*305A 
Cocaine Use Is Strongly Associated With [+eft 
Ventricular Hypertrophy in Young, Hypertensive 
African-American Men 804-5-239A 
Nonsurgical Septal Reduction Therapy l~r 
Hypertrophic Obstructive Cardiomyopathy: 
One-Year Follow-Up 1142-103.502A 
Purple Grape Juice Improves Flow-Mediated 
Vasodilation i  Patients With Coronary Artery 
Disease 836-4° 276A 
Aldosterone 
1 l b Hydroxysteroid Dehydrogenase D ficiency 
Regulates Endotbelins, Angiotensins, and Nitric 
Oxide: A Novel Mechanism inHypertension? 
1165-117* 284A 
Early Morning Sympathovagal Balance Is Improved 
by Aldosterone Blockade in Chronic Heart 
Failure 1110-13.184A 
Plasma Aldosterone Levels Do Not Predict Degree 
of Angiotensin-Converting-Enzyme Inhibition 
in Heart Failure Patients 881-5o214A 
Alpha-adrenergic receptor agonists 
a la-Adrenergic Receptor and Protein Kinase C 
Stimulation Suppress Delayed 
Afierdepolarizations in Hypertrophic 
Cardiomyopathic Hamsters 913-2.167A 
Aspirin 325mg, Single-dose, Increases 
Venoconstriction to Norepinephrine in Normal 
Subjects 1104-67.254A 
Alpha-adrenergic receptor blockers 
Episodic Activation of Cyclooxygenase 2 in Patients 
with Unstable Angimt 1068-52.39A 
Plasma Concentrations of Interleukin-6 and 
Abdominal Aortic Diameter Among Subjects 
Without Aortic Dilatation 880-2.310A 
Ambulatory blood pressure 
ABPM and Ergometry inthe Assessment of Blood 
Pressure in Normotensive and Hypertensive 
Patients 851-5,288A 
Betaxolol. a New. Long-Acting Beta-Blocker, 
Suppresses Intraoperative Myocardial lscbemia 
During Vascular Surgery in Patients With 
Preoperative lschemia in Coronary Artery' 
Disease 1163-29.281A 
CAASET (Canadian Amlodipine and Atenolol 
Stress Echo Trial) 1066-137.340A 
Is Plasma LDL-Cholesterol Level Correlated With 
Blood Pressure in Normotensive and 
Hypertensive Palients? 1164-73•283A 
Relationship Between Left Ventricular Mass and 
Day or Nighttime Blood Pressure in 649 Patients 
With Treated Essential Hypertension 1014-112 
• 227A 
Ambulatory ECG 
Alterations of Autonomic Nervous Activity in 
Recurrence of Variant Angina 1086-189.121A 
Ambulatory ECG Analysis Following Transcatbeter 
Closure of Atrial Septal Defects Using the 
Amplatzer Septa[ Occluder Device 1030-160- 
520A 
Circle Maps of Respiratory Sinus Arrhythmia 
Patterns: A New Method to Differentiate 
Cardiac Denervation From Vagal Modulations 
After AV Node Modification 1146-185.135A 
Development ofSinus Nodal Disease in Patients 
With AV Block: Implications for Single Lead 
VDD Pacing 861-4* 153A 
Differences in Heart Rate Variability Between 
African-Americans and Whites With Coronary 
Artery Disease and lschemia 1086-188.121A 
Effects of Beta-Adrenergic Blockade on 24-Hour 
QT Interval Variability in Newborn Infants With 
Prolonged Ventricular Repolarization 1024-189 
• 108A 
Methods for the Assessment of Heart Rate 
Turbulence in Holter-ECGs I 117-189°351A 
QT Dispersion Should Be Adjusted for Age: 
Observations From 1,096 Normal Subjects 
830-2-129A 
Repolarization Characteristics and Sudden Death 
After M~ocardial Infarction: A Case Control 
Study 847-6* 146A 
RR Intervals and Heart Rate Variability Rise 
Gradually, Then Decline Rapidly, Before the 
Onset of Sustained Ventricular 
Tachyarrhythmias 1085-155° 118A 
Amiodarone 
Electrophysiologic Effects of Long-Term Treatment 
With SR33589B on Rabbit Atrial Muscle: 
Comparison With Aroiodarone 1143-148 * 
131A 
Aneurysms 
A New Technique of Percutaneous Closure of 
Pseudo-Aneurysms of Femoral Artery 1008-97 
• 16A 
Abdominal Aortic Aneurysm Repair by 
Percutaneous Implantation of Uncovered Wire 
Mesh Stents and Coil Embolization of the 
Aneurysm 78-6• 22A 
Diastolic Leaflet Tenting: A New Echocardiographic 
Sign That Identifies the Mechanism of 
Functional Aortic Regurgitation 812-1 +426A 
Functional Aortic Regurgitation i Ascending Aortic 
Aneurysms: A Disease of Sinotubular, Not 
Annular, Dilatation 1047-190+545A 
Isolated Coronary Artery Ectasia Does Not Have a 
Benign Long-Term Prognosis 1 ] 28-140-363A 
Percutaneous Endoluminal Treatment of lilac 
Aneurysms: A Single Center Experience With a 
Series of 25 Aneurysms 1069-135.43A 
Percutaneous Exclusion of Abdominal Aneurysm 
With Wallstent PTFE Endoluminal Grafts: 
Immediate and Early Results 1069-134•43A 
Relationship Between Aortic Dissection and Atrial 
Septal Aneurysm: A Transesophageal 
Echocardiographic Case Control Study 
1074-70 ° 243A 
Risk Factor Analysis for Secondary Valve Failure 
After Aortic Root Reconstr0ction 842-3.554A 
Transesophageal Ecbocardiography Could Evaluate 
the Stage of Takayasu's Arteritis With Aortic 
Aneurysm 1074-71.243A 
Treatment of Pseudoaneurysm of the Femoral Artery 
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Wallgraft Endoprosthesis for Endoluminal 
Treatment of Traumatic and Aneurysmal 
Peripheral Vascular Disease 1130-41-64A 
Wallgrafl Versus Wallstent Endoprosthesis for 
Treatment ofComplex Stenotic Arterial 
Lesions: Three-Month Follow-Up of a 
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Angina pectoris 
Acid-Evoked Currents in Cardiac Sensory Neurons: 
A Possible Mediator of Myocardial lschemic 
Sensation 1093 172.344A 
Angina, Normal Coronary Arteries. Normal and 
Abnormal Coronary Sinus Lactates: 20-Year 
Follow-Up 118fi-139.378A 
Beneficial Effects of Enhanced External 
Counterpalsation CEECPI Are Independent of
the Severity of Angina Pectoris: Results of the 
MUST-EECP Trial I097-140.349A 
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Grafted Saphenous Vein: Evidence From 
I ntravascular Ultrasound 1159+46-75A 
Calcium Antagonists Versus Beta Blockers for 
Stable Angina: A Meta~Analysis 892-4°313A 
Chest Pain in Women: New Considerations in
History and Physical Examination 1005-138,, 
327A 
Community Presentation and Management of New 
Onset Chest Pain in Women Compared to Men 
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Clinic (RACPC) 1005-137°326A 
Comparison of Coronary Remodeling in the Culprit 
Lesion in the Acute Coronary Syndrome and 
Stable Angina Pectoris 1010-45° 18A 
Continuous 12-Lead ST Segment Monitoring Is 
Superior to Early Echocardiography for 
Identifying Low-Risk Chest Pain Patients With a 
Worse In-Hospital Outcome 1212-132-389A 
Does Culprit Lesion Morphology Improve 
Prognostic Assessment in Acute Coronary 
Syndromes? 903- I * 399A 
Does the Diagnosis of Unstable Angina Require the 
Presence of Ischemic ECG Changes'? 876-2° 
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Double Blind, Placebo-Controlled Trial of 
Recombinant Human Vascular Endothelial 
Growth Factor: The VIVA Trial 874-4.384A 
Effect of Coronary Risk Factors on Arterial 
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Expansion of Unusual CD4+T Lymphocytes as a 
Prognostic Indicator of Short- and Long-Term 
Outcome in Ischemic Heart Disease 1127-162• 
362A 
Incremental Value of Electron Beam Computed 
Tomographic Scanning in the Evaluation of 
Patients With Chest Pain 1059-84*415A 
Intravenous Administration of Vitamin C Acutely 
Improves Endothelium-Dependent Dilation in 
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the Management of New Angina in the 
Community 1215-137.392A 
The Medicine. Angioplasty, and Surgery Study 
(MASS), a Prospective Randomized Trial of 
Medical Therapy, Balloon Angioplasty or 
Bypass Surgery for Single Proximal Left 
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IGF-1 Deficient Mice 1093-170o344A 
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Basic Fibroblast Growth Factor (bFGF) 
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Artery Bypass Surgery 874-2-383A 
Six-Month Follow-Up or" Percutaneous 
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Study of Angiogenesis and Cardiac Denervation 
Following Radiofrequency Transmyocardial 
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Transmyocardial Implants: A Novel Approach to 
Transmyocardial Revascularization 813-6" 
343A 
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Angiogenic Response 813-3,,342A 
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Intervention: Less than 9% Subsequent Target 
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1188-51 •83A 
Accuracy of Gated-SPECT Imaging in Diagnosing 
Individual Coronary Artery Stenosis: A
Comparison Between Ungated, Gated 
End-Systolic, and Gated End-Diastolic Images 
1029-34.409A 
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Catheterization in Patients With NonST 
Segment Elevation Acute Coronary Syndromes 
May Be Associated With Improved Outcomes 
1214-162o391A 
Analysis of Angiographic Plaque Burden in Stable 
and Unstable Coronary Syndromes 1002-197• 
323A 
Angiographic No-Reflow Predicts Long-Term 
Cardiac Complications and Mortality in Patients 
With Acute Myocardial Infarction 1004-163-, 
326A 
Angiographic Prevalence and Clinical Predictors of 
Left Subclavian Stenosis in Patients Undergoing 
Diagnostic Cardiac Catheterization 1193-72m 
292A 
Arterial Access Site Closure With a Novel Sealing 
Device: Duett 1216-38o92A 
C-Reactive Protein Levels in Acute Coronary 
Syndromes Are Unrelated to the Extension of 
Coronary Atherosclerosis 1183-133o374A 
Cardiac Catheterization in Infants Weighing <2.5kg: 
Analysis of 103 Consecutive Cases 1030-161 •
520A 
Community Presentation a d Management ofNew 
Onset Chest Pain in Women Compared to Men 
Assessed Through a Rapid Access Chest Pain 
Clinic (RACPC) 1005-137e326A 
Comparison of lntravascular Ultrasound and 
Quantitative Angiographic Measurement of 
Lesion Length in 1,938Lesions t159-53..77A 
Comparison of the Protection Against Restenosis 
Afforded by Stenting or Abciximab 1006-39. 
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Coronary Anatomy of Diabetic Patients Being 
Assessed for Renal Transplantation 1097-138" 
349A 
Coronary Lesion Angiographic Morphology and 
Coronary Vasospasm: A Complex Link 
1207-82 • 465A 
Delayed Systolic Blood Pressure Recovery After 
Graded Exercise: No Advantage Over Exercise 
Blood Pressure Increase for Predicting 
Angiographic Coronary Disease 1017-193- 
543A 
Does Culprit Lesion Morphology Improve 
Prognostic Assessment in Acute Coronary 
Syndromes? 903-1 •399A 
Early Ambulation After PTCA in Anticoagulated 
Patients With the ProStar-Perclose P rcutaneous 
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Randomized Trial 806-I •35A 
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Outcomes 853-5 •459A 
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Access for Coronary Procedures 1187-60,83A 
Effects of Arterial Remodeling on the Degree of 
Discrepancy Between Quantitative Coronary 
Angiography and Ultrasound Imaging in 
Determining True Vessel Dimensions 1159-89• 
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Ethnic Differences in Coronary Calcium Prevalence 
in a Symptomatic Population 1059-66"414A 
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Angiography Among Hospitals 808-5•249A 
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Lesions in Coronary Interventions 1188-90- 
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Left Ventricular Dysfunction Is Related to Macro- 
and Microcirculatory Dysfunction After 
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Lower Re-PTCA Rates After Balloon Angioplasty 
Alone: Is Optional Stent Implantation a 
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Magnitude and Location of New Angiographically 
Apparent Coronary Collaterals Following 
Intravenous Vascular Endothelial Growth Factor 
Administration 874-5• 384A 
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Myocardial Infarction by ST Resolution: Results 
of the HIT-4 Angiographic Substudy 1003-129 
• 324A 
Noninvasive Cardiac Assessment of Diabetic 
Nephropathy Renal Transplant Candidates 
1062-166 • 335A 
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Supply-Demand Mismatch in a US Public 
Hospital: Analysis of a Waiting List Registry 
I 166-77 •286A 
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Imaging of the Coronary Arteries 1121-63. 
434A 
Why Do the Coronary Vessels in Diabetics Appear 
to Be Angiographically Small? 1159-55•78A 
Angioplasty 
2.5-Year Follow-Up of the CLOUT Study: 
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the UPS1ZE Pilot Trial 810-1.46A 
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1184-171 o376A 
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Clinical Outcomes Following RESCUE 
Administration of Abciximab in Patients 
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Long-Term Results 1068-56e40A 
Comparison of Coronary Stenting in Hem.dialysis 
and Nonhemodialysis Patients 873-5.92A 
Comparison of Deferral Versus Performance of
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Distribution of Neointimal Proliferation i  Human 
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Acute Myocardial Infarction 1213 197o390A 
Value of Exercise Treadmill Testing for the 
Assessment of Functional Capacity Following 
Percutaneous Revascularization 840-6. 278A 
Ventricular Function After Mechanical Reperfusion 
Therapy: Observations From the Stent PAMI 
Trial 898-4o398A 
What Is the Clinical Significance of an Elevated 
CPK-MB Band Fraction After Percutaueous 
Intervention If the Total CPK ls Normal? 846-6 
• 80A 
Angioscopy 
Angioscopic Evaluation of Coronary Endothelial 
Lesions by Staining With Evans Blue in Patients 
With Acute Myocardial Infarction I 131-134° 
67A 
Characteristics of the Culprit Coronary Lesions and 
Estimation of the lnterventional Treatments in
Patients With Acute Myocardial Infarction by 
Coronary Angioscopy 1100+48o54A 
Damages of Coronary Endothelial Cells Are Easily 
Caused Even by Floppy Guidewire: In Vivo 
Staining Angioseopic Study 1131-96 * 67A 
Detection of Plaques Vulnerable to Disruption With 
Quantitative Colorimetry During Angioscopy of 
Human Plaque 1002-196-323A 
Differing Coronary Arterial Responses to Balloon 
Angioplasty Between Stable and Unstable 
Lesions: A Combined Study of lntravascular 
Ultrasound and Angioscopy 1216-41 °93A 
Angiotensin I1 
A Randomized Trial Evaluating Tolerability of 
Candesartan for Patients With Congestive Heart 
Failure and Intolerance to Angiotensin 
Converting Enzyme Inhibitors 825-5 *189A 
Absence of Down-Regulation f Angiotensin I1Type 
I Receptor in Isolated Diastolic Heart Failure 
Due to Hypertension: Key to Benefits of 
Receptor Antagonist 1165-116°284A 
Activation of the Jak/STAT Signaling Pathway by 
Blocking G Protein-Coupled Receptor Kinases 
in Cardiomyocytes 1195-110*295A 
Altered Activation of c-Jun N-Terminal Kinase in 
the Hypertrophied and Failing Rat Myocardium 
811-5° 183A 
Angiotensin 11 Receptor Blockade Antagonizes the 
Proliferative Effects of Oxidized LDL on 
KEY." Abstract title, Session-abstract number •page number 
JACC February 1999 SUBJECT INDEX 621A 
Coronary Smooth Muscle Cells Via Inhibition of 
Angiogenic Chemokines 1153-165•364A 
Angiotensin 11 Receptor Blockade Does Not 
Suppress Compensatory Hypertrophy but 
Prevents Excess Hypertrophy Contributing to 
Transition to Heart Failure in Hypertensive Rats 
1165-118 •284A 
Angiotensin 1I Receptor Blockade in Normal 
Subjects: A Direct Comparison of Three AT 1 
Receptor Antagonists 872-I o298A 
Angiotensin 1I Subtype 1 Receptors Contribute to 
Ischemic Contracture and Regulate 
Chemomechanical Energy Transduction i  
Isolated Transgenic Rat Hearts 1153-137 • 364A 
Angiotensin-Converting Enzyme Inhibitors Restore 
Hepatocyte Growth Factor Production in 
Patients With Congestive Heart Failure 856-6* 
207A 
Cardiotrophin- 1 Induces Cardiomyocyte 
Hypertrophy Through Stimulation of the 
Renin-Angiotensin System 893-4.315A 
Clinical Impact of Angiotensin-Converting Enzyme 
Genotype on Intergrated Backscatter of Carotid 
Artery 1237-81 •477A 
Comparative Effects of Losartan and Captopril on 
Myocardial Infarct Size in Arrhythmias in a Rat 
Model of Ischemia nd Reperfusion I 155-140- 
366A 
Contribution of Bradykinin to the Vasodilator 
Effects of Enalapril and Losartan in Patients 
With Heart Failure 1044-112°235A 
Effect of Chronic Activation of Angiotensin I1, 
Endothelin, and Catecholamines in the Absence 
of Cardiac Volume or Pressure Overload on Left 
Ventricular Mass In Vivo 1107-116o258A 
Effects of Angiotensin II Blockade on 
Cardiomyocyte Apoptosis During Remodeling 
of Reperfused Myocardial Infarction in Dogs 
1153-138•364A 
Effects of Candesartan Cilexetil in Patients With 
Severe Systemic Hypertension 872-6o299A 
Endothelin Is Activated Prior to the 
Renin-Angiotensin-AIdosterone System During 
the Evolution of Congestive Heart Failure 
1080-14.177A 
Exposure to Hypoxia and Angiotensin-II Increases 
the Expression of Mitogen-Activated Protein 
Kinase in Cardiomyocytes Isolated From 
Explanted Failed Human Hearts 811-3,,182A 
Functional Evaluation of Novel Amino-Acid 
Altering Angiotensin lI Type I Receptor Gene 
Variants in Essential Hypertension 1106-110. 
257A 
Genetic ACE Underexpression Affects Pattern of 
Hypertrophy but Does Not Prevent Cardiac 
Hypertrophy Due to Aorto-Caval Fistula 
1019-4• 171A 
Genetic Polymorphism of Renin-Angiotensin 
System and Left Ventricular Hypertrophy in 
Endurance Athletes 1195-74. 293A 
Greater Extent and Duration of Antagonism of 
lrbesartan on Angiotensin I1 Pressure Response 
and Radioligand Binding in Man Compared to 
Losartan and Valsartan 1165-119o284A 
Implication of Angiotensin II in the Expression of 
Na+-HCO-3 Symporter and Na+-H+ Exchanger 
in Rat Myocardium After Myocardial Infarction 
1153-166. 365A 
[rbesartan Reduces QT Dispersion in Hypertensives 
872-4 • 299A 
Lack of Increase in Angiotensin ll Type 1 Receptor 
Protein After Acute Ischemia-Reperfusion n 
lsolated Working Rat Hearts 1011-22°221A 
Nonangiotensin Converting Enzyme Dependent 
Angiotensin II Generation in Resistance Arteries 
From Patients With Chronic Heart Failure 
881-2•214A 
Responsiveness to Angiotensin 11 (A 1I) Predicts 
Left Ventricular (LV) Mass in Hypertensive 
Subjects 872-2 •298A 
Vascular Reactivity to Angiotensin I] in Heart 
Failure Patients on Chronic 
Angiotensin-Converting-Enzyme Inhibition 
881 -1 * 213A 
Vascular Responsiveness to Angiotensin I1 Is 
Correlated With LDL-Cholesterol in 
Normocholesterolemic Humans 912-4 • 320A 
Antiarrhythmia agents 
Analysis of Repolarization Changes in a 
Double-Blind Crossover Study on Dofetilide 
Versus Sotalol for Ventricular Tachycardia 
1085-179o I19A 
Are There Differential Effects of the New Iks 
Blocking Agent Chromanol 293b in Normal and 
Infarcted Canine Hearts? 1204-186-152A 
Dofetilide a New Class III Antiarrhythmic Drug 
Prevents Atrial Fibrillation in Patients With 
Congestive Heart Failure in Normal Sinus 
Rhythm: Results of the DIAMOND-CHF Study 
1144-152• 132A 
Dofetilide Decreases Functional Reentry During 
Ventric ular Fibrillation 1204-t87 •152A 
Dofetilide Improves Heart Failure in Patients With 
Atrial Fibrillation and Left Ventricular 
Dysfunction: A DIAMOND Subanalysis 
I 110-19.186A 
Effect of Ibutilide on Atrial Defibrillation Energy 
Requirement 1144-154.132A 
Efficacy and Safety of Dofetilide in the Prevention 
of Symptomatic Attacks of Paroxysmal 
Supraventricular Tachycardia 1231-148• 156A 
Efficacy and Safety of Oral d,l-Sotalol in Patients 
With Implanted Defibrillators: Results of a 
Prospective, Double Blind, Randomized, 
Placebo-Controlled Malticenter Trial 801-3,, 
115A 
Efficacy of the Potassium Channel Antagonist 
Tedisamil in a Model of Sustained Atrial 
Fibrillation 1052-151. IlOA 
Electrophysiologic Effects of Long-Term Treatment 
With SR33589B on Rabbit Atrial Muscle: 
Comparison With Amiodarone 1143-148. 
131A 
Low Dose Sotalol s Superior to Metoprolol in the 
Prevention of Supraventricular A rhythmias 
After Cardiac Surgery 1144-156 • 132A 
Mechanism of Termination of Atrial Fibrillation by 
Flecainide in a Canine Model of Atrial 
Fibrillation 1052-150.109A 
Outpatient Initiation of Antiarrhythmic Therapy 
With Flecainide, Propafenone, and Sotalol in 
Patients With Atrial Fibrillation 1134-28 •270A 
Patients With Longer QT (QTc) Interval Are More 
Likely to Remain in Sinus Rhythm After 
One-Year Treatment on Doletilide: The 
EMERALD (European and Australian 
Multicenter Evaluative Research on Atrial 
Fibrillation Do fetilide) Study 1144-153.132A 
Pharmacoeconomic Analy~is of lbutilide Versus 
Electrical Cardioversion for Patients With Atrial 
Fibrillation or Flutter 1022-153.104A 
Predictors of Atrial Fibrillation in the 
Tachycardia/Bradycardia Syndrome: Results 
From the Pacing and Atrial Tachycardia Trial 
820- I • 127A 
Time Course of lbutilide Effect on Atrial Rate in 
Patients With Atrial Fibrillation 1144-155° 
132A 
Antibodies 
Abciximab Reduces Vascular Lesion Formation in 
Nonhuman Primates 845-1.69A 
Anticardiolipin Antibodies Are Independent 
Predictors of Survival in Patients With Chronic 
Peripheral Arterial Disease 900-4•317A 
Chlamydia Pneumoniae Seropositivity Predicts the 
Risk of Restenosis After Percutaneous 
Transluminal Coronary Angioplasty 846-3• 
80A 
Construction and Functional Evaluation of a Single 
Chain Antibody Fusion Protein With 
Fibrin-Targeting and Thrombin Inhibition After 
Activation by Factor Xa 407-5 °2A 
In Vivo Aortic Uptake of MDA2, and 
Oxidation-Specific M~moclonal Antibody, 
Highly Correlates With Atherosclerosis Burden 
1011-23•221A 
No Evidence for the Direct Involvement of 
Chlamydia Pneumoniae in the Path•genesis of
Acute Coronary Syndromes 876-4.394A 
Smooth Muscle Cell Phenotype Modulation in 
Balloon Injured Rat Carotid Arteries as 
Monitored by Smoothelin Expression 1012-78. 
224A 
The F (ab') 2 Fragment of 7E3, the Parent Antibody 
of Abciximab, Blocks GPIIb/Illa-Mediated 
Thrombosis in Rats 1133-77 *269A 
Anticoagulants-see Thrombin and Platelet 
inhibitors 
Are We Under-Anticoagulating Our Patients With 
Unstable Angina? 889-6-396A 
Clopidogret for the Prevention of Stent Thrombosis 
82-2.34A 
Clopidogrel Versus Ticlopidine for Coronary Stents 
82-1 ° 34A 
Comparison of the Protection Against Restenosis 
Afforded by Stenting or Abciximab 1006-39o 
l lA 
Coronary Perforation and Pericardial Tamponade 
Risk in the Abciximab Era 1157-41.72A 
Cost Analysis Model of Low Molecular Weight 
Heparin Versus Unfractionated Heparin for 
Antithrombotic Therapy in Patients Undergoing 
TEE-Guided Cardioversion From Atrial 
Fibrillation 1196-116°295A 
Early Clinical Evaluation of rNAPc2, a Novel 
Inhibitor of Blood Quantitation Factor 
Vlla,q'issue Factor (fVIIa/TF) 1104-74.255A 
Effects of Aspirin or Picotamide, an 
Antithromboxane Agent, in Combination With 
Low-Intensity Oral Anticoagulation i Patients 
With Acute Myocardial Infarction: A Controlled 
Randomized Pilot Trial 869-6° 383A 
Enhanced Speed and Stability of Reperfusion With 
High Dose Himlog Versus Heparin as Adjuncts 
to Thrombolytic Therapy for Acute Myocardial 
Infarction: Continuous ST Segment Recovery in 
The HERO-I Study I 184-165 •375A 
Enoxaparin for Unstable Angina/Non-Q Wave 
Myocardial Infarction: Meta-Analysis of TIMI 
11 B and ESSENCE 819-1 °351A 
Enoxaparin Is Superior to Unfractionated Heparin 
Regardless of aPTT Range Achieved: A TIMI 
1 IB Substudy 819-3•352A 
Enoxaparin Versus Unfractionated Heparin as 
Adjunctive Therapy to rt-PA in Acute 
Myocardial Infarction: Results of the Heparins 
and Reperfusion Trial II (HART 11) Pilot Study 
869-5 • 383A 
PFA-100 Plat*let Function Assay Detects Platelet 
Inhibition With Tirofiban 1032-132.330A 
Pocket Hematomas Following Device Implantation 
1174-180.142A 
Predictors of Oral Anticoagulant Utilization in 
Congestive Heart Failure: A Survey on 6428 
Outpatients of The Italian Network-Congestive 
Heart Failure (IN-CHF) 1199-12-201A 
Randomized Trial of Oral Anticoagulation Therapy 
in Patients With Acute lschemic Syndromes 
Without ST Elevation: Importance of Good 
Compliance 896-2 -396A 
Role of Coumadin in Patients After Mitral Valve 
Repair: Analysis of 202 Patients Followed Up to 
12 "tears After Surgery 1046-175.544A 
Safety of Plat*let Glyeoprotein llb/IIla Inhibitor and 
Stems in Multivessel Coronary Intervention 
1006-43• 12A 
Superiority of Enoxaparin Over Unfractionated 
Heparin in Unstable Angina Occurs Early in 
Treatment: Results From TIMI 1 IB 819-6o 
352A 
Thrombin Generation After Heparin Discontinuation 
Is Related to Low Antithrombin Activity 889-5 
•396A 
Treatment Benefit With Enoxaparin in Unstable 
Angina Is Greatest in Patients at Highest Risk: 
A Multivariate Analysis From TIMI 11B 819-4 
°352A 
Unique Inhibiting Effects of 7E3 on Shear-Induced 
Von Willebrand Factor-Dependent Plat*let 
Activation and P-Setectin Expression 1133-76o 
268A 
Usefulness of Transesophageal Echocardiography 
Before Electrical Cardioversion of Atrial 
Fibrillation 1177-80*453A 
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Antihypertensive therapy 
Angiotensin II Receptor Blockade in Normal 
Subjects: A Direct Comparison of Three AT I 
Receptor Antagonists 872-1 o298A 
Effect of Sildenafil on Blood Pressure in Men With 
Erectile Dysfunction Taking Concomitant 
Antihypertensive M dications 804-3 • 238A 
Effect of Verapamil on Exercise Tolerance and 
Doppler-Echographic Left Ventricular Diastolic 
Filling Parameters in Hypertensive Patients 
1076-114•246A 
Effects of Candesartan Cilexetil in Patients With 
Severe Systemic Hypertension 872-6~,299A 
Greater Extent and Duration of Antagonism of 
Irbesartan on Angiotensin II Pressure Response 
and Radioligand Binding in Man Compared to 
Losartan and Valsartan 1165-119•284A 
Regression of Left Ventricular Hypertrophy in 
Hypertensive Patients Treated With lndapamide 
SR 1.5 Versus Enalapril 20: Results of LIVE 
Study 1076-113`,246A 
Serum Arnyloid A Levels in Patients With Mild to 
Moderate Hypertension, Before and After 
Treatment With a Calcium Antagonist 1223-72 
.306A 
Antioxidants 
A New Precedent in Percutaneous Coronary 
Intervention: Less than 9% Subsequent Target 
Vessel Revascularization n a Large Scale, 
Diverse Patient, Randomized Trial of Stenting 
1188-51 °83A 
Allopurinol Improves Endothelial Dysfunction i
Patients With Chronic Heart Failure 895-1 `, 
216A 
Alpha-Tocopherol Levels Are Associated With 
Platelet Release of Nitric Oxide Oxide 831-1 • 
264A 
Antioxidant Therapy With Vitamin E Does Not 
Improve Fibrinolysis in Postmenopaasal Women 
83 I-3 ° 265A 
Function and Gone Expression of Antioxidative 
Enzymes in Human Hearts With End-Stage 
Heart Failure 1048-19* 174A 
High Dose Vitamin E Decreases Arterial Wave 
Reflection and Improves Ventricular/Vascular 
Coupling 1040-20`, 229A 
Intravenous Administration of Vitamin C Acutely 
Improves Endothelium-Dependent Dilation in 
Brachial Arteryin Vasospastic Angina 1013-67 
* 224A 
Lack of Long-Term Beneficial Effects of Ascorbic 
Acid on Endothelial Vasomotor Dysfunction i  
Patients With Insulin-Dependent Diabetes 
Mellitus 1163-30•281A 
Molsidomine Improves Endothelial Dysfunction i
Patients With Coronary Heart Disease 900-3• 
317A 
Purple Grape Juice Improves Flow-Mediated 
Vasodilation i Patients With Coronary Artery 
Disease 836-4 • 276A 
Purple Grape Juice Protects LDL From Oxidation in 
Coronary Artery Disease Patients Taking 
Vitamin E 1164-68•282A 
Randomized Trial of Cholesterol-Lowering Therapy 
and Antioxidant Vitamin Supplementation n 
6,000 People With Diabetes Mellitus 1164-72,, 
283A 
Randomized Trial of Cholesterol-Lowering Therapy 
and Antioxidant Vitamin Supplementation n 
Over 20,000 Higher Risk Patients 824-2`,263A 
The Effects of Hydralazine on the Prevention of 
Nitrate Tolerance in Patients With Chronic Heart 
Failure I 110-16`,185A 
The Effects of Vitamin E on Chronic and Acute 
Endothelial Dysfunction i Smokers 836-2• 
275A 
Vitamin E Counterbalances the Action of the 
Phosphatase Inhibitor Cyclosporine A (CsA) on 
the Na+-K+ Pump 1043-73* 233A 
Aorta 
Ambulatory Follow-Up of Aortic Dissection: 
Comparison Between Computed Tomography 
and Biplane Transesophageal Echocardiography 
1148-62`,443A 
Aortic Energetics Are Improved After Enalaprilat 
Administration i  Hypertensive Patients 
1223-73 •306A 
Cardiovascular Effects of Aging: Interrelationships 
of Aortic, Left Ventricular, and Left Atrial 
Function 1113-101`,499A 
Current Management ofType A Thoracic Aortic 
Dissection: Results From The Interventional 
Registry of Aortic Dissection (IRAD) 1074-67• 
242A 
Different Clinical Features of Aortic Intramural 
Hematoma Versus Dissection Involving the 
Ascending Aorta 880-6`,311A 
Does Tissue Affinity Affect the Vascular Protection 
Induced by Angiotensin Converting Enzyme 
Inhibitors? 1072-22°240A 
Effect of Active and Passive Smoking on Wave 
Reflection as Measured From the High-Fidelity 
Aortic Pressure Waveform 1073-3 / * 242A 
Is Aortic Atherosclerosis Heritable? Familial 
Aggregation ofLumbar Aortic Calcification i  
The Framingham Study 880-I `,310A 
Long-Term Estrogen Therapy Does Not Alter 
Systemic Arterial Compliance and 
Hemodynamics in Biological Males 1163-3t,, 
281A 
Practice Variations in Utilization of Diagnostic 
Techniques to Evaluate Acute Aortic Dissection: 
Results From the International Registry of 
Aortic Dissection (IRAD) 880-3•310A 
Recanalization f Chronic Total Occlusions of the 
Abdominal Aorta and the lliac Arteries 
1130-,M-• 65A 
Relationship Between Aortic Dissection and Atrial 
Septal Aneurysm: A Transesophageal 
Echocardiographic Case Control Study 
1074-70 • 243A 
Ultrasonic Tissue Characterization f Aortic 
Atherosclerosis U ing Transesophageal 
Echocardiography 901-1 •483A 
Aortic coarctation 
Effect of Proximal Descending Aortic Compliance 
on Pressure Gradients Across Aortic Coarctation 
and Their Evaluation by Doppler Ultrasound: 
An In Vitro Study 814-4`,525A 
Elective Stent Repair of Coarctafion of Aorta as a 
Planned Single Stage Treatment 1030-143`, 
519A 
Outcomes of Balloon Angioplasty of Residual or 
Recurrent Aortic Arch Obstruction After 
Norwood Procedure 1181-159`,532A 
Stents in Aortic Coarctation: Immediate Results and 
Short Follow-Up 1030-144•519A 
Aortic diseases 
Abdominal Aortic Aneurysm Repair by 
Percutaneous Implantation ofUncovered Wire 
Mesh Stents and Coil Embolization of the 
Aneurysm 78-6`, 22A 
Acute Aortic Dissection, Modern Clinical Spectrum: 
Results From The International Registry for 
Aortic Dissection (IRAD) 1074-68`,242A 
Aortic Root Height Accurately Predicts Site of 
Aortic Root Replacement With Aortic Valve 
Presern'ation 866-4 •471A 
Aortic Root Size in Aortic Stenosis 1150-106• 
446A 
Aortic Valve-Sparing Procedures (VSP) in Young 
Adults With Marfan Syndrome and 
Annuloaortic Ectasia: Serial Echocardiographic 
Assessment of Postoperative Valve Function 
1197-173,,558A 
Atheromas of the Thoracic Aorta: Comparison of 
TEE in MRA 1059.79`,414A 
Current Management of Type A Thoracic Aortic 
Dissection: Results From The Interventional 
Registry of Aortic Dissection (IRAD) 1074-67`, 
242A 
Deternfinants of Progression of Aortic Dilatation in 
Marfan Syndrome 1074-69,,243A 
Effect of Beta Blocker Therapy on Clinical Outcome 
in Patients With Marfans Syndrome: 
Meta-Analysis of Data From 802 Patients 
1074-72 ° 243A 
Nonsurgical Reconstruction f Thoracic Aortic 
Dissection 880-5 •311A 
Percutaneous Endovascular T eatment of Abdominal 
Aortic Occlusive Diseases 1130-48°65A 
Percutaneous Endovascular T eatment of Aortic 
Bifurcation Occlusive Diseases 78-7`, 23A 
Plasma Concentrations of lnterleukin-6 and 
Abdominal Aortic Diameter Among Subjects 
Without Aortic Dilatation 880-2 •310A 
Predicting Mortality for Aortic Valve Surgery? 
1046-177.544A 
Recanalization f Chronic Total Occlusions of the 
Abdominal Aorta and the lilac Arteries 
I 130-44 • 65A 
Relationship Between Aortic Dissection and Atrial 
Septal Aneurysm: A Transesophageal 
Echocardiographic Case Control Study 
1074-70 • 243A 
Risk Factor Analysis for Secondary Valve Failure 
After Aortic Root Reconstruction 842-3-554A 
Severe Familial Cardiovascular Involvement Is 
Associated With an Increased Aortic Diameter 
in Pediatric Marfan Patients 1240-161 •537A 
Transesophageal Echocardiography Could Evaluate 
the Stage of Takayasu's Arteritis With Aortic 
Aneurysm 1074-71 •243A 
Transesophageal Echocardiography in the Diagnosis 
and Management ofAortic Dissection: An 
Analysis of Data From the International 
Registry for the Study of Aortic Dissection 
(IRAD) 866-1 ,,470A 
Aortic regurgitation 
Aortic Regurgitant Volume Measurement by 
Automated Cardiac Output Validation by 
Magnetic Resonance lmaging 1090-81 *424A 
Aortic Root Height Accurately Predicts Site of 
Aortic Root Replacement With Aortic Valve 
Preservation g66~•471A 
Aortic Valve-Sparing Procedures (VSP) in Young 
Adults With Marfan Syndrome and 
Annuloaortic Ectasia: Serial Echocardiographic 
Assessment of Postoperative Valve Function 
1197-173. 558A 
Assessment of Left Ventricular Long Axis 
Contraction Can Detect Early Myocardial 
Dysfunction i  Asymptomatic Patients With 
Severe Aortic Regurgitation 871-2. 563A 
Comparisons of Long-Term Effects of Quinalapril 
Versus Nifedipine Therapy in Patients With 
Moderate to Severe Chronic Aortic 
Regurgitation 1150-104•445A 
Determinants of Progression of Aortic Dilatation in 
Marfan Syndrome I074-69•243A 
Diastolic Leaflet Tenting: A New Echocardiographic 
Sign That Identifies the Mechanism of 
Functional Aortic Regurgitation 812-1 •426A 
Differential Left Ventricular Remodeling in Volume 
Overload: A Quantitative Echocardiographic 
Study 812-6•428A 
Early Effect of Valve Replacement for Severe Aortic 
Regurgitation  Left Ventricular Dysfunction 
1197-177. 559A 
Functional Aortic Regurgitation in Ascending Aortic 
Aneurysms: A Disease of Sinotubular, Not 
Annular, Dilatation 1047-190-545A 
Mid-Term Clinical and Echocardiographic 
Follow-Up After Ross Procedure 842-2- 554A 
Prediction of Long-Term Survival After Valve 
Replacement in Chronic Aortic Regurgitation: ls 
Angiography Superior to Echocardiography? 
87 l-3 • 563A 
Real-Time Three-Dimensional Echocardiography 
and Semiautomated Digital Doppler Color Flow 
Mapping for Evaluating Stroke Volume and 
Aortic Regurgitant Volume 829-6`,441A 
The prevalence ofSignificant Valvular Regurgitation 
and Pulmonary Hypertension i  753 Patients 
Who Took Fenfluramine and Phentermine in a 
Community Setting 1079-190o549A 
Valvular Heart Disease in Patients With Chinese 
Herbs Nephropathy 1079-193.549A 
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Aortic valve 
Comparison of Stress Hemodyamics Between 
Nonstented Aortic Bioprostheses, Mechanical 
Valves, and Normal Native Aortic Valves 
1197-1910560A 
Comparisons of Long-Term Effects of Quinalapri] 
Versus Nifedipine Therapy in Patients With 
Moderate to Severe Chronic Aortic 
Regurgitation 1150-1040445A 
Detection of Chlamydia Pneumoniae in Human 
Nonrheumatic S lerotic Heart Valves by 
lmmunhistochemical Analysis and Polymerase 
Chain Reaction 1139-191 *552A 
Diastolic LV Dysfunction ls a Major Predictor of 
Symptom Persistence Nine Years After Aortic 
Valve Replacement 805-5.547A 
Early Effect of Valve Replacement for Severe Aortic 
Regurgitation  Left Ventricular Dysfunction 
1197-177o559A 
Exercise Echocardiography After the Pulmonary 
Autograft (Ross) Operation for Patients With 
Aortic Valve Disease 1197-1900559A 
Mid-Term Clinical and Echocardiographic 
Follow-Up After Ross Procedure 842-2*554A 
Myocardial Viability Assessment by 
Nonfluoroscopic Catheter-Based 
Electroanatomical Mapping: Validation of a 
New Method by Radionuclide Imaging 
1186-138.378A 
Nonfluoroscopic Catheter-Based Electroanatomical 
Mapping Predicts Regional Wall Motion 
Improvement After Successful Myocardial 
Revascularization 1035-141 o334A 
Nonfluoroscopic Three-Dimensional Catheter-Based 
Electroanatomical Mapping: Follow-Up Study 
After Successful Myocardial Revascularization 
1035-140*334A 
Predicting Mortality tor Aortic Valve Surgery? 
1046-177 *544A 
Risk Factor Analysis for Secondary' Valve Failure 
After Aortic Root Reconstruction 842-3*554A 
Role of Endothelial Adhesion Molecules in the 
Path*genesis of Degenerative Aortic Valve 
Disease 1139-190*552A 
Short- and Long-Term Follow-Up in 771 Patients 
Undergoing Reoperative Heart Valve Surgery 
1078-177.548A 
Stentless Bioprosthesis Are Perfect for the Small 
Aortic Root 842-1.553A 
The Different Strata of Left Ventricular Remodeling 
After Aortic Valve Replacement With a 
Stentless Valve 1197-176*559A 
Valvular Hem,dynamics at Rest and Exercise 
Following Pulmonary Autograft Replacement of
the Aortic Valve (Ross Procedure) 1197-175* 
559A 
Aortic valve stenosis 
An Automated Three-Dimensional Digital Color 
Doppler Stroke Volume Method Yields Accurate 
Effective Orifice Areas in an In Vitro Model of 
Aortic Stenosis 1090-80*423A 
BNP Increases Following Maximal Aerobic Exercise 
in Valvular Aortic Stenosis and Healthy 
Controls 1226-193* 566A 
Comparisons ofLong-Tern1 Effects of Quinalapril 
Versus Nifedipine Therapy in Patients With 
Moderate to Severe Chronic Aortic 
Regurgitation 1150-104*445A 
Diastolic Dysfunction With Severe Aortic Stenosis: 
Normalization Early After Aortic Valve 
Replacement 805-4. 546A 
Estrogen Supplementation Causes Increased Aortic 
Valvular Thickening and Aortic Stenosis in a 
Menopausal Rabbit Model 1139-1940553A 
Incidence and Mechanism of Aortic Stenosis in 
Familial Hyperchnlesterolemia 1139-193* 
553A 
Noninvasive Quantification f the Aortic Valve Area 
in Patients With Calcified Aortic Valve Stenosis 
by Magnetic Resonance Imaging 805-3.546A 
Smoking, High Serum Cholesterol, and the Presence 
of Coronary Artery' Disease Are Associated 
With Progression of Calcitic Aortic Stenosis 
(AS): Implications for Secondary Prevention 
1139-192*553A 
The Change in Aortic Valve Area During a Cardiac 
Cycle Can Be Used to Predict he Rate of 
Hem,dynamic Progression of Aortic Stenosis 
812-2•427A 
The Pressure Drop-Flow Slope Predicts the 
Development of Symptoms in Aortic Stenosis 
805-2 •546A 
The Role of lntraoperative Transesophageal 
Echocardiography in the Assessment ofMitral 
Regurgitation Among Patients Undergoing 
Aortic Valve Replacement for Aortic Stenosis 
866-5 • 471A 
Aortoeoronary bypass 
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Pump Reflex 884-1•161A 
630A SUBJECT INDEX JACC February 1999 
Baroreceptors 
Heart Rate Turbulence in Patients With and Without 
Autonomic Dysfunction 1146-188 • 136A 
Is There Any Clinical Importance of a 
Nondiagnostic Baroreflex Sensitivity 
Measurement? 1086-186° 120A 
The Temperature of Atherosclerotic Lesions in the 
Hypercholesterolemic Rabbit Double Injury 
Model Are Elevated Following Angioplasty 
1131-95•67A 
Beta-adrenergic receptor agonists 
Differences in Vasomotor Function in Patients With 
Vasovagal Syncope 884-5.162A 
Dobutamine-lnduced Hypersensitivity M ocarditis: 
A Potential Mechanism to Explain the Increased 
Mortality With Chronic Intravenous Infusion 
1199-I 1 •200A 
Impaired Atrial b-Adrenergic Responsiveness 
Contributes to Atrial Stunning 868-2o154A 
Potentiation of the B-Adrenergic Responsiveness in 
Failing Human Myocardium by Dantrolene 
Sodium 1227-15.209A 
The Effect on Heart Rate of Immediate and 
Slow-Release Metoprolol in Patients With 
Chronic Heart Failure 1 110-10-183A 
Upregulation ofCatecholamine-Sensitive Focal 
Automaticity From the Ligament of Marshall in 
a Canine Model of Chronic Atrial Fibrillation 
913M- 167A 
Beta-adrenergic receptor blockers 
ABC (Aspirin, Beta Blocker, Clot Buster: 
Thrombolytic or PTCA) for Day One of Acute 
Myocardial Infarction in Medicare Patients 
1064-- 197,, 338A 
Acute Effects of Selective and Nonselective 
Beta-Receptor Antagonism and Potassium on 
QT Interval in LQT l Type of Long QT 
Syndrome /204-189.152A 
African-American Women: The Highest Risk 
Subgroup of the Cardiovascular Cooperative 
Project 832-5 •356A 
b-Blocker-Related Improvement in Ventricular 
Function Is Associated With Increased Gene 
Expression of SR Ca2+ ATPase 894-5.216A 
b-Blockers for Chagas's Heart Disease: The 
Reduction in Heart Rate May Not Be Associated 
to Improvement in Left Ventricular Ejection 
Fraction and Remodeling Process 1110-11 *
184A 
b-Blockers in Heart Failure: A Randomized Double 
Blind Trial of Carvedilol and Metoprolol 
1110-9* 183A 
Beta Adrenergic Blockade Decreases T Wave 
Altemans 1024-188-108A 
Betaxolol. aNew, Long-Acting Beta-Blocker, 
Suppresses Intraoperative Myocardial Isehemia 
During Vascular Surgery in Patients With 
Preoperative Ischemia in Coronary Artery 
Disease 1163-29°281A 
Both Atenolol and Propanolol Blunt the Flbrinolytic 
Response to Exercise but Not Resting 
Fibrinolytic Potential 1220-31 o302A 
Calcium Antagonists Versus Beta Blockers for 
Stable Angina: A Meta-Analysis 892-4-313A 
Cardioprotective Effect of b-Blocker Therapy in 
Reducing CK-MB Release After Coronary 
Intervention 1067-38 °38A 
Cardiovascular Responses to Dobutamine and 
Exercise Stress Testing in Patients Taking 
Beta-Adrenergic Blocking Agents 1226-191. 
565A 
Carvedilol Reduces QT Interval Dispersion in 
Patients With Chronic Heart Failure 1199-8- 
200A 
Do Elderly Patients Who Undergo Coronary 
Revascularization After Myocardial Infarction 
Benefit From Beta Blocker Therapy? 878M-* 
512A 
Effect of Beta Blocker Therapy on Clinical Outcome 
in Patients With Marfans Syndrome: 
Meta-Analysis of Data From 802 Patients 
1074-72 * 243A 
Effect of Beta-Blockade on Mortality in Patients 
With Clinical Evidence of Congestive Heart 
Failure After Myocardial Infarction 898-1 • 
398A 
Effects of Beta-Adrenergic Blockade on 24-Hour 
QT Interval Variability in Newborn Infants With 
Prolonged Ventricular Repolarization 1024-189 
* 108A 
Effects of Carvedilol on Renal Function in Patients 
With Heart Failure 1110-8 •183A 
Effects of Metoprolol on Cardiac Function and 
Remodeling in Postinfarct Failing Rats 1227-14 
• 209A 
Effects of Nicardipine and Esmolol on Artery 
Circumferential Wall Stress: Implications for the 
Risk of Plaque Rupture 1128-139•363A 
Efficacy and Limitations of Beta-Blocker Therapy in 
Long QT Syndrome 839-1 *138A 
Impact of Glucagon Administration on Dobutamine 
Stress Testing Using Tc99m Sestamibi Single 
Photon Emission Computed Tomographic 
(SPECT) Imaging in Patients Receiving Acute 
Beta Adrenergic Receptor Blockade 802-1 • 
417A 
Long-Term Effects of Heart Rate Reduction in 
Patients With Heart Failure: Comparison With 
Chronic b-Adrenergic Blockade 825-6. lggA 
Myocardial Oxidative Metabolism in Remote Infarct 
Regions in the Hearts With Remodeling 
1238-106°478A 
Prognostic Role of the Early Prescription of 
ACE-Inhibitors and Beta-Blockers in Early 
Hospital Survivors of Acute Myocardial 
Infarction: One-Ye;~r Results From the 
Nationwide French US1K Study 11133-198. 
332A 
Protective Effects of Carvedilol in Pressure-Induced 
Left Ventricular Hypertrophy and Diabetes 
1229-85 • 509A 
Quantitative Fatty Acid Myocardial Scintigraphy 
Predicts Responders for b-Blockade Therapy in 
Patients With Dilated Cardiomyopathy 
1209-124•468A 
Time Course of Functional Changes in Long-Term 
Survivors With Idiopathic Dilated 
Cardiomyopathy: Effects of Metoprolol 
1083-100. 497A 
Withdrawal of Chronic Beta Blockade in Heart 
Failure Patients Does Not Influence Exercise 
Hemodynamics 1199-9 °200A 
Biology, developmental 
A Novel Mouse Model of Cardiac Hypertrophy Due 
to Mutation of an Architectural Transcription 
Factor 1237-83.477A 
Developmentally Regulated Endothelial Cell Locus: 
A Novel Angiogenic Protein g09-4•250A 
Blood cells 
Baseline Levels of Cell Adhesion Molecules 
P-Selectin and ICAM-I Predict Five Year 
Survival in Patients With Coronary Artery 
Disease 1220-24 ° 300A 
Baseline Relative Lymphocyte Concentration: A 
Powerful Prognostic Indicator in Advanced 
Heart Failure IlZ-0-12°192A 
Detection of Different Formation of Superoxide 
Radicals by Nitro:glycerin in Contrast to 
Pentaerithrityl Tetranitrate 11111-25.222A 
Plasma nd Red Blood Cell Membrane Cholesterol 
Impacts Red Blood Cell Oxygen Transport and 
My ocardial Oxygenation 1062-171 •336A 
Blood coagulation 
Absence of Excess Bleeding Risks in Patients With 
Coagulation Abnormalities Undergoing 
Echo-Guided Pericardiocente sis 1087-32 ° 
419A 
Comparison of an Intravenous Bolus of Enoxaparin 
Versus Unfractionated Heparin in Elective 
Coronary Angioplasty 1007-56• 14A 
Does Blood Pressure Influence the Hypercoagulable 
State in Atrial Fibrillation? 1223-71 *306A 
Early Clinical Evaluation of rNAPc2, a Novel 
Inhibitor of Blood Quantitation Factor 
Vlla/Tissue Factor (fVIla/TF) 1104-74o255A 
Factor VII and Factor XII Plasma Levels Are 
Elevated in Healthy Offspring of Men With 
Premature Myocardial Infraction 1137-119 • 
274A 
Inhibition of PIatelet Adhesion by Thrombostatin, a 
PAR1 Activation Inhibitor, in a Model of 
Arterial Wall Injury Using Balloon Angioplasty 
904-2.401A 
The Contribution of Genetic (4G/5G Polymorphism) 
and Environmental Factors to Plasminogen 
Activator Inhibitor-I Antigen Levels: The 
Framingham Offspring Study 883-6-312A 
The Plasminogen Activator Inhibitor-I Gene4G/5G 
Polymorphism and Cardiovascular Disease: The 
Framingham Heart Study 1191-21-288A 
TNK-t-PA Is Devoid of Procoagulant Effects in 
Sharp Contrast With Streptokinase and rt-PA 
1003-132.325A 
Use of the Rapid Platelet Function Analyzer (RPFA) 
to Evaluate Platelet Function in Patients 
Receiving Incremental Bolus Dosing of 
Abciximab During Percutaneous Coronary 
Interventions (PCI) 1068-51 *39A 
Blood flow 
Assessment of the Epicardial Coronary Flow 
Velocity by Transthoracic Color Doppler 
Echocardiography Is aUseful Screening Test for 
Angina Pectoris 1025-66 • 4(MA 
Blood Volume Effect on MRI Determination f 
Myocardial Oxygenation 1238-107 o478A 
Direct Comparison of Intracoronary Pressure and 
Doppler-Derived Parameters of Intermediate 
Lesions in Multivessel Disease 1071-50e46A 
Direct Demonstration f Coronary Collateral 
Recruitment During Brief Vascular Occlusions 
1071-45- 45A 
Direct Relation Between Quantitatively Determined 
Coronary Collateral Flow and Intracoronary 
Basic Fibroblast Growth Factor Concentration 
826-5 • 355A 
Discrete Three-Dimensional P thways of Right and 
Left Pulmonary. Venous Inflow Studied With 
Phase Contrast MRI 1238-104o477A 
Distribution of Atherosclerosis in Human Coronary 
Arteries in Dependence of High and Low Shear 
Stress Zones 1131 - 135 - 67A 
Does the Blood Flow/Metabolism Mismatch Pattern 
Represent Hibernating Myocardium. Repetitive 
Stunning, or Both? 854-5-461A 
Early Postoperative Changes in Regional Systolic 
and Diastolic Left Ventricular Function 
Following Trausmyocardial L ser 
Revascularization (TMR) With Holmium: YAG 
and CO2 Lasers 813-4.342A 
Effect of Collateral and Collateral-Adjacent Vascular 
Resistance Alterations on the Coronary Flow 
Reserve of a Collateral-Receiving Artery 864-4 
.90A 
Effect of Sildenafil (Viagra) on Coronary Blood 
Flow and Hemodynamics During Exercise 
1221-113 °303A 
Effects of Adjunctive Atropine During Dobutamine 
Stress Echocardiography: Assessment of
Coronary Blood Flow and Myocardial Oxygen 
Consumption i Humans 1056-32.410A 
Endocardial F ow Reserve Determines Resting 
Myocardial Function in Chronic Coronary 
Disease When Resting Flow Is Normal 821-1. 
437A 
Exercise-induced QT-Interval Changes for 
Predicting Improvement in Regional Myocardial 
Blood Flow and Cardiac Output After Coronary 
Angioplasty in Patients With Right Bundle 
Branch Block 1146-186.135A 
Flow Characteristics of the Internal Mammary 
Artery After Minimal lnvasive Bypass: Change 
From Systemic to Coronary Circulation 
1191-24,, 289A 
Flow Kinetics of Perguoropropane-Contairdng 
Albumin Ultrasound Contrast Microspheres in
Normal and Inflamed Rat Microcirculation 
1028-124-408A 
How Much Coronary Collateral Flow Protects 
Against Myocardial Ischemia? 864-5-90A 
Impairment of Myocardial Blood Flow Alters the 
Myocardial Stress-Strain Relations in lschemic 
Cardiomyopathy 910-2-485A 
KEY: Abstract title, Session-abstract number •page number 
JACC February 1999 SUBJECT INDEX 631A 
Increase of Metalloproteinase-2 and -9 Activity 
During Flow Induced Remodeling Is Regulated 
atthe Posttranscriptional Level 1132-23,,268A 
Influence of Preoperative Internal Mammary Artery 
Flow Reserve and Postoperative Flow at Rest on 
Functional Graft-Assessment After Minimal 
Invasive Bypass Surgery 1025-62 • 403A 
Left Coronary Artery Flow Is Slower Than Right 
Coronary Artery Flow Following Adjunctive 
PTCA After Thrombolytic Administration 
869-2 • 382A 
Long-Term Estrogen Therapy Improves 
Acetylcholine-Induced Nitric Oxide Mediated 
Vasodilation but Not Metabolic-Induced 
Vasodilation in the Skeletal Resistance Vessels 
of Biological Males 912-1 •319A 
Magnitude and Location of New Angiographically 
Apparent Coronary Collaterals Following 
Intravenous Vascular Endothelial Growth Factor 
Administration 874-5 • 384A 
Method•logic Drift in the Assessment of the TIMI 
Flow Grades and Its Impact on Angiographic 
Trial Results 1126-200,, 362A 
Modified AHA/ACC Lesion Classification: Effect on 
Fractional Flow Reserve in Patients With Single 
Vessel Coronary Artery Disease 1219-45*99A 
Obstruction Severity and Outflow Angle, but Not 
Stenosis Length, Determine Hem•dynamic 
Significance of Coronary Artery Stenosis In 
Vivo 1128-138*363A 
Phasic Changes in Video Intensity Can Be Used to 
Detect Coronary Stenosis at Rest Without Need 
for Stress 841-3•450A 
Quantification of Myocardial Perfusion During Left 
Venwicular Remodelling: A Noncontrast Agent 
Nuclear Magnetic Reasonance (NMR) Imaging 
Technique 849-6. 372A 
Relationship Between the Presence and Duration of 
Chest Pain and Blood Flow at 90 Minutes 
Following Thrombolytic Administration 
1184-164° 375A 
Tamoxifen's Versus Estrogen's Effect on the 
Microvasculature ofPostmenopausal Women 
899-6.317A 
Testosterone Enhances Brachial Artery Reactivity in 
Men With Coronary Artery Disease 1013-74. 
226A 
The Balance Between Nitric Oxide and Free 
Radicals Affects the Coronary Vasodilator 
Reserve 1192-29•290A 
The Effects of Short-Term Passive Smoke Exposure 
on Endothefium-Dependent a d Independent 
Vasodilation 1042-67 • 232A 
The SAFE Study: Multicenter Evaluation of a 
Protection Catheter System for Distal 
Embolization in Coronary Venous Bypass Grafts 
(SVG's) 807-5 •37A 
Underestimation f "True" Coronary Flow Reserve 
by Adenosine? 1071-48*46A 
Validation of Myocardial Perfusion Assessed by 
Digitally Subtracted, Dual Gated, Power 
Doppler Harmonic Contrast Echocardiography 
841-5 • 451A 
Blood pressure 
ABPM and Ergometry in the Assessment of Blood 
Pressure in Normotensive and Hypertensive 
Patients 851-5 ° 288A 
Biventricular Triggered Pacing for the Treatment of
Ventricular Tachycardia: An In Vivo 
Experimental Study 1232-155 • 158A 
Cardiorespiratory Fitness Attentuates Exercise 
Blood Pressure and Left Ventricular 
Hypertrophy in Normotensive and Hypertensive 
Women 851-1 *287A 
Chronic Transdermal Estradiol-17b Therapy Lowers 
Blood Pressure in Newly Diagnosed 
Hypertensive Postmenopausal Women 877-4° 
309A 
Clinical and Prognostic Significance of an 
Exaggerated Systolic Blood Pressure Response 
to Exercise After Coronary Artery Bypass 
Grafting 1109-190* 550A 
Delayed Systolic Blood Pressure Recovery After 
Graded Exercise: No Advantage Over Exercise 
Blood Pressure Increase for Predicting 
Angiographic Coronary Disease 1017-193. 
543A 
Does Blood Pressure Influence the Hypercoagulable 
State in Atrial Fibrillation? 1223-71.306A 
Does Diabetes Effect LV Structure and Systolic 
Function Independent of Blood Pressure, Age, 
and Gender? A Population Sample-Based Study 
From the Hypertension Genetic Epidemiology 
Network (HyperGEN) Study 888-6.514A 
Effect of Sildenafil on Blood Pressure in Men With 
Erectile Dysfunction Taking Concomitant 
Antihyperte nsive Medications 804-3 ,, 238A 
Effect of Smoking on Arterial Wave Reflection in 
Young Adult Males 1221-110-302A 
High Dose Vitamin E Decreases Arterial Wave 
Reflection and Improves Ventricular/Vascular 
Coupling 1040-20 • 229A 
Impaired Diastolic Relaxation and Left Ventficular 
Systolic Function: The Hypertension Genetic 
Epidemiology Network (Hyper GEN) Study 
1051-102-493A 
Is Plasma LDL-Cholesterol Level Correlated With 
Blood Pressure in Normotensive and 
Hypertensive Patients? 1164-73 * 283A 
Left Ventricular Mass in Normotensive Black 
Patients With a Hypertensive Response to Stress 
Testing 1014-113•227A 
Long-Term Effects of the ACE Inhibitor, Ramipril, 
on Atherosclerosis inPatients With Coronary 
Heart Disease or Other Occlusive Arterial 
Disease: Final Results From the PART-2 Trial 
899-4 • 316A 
Problems With Casual Blood Pressure Measurement 
in a University Hospital Cardiovascular Clinic 
804-4 • 238A 
Relationship Between Left Ventricular Mass and 
Day or Nighttime Blood Pressure in 649 Patients 
With Treated Essential Hypertension 1014-1 i2 
• 227A 
The Blood Pressure Lowering Effect of Chronic 
Dietary L Arginine Supplementation in Newly 
Diagnosed Hypertensives Is Associated With 
Improved Endothelial-Mediated Vasodilation 
1044-113"235A 
Valsartan (Diovan): Effect on Microalbuminuria n
Patients With Type II Diabetes and Nephropathy 
872-5 *299A 
Blood pressure determination 
Angiographic Prevalence and Clinical Predictors of 
Left Subclavian Stenosis in Patients Undergoing 
Diagnostic Cardiac Catheterization 1193-72 • 
292A 
Change in Radial Pulse Wave Contour With Glyceryl 
Trinitrate as a Method to Assess Severity of Left 
Ventricular Failure 1228-4•211A 
Direct Comparison of Intracoronary Pressure and 
Doppler-Derived Parameters of Intermediate 
Lesions in Multivessel Disease 1071-50° 46A 
Is Blood Pressure Response to the Valsalva 
Maneuver Related to Neurohormones, Exercise 
Capacity, and Clinical Findings in Heart 
Failure? 1019-13,, 173A 
Problems With Casual Blood Pressure Measurement 
in a University Hospital Cardiovascular Clinic 
804-4 • 238A 
Radial Artery Pulse Wave Analysis for Assessment 
of Left Ventricular Failure 1228-5.211A 
Blood vessel prosthesis 
Abdominal Aortic Aneurysm Repair by 
Percutaneous Implantation of Uncovered Wire 
Mesh Stents and Coil Embolization of the 
Aneurysm 78-6 ° 22A 
Five-Loop Coil Occlusion of Patent Ductus 
Arteriosus Produces No Recurrence of Shunt at 
Follow-Up t 123-143-526A 
Follow-Up Results of Transvenous Occlusion of 
Patent Ductus Arteriosus With the Buttoned 
Device 1123-t44•526A 
Bradycardia 
Effect of Pacing Modality on Quality of Life in 
Patients With the Tachycardia-Bradycardia 
Syndrome 861-1.153A 
KEY." Abstract itle, Session-abstract number •page number 
Predictors of Death in VVI-R and DDD-R Paced 
Patients With the Tachycardia-Bradycardia 
Syndrome 861-3.153A 
Bradykinin 
Bmdykinin Is a Potent Dose-Dependent Stimulus for 
Release of Tissue Plasminogen Activator (tPA) 
in the Human Forearm Circulation 911-3*319A 
Bradykinin Pretreatment Protects Ischemic Rabbit 
Heart: Role of Potassium Channels 1124-166 • 
357A 
Contribution of Bradykinin to the Vasodilator 
Effects of Enalapril and Losartan in Patients 
With Heart Failure 1044-112 • 235A 
In Vivo Human Coronary Vasomotor Response to 
the Selective B 1 Kinin Receptor Agonist 
Des-Arg9-Bradykinin 1013-69*225A 
lschemic Stress Adaptation of Cardiac Contractile 
Function Is Mediated by Stress Activated 
Protein Kinase Signaling 1093-168•344A 
Muscarinic and Bradykinin Receptor Function in the 
Human Coronary Circulation: What Predicts 
Physiologic Coronary Vasomotion? 1162-20o 
279A 
Study of Angiogenesis and Cardiac Denervation 
Following Radiofrequency Transmyocardial 
Revascularization 813-2,342A 
Brain 
Vasopressin Modulates Sympathetic Nerve Activity 
in Various Models of Hypertension 1107-121 - 
259A 
CaLcium 
Altered Force Frequency Relationship of Human 
Myocardium in Mitral Valve Incompetence 
852-5 "558A 
Atrial Stunning: Increased Myocardial 
Na+/Ca2+-Exchanger butUnchanged SR Ca2+ 
Transport Protein Expression 868-3.155A 
cAMP-Dependent Phosphorylation I creases PN 
200-110 Binding to DHP Receptor During 
Membrane Depolarization 1040-25 • 230A 
Coronary Artery Calcium Scores on Electron Beam 
Computed Tomography: A Norm•gram for 
1,628 Patients 1059-82-415A 
Cytosolic Calcium Is Increased in Patients With Left 
Ventricular Hypertrophy 1043-78 •235A 
Dantrolene Sodium Restores the Altered 
Force-Frequency Relationship in Failing Human 
Myocardium 1227-16.209A 
Does Age Affect the Accuracy of Coronary Calcium 
for Predicting Coronary Events? 1059-83• 
415A 
Dowuregulation ofL-Type Calcium Channel and 
Sarcoplasmic Reticular Ca2+-ATPase mRNA in 
Human Atrial Fibrillation: An Insight Into the 
Mechanism of Atrial Electrical Remodeling 
820-6* 128A 
Effects of Ischemic Preconditioning on Relaxation 
Abnormalities During Low-Flow Ischemia 
1211-172o388A 
Estrogen Supplementation Causes Increased Aortic 
Valvular Thickening and Aortic Stenosis in a 
Menopausal Rabbit Model 1139-194•553A 
Functional Excitation-Contraction Coupling in the 
Absence of Calcium-Induced Calcium Release 
868-5 • 155A 
How Should We Use Coronary Artery Calcium 
Scores to Predict Events? 1059-65 • 414A 
Inositol Trisphosphate-lnduced Calcium Release 
During Ischemia Contributes to Myocardial 
Necrosis in Rabbit Heart 1124-170•358A 
Is Aortic Atherosclerosis Heritable? Familial 
Aggregation of Lumbar Aortic Calcification in 
TheFramingham Study 880-1°310A 
Mechanical Restitution Reflects Impaired Calcium 
Handling in Pacing Induced Heart Failure in 
Immature Goats 891-6.516A 
Mechanisms Causing Alterations in Cardiac Muscle 
Cell Relaxation Rate in Pressure Overload 
Hypertrophy (POH) 803-4•494A 
New Insights Into Calcium Cycling Using 
Post-Extrasystolic Potentiation i  
Phospholamban Overexpression 891-2•515A 
Novel Cardioprotective Agent, JTV519, Confers 
lschemic Preconditioning-Like Effects Through 
632A SUBJECT INDEX JACC February 1999 
Specific Activation of d-Protein Kinase C 
1211-169•387A 
Novel Model of Arterial Calcification by Direct 
Intramural Hydroxyapatite Injection 1130-39, 
64A 
Potentiation of the B -Adrenergic Responsiveness in 
Failing Human Myocardium by Dantrolene 
Sodium 1227-15° 209A 
Protein Phosphatase Activity Is Increased in Left 
Ventricular Myocardium of Explanted Failed 
Human Hearts 1048-16,173A 
Reduced Myofilament Ca2+ Responsiveness 
Underlies Postfibrillatory Contractile 
Dysfunction 913-1 °167A 
Regulation of Atrial Contractility in the Human 
Heart 1019-7-171A 
Regulation of Ryanodine Receptor by Cyclic ADP 
Ribose in Guinea Pig Isolated Ventricular 
Myocytes: Possible Inotropic and 
Arrhythmogenic A tions 1052-149,109A 
Sarcoplasmic Reticulum Calcium Cycling Proteins 
in Human Hypertensive L ft Ventricular 
Hypertrophy 1048-17 • 174A 
Sudden Coronary Death as the First Manifestation of
Ischemic Heart Disease in Persons Under Age 
50: Can Extent of Calcification Predict Presence 
of Plaque Rupture? 1220-29"301A 
Calcium channel blocking drugs 
Amlodipine Improves Mortality and Function in a 
Murine Model of Myocarditis-Dilated 
Cardiomyopathy: The Role of Microvascular 
Blood Flow 1199-14,201A 
Calcium Antagonists Versus Beta Blockers for 
Stable Angina: A Meta-Analysis 892-4,313A 
Dose-Dependent Protection of Atrial 
Tachycardia-induced Electrical Remodeling by 
Mibefradil 1143-147 ° 130A 
Effect of Amlodipine on Cardiovascular Events and 
Procedures 892-5,314A 
Effect of Verapamil on Exercise Tolerance and 
Doppler-Echographic Left Ventricular Diastolic 
Filling Parameters in Hypertensive Patients 
1076-114.246A 
Effects of Nicardipine and Esmolol on Artery 
Circumferential Wall Stress: Implications for the 
Risk of Plaque Rupture 1128-139,363A 
Incomplete Infarction Trial of European Research 
Collaborators Evaluating Prognosis 
Post-Thrombolysis (INTERCEPT Trial): A 
Randomized. Placebo-Controlled Study of 
Adjunctive Diltiazem + Aspirin Versus Aspirin 
Alone in Patients With ST Segment Elevation 
My 858-1,379A 
Quinapril Restores Endothelial Dysfunction i
Patients With Essential Hypertension Through 
Independent Mechanisms on Plasma Bradykinin 
Increases and Blood Pressure Reductions 836-6 
• 276A 
Serum Amyloid A Levels in Patients With Mild to 
Moderate Hypertension. Before and After 
Treatment With a Calcium Antagonist 1223-72 
-306A 
Cardiac arrest 
Cardiopulmonary Cerebral Resuscitation Using 
Emergency Cardiopulmonary Support: Coronary 
Reperfusion Therapy and Hypothermia 
Increases Patient Survival 905-4,402A 
Cardiopulmonary Resuscitation for In-Hospital 
Cardiac Arrest: Prospective Results From 415 
Patients 905-3,402A 
Epinephrine Plasma Levels and Hemodynamic 
Effects After Airway and Central Venous 
Epinephrine Administration i  Patients 
Predisposed for Cardiac Arrest 1156-198', 
370A 
Inducible Ventricular Fibrillation Is a Predictor of 
Recurrent Arrhythmias in Patients Presenting 
With Syncope or Cardiac Arrest 1085-156, 
l I8A 
Long-Term Adaption of Cardiac Arrest Survivors 
905-2 o 402A 
Optimizing Ventilation With Phased Chest and 
Abdominal Compression-Decompression 
(Lifestick) CPR 1156-195,369A 
Prediction of Predischarge Cognitive Deficits in 
Cardiac Arrest Survivors Using Serum Protein 
S-100 and Neuron Specific Enolase 905-1 *
401A 
Pulmonary Embolism in Unexplained Cardiac 
Arrest: Role of Transesophageal 
Echocardiography 1148-66*444A 
Recurrence of Out-of-Hospital VF Following 
Low-Energy Biphasic and High-Energy 
Monophasic DefibrilHation Shocks 1116-183,. 
127A 
Cardiac mapping 
Ablation of Isthmus-Dependent Atrial Flutter Using 
the CARTO Nonfluoroscopic Mapping System 
887-5,164A 
Activation Effects of Single Site and Dual Site Atrial 
Pacing 1173-156¢141A 
Anisotropic Conduction Over the Trabeculated Right 
Atrial Wall 12(12-157 ° 148A 
Atrial Defibrillation Energy Requirements and 
Activation Wavefronts in the First Four Hours of 
Atrial Fibrillation 848-3 • 146A 
Characterization f the Configuration and 
Dimensions of the HIS Bundle Region Using the 
CARTO System: Defining the HIS Cloud 
I114-147o 123A 
Different Pattern Related to Anatomical Site in 
Atrial Cycle Length Before Spontaneous 
Termination of Atfizd Fibrillation 1052-148° 
109A 
Discordant Recovery of Electrophysiotogic 
Parameters After Conversion of Lone Atrial 
Fibrillation in Humans 1114-151•124A 
Electroanatomic Mapping of Chronic Porcine 
Anterior Infarction: Correlation With Pathology 
and Intracardiac Echo 816-5 ° 122A 
Electromechanical Characterization f Chronic 
Experimental Myocardial ischemia in a Pig 
Model 849-5.371A 
Endocardial Mapping of Induced Atrial Fibrillation 
Initiated by Premature Atrial Extrastimuli 
Delivered at Different Right Atrial Sites in 
Patients With Recurrent Sustained Atrial 
Fibrillation 890-5,, 165A 
Influence of Right or Left Atrial Linear Lesions on 
Heart Rate Response in Canine Pacing Model of 
Atrial Fibrillation 1052-146°10gA 
Initial Experience With the Noncontact Mapping 
Guided Radiofrequency Ablation of Atrial 
Flutter 887-6.164A 
lnteratrial Electrical Activation in Man: Correlation 
of Anatomy With Activation Sequence Mapping 
887-4-163A 
Linear Lesions for Control of Unmappable 
Ventricular Tachycardia n Iscbemic and 
Noniscbemic Cardiomyopathy 816-4.122A 
Mechanism of Termination of Atrial Fibrillation by 
Flecainide in a Canine Model of Atrial 
Fibrillation 1052-150° 109A 
Multisita Mapping of Interatrial Septal Activation in 
Canine 1202-155,. 148A 
New Insights Into Atrial Flutter: Studies in a Canine 
Model 12t12-152• 147A 
New Insights Into the Initiation Mechanism of 
Vagally-Mediated Atrial Fibrillation 1202-154,. 
148A 
Right Atrial Activation With Coronary Sinus Pacing: 
Insight Into Patterns of Interalrial Conduction 
12(/4-180,151A 
The Clinical Usefulness of Multielectrode Basket 
Catheter in Mapping and Ablation of Type I 
Atrial Flutter 1114-149°123A 
The Value of Epicardial Mapping of Ventricular 
Tachycardia From the Coronary Venous System: 
A Prospective Multicenter Study 816-1 °121A 
Cardiac output 
Complete Four-Dimensional Color Doppler Flow 
Integration: A Rapid and Accurate Tool for 
Quantitation of Cardiac Flows 1090-104,425A 
Exercise-loduced QT-lnterval Changes for 
Predicting Improvement in Regional Myocardial 
Blood Flow and Cardiac Output After Coronary 
Angioplasty in Patients With Right Bundle 
Branch Block 1146-186°135A 
KEY.' Abstract title. Session-abstract number • page number 
Influence of Cardiac Output on Mitral Valve Area 
Determined by Pressure Half-Time 1016-177* 
542A 
Low Peak Oxygen Consumption May Not Represent 
Poor Cardiac Function in Patients With Severe 
lschemic Heart Disease 1109-192*550A 
Noninvasive Assessment of Hemodynamic Subsets 
in Patients With Acute Myocardial Infarction 
Using Digital Color Doppler Velocity 
Integration Method and Pulmonary Venous Flow 
Analysis 1090-66- 423A 
Real-Time Three-Dimensional Contrast 
Echocardiography for Left Ventricular Cavity 
Visualization: Animal and Clinical Studies 
1119-83,431A 
Cardiac pacing artificial 
Bedside Evaluation of New Onset Chest Pain by 
Transthoracic Stress Echocardiography Using 
Transesophageal Atrial Pacing Is Comparable to
Nuclear Perfusion Stress Imaging 1212-130o 
389A 
Biventricular Pacing Is Also of Benefit in Less 
Severe Heart Failure 1115-157°125A 
Clinical Algorithm for Selection of Pacing and 
Defibrillation Therapies in Drug-Refractory 
Atrial Fibrillation 1173-154,141A 
Comparison of Dual-Chamber Pacing Versus Septal 
Myectomy for the Treatment of Patients with 
Hypertrophic Obstructive Cardiomyopathy: A 
Comparison of Objective Hemodynamic and 
Exercise Endpoints 1142-99-501A 
Long-Tern1 Survival Benefit Associated With Dual 
Chamber Pacing 861-2* 153A 
Mortality. Injury. and Remaining Population at Risk 
Related to the Telectronics Accufix Atrial 
Permanent Pacemaker Lead: Management 
Implications of Database Results at 31/2 Years 
After Lead Recall 1232-152,157A 
Pacemaker Syndrome in the Pacemaker Atrial 
Tachycardia Trial 1173-157,141A 
Prevention of Refractory Proxysmal Atrial 
Fibrillation With Sequential Biatrial Pacing 
1173-152,140A 
Time-Dependence and Pattern of Atrial Fibrillation 
Recurrences After Single and Dual Site Right 
Atrial Pacing 1173-153-140A 
Cardiac surgery 
A Regional Pediatric Congenital Heart Surgery 
Model: Early Experience and Outcomes 
1152-143* 529A 
Absence of a Learning Curve in Beating Heart 
Operations: Results From the Seven-Year 
Follow-Up Study of Bypass With and Without 
the Heart-Lung Machine 879-1,566A 
Acute Mechanical Transmyocardial Channelling 
Provides Protection for lscbemia 813-1 °341A 
Aortic Root Height Accurately Predicts Site of 
Aortic Root Replacement With Aortic Valve 
Preservation 866-4* 471A 
Aortic Valve-Sparing Procedures (VSP) in Young 
Adults With Marfan Syndrome and 
Annuloaortic Ectasia: Serial Echocardiographic 
Assessment ofPostoperative Valve Function 
1197-173 •558A 
Argentine Randomized Study Optimal Coronary 
Balloon Angioplasty and Stenting Versus 
Coronary Bypass Surgery in Multiple Vessel 
Disease (ERAC111): In-Hospital and 30-Day 
Results 81-9,33A 
Changes in Atrial Conduction Following 
Cardiopulmonary B pass: Relationship to the 
Development ofPostoperative Atrial Fibrillation 
1175-185o 143A 
Comparison of Dual-Chamber Pacing Versus Septal 
Myectomy for the Treatment of Patients with 
Hypertrophic Obstructive Cardiomyopathy: A 
Comparison of Objective Hemodynamic and 
Exercise Endpoints 1142-99o501A 
Current Management ofType A Thoracic Aortic 
Dissection: Results From The lnterventional 
Registry of Aortic Dissection (IRAD) 1074-67o 
242A 
Early Effect of Valve Replacement for Severe Aortic 
Regurgitation  Left Ventricular Dysfunction 
1197-177-559A 
JACC February 1999 SUBJECT INDEX 633A 
Early Versus Medium Term Effects of Partial Left 
Ventriculectomy onLeft Ventricular Function: 
An lnvasive Study 1200-3.203A 
Echocardiographic Features of Early Procedural 
Failure Following Percutaneous Balloon Mitral 
Valvotomy 1167-176.555A 
Ejection Fraction Changes During Dobutamine 
Stress Echocardiography Predict Functional 
Recovery After Revascularization in Patients 
With Left Ventricular Dysfunction 1049-6o 
175A 
Estimation of Operating Room Costs for Coronary 
Artery Bypass Graft Surgery 1015-121.229A 
Examining Increased CABG Mortality Risk in 
Females 879-2.566A 
Final Results of the Randomized Watlstent 
Endoprostbesis in Saphenous Vein Graft Trial 
(WINS) 807-4+37A 
Final Results of the Wallstent Eudoprosthesis in 
Large Saphenous Vein Graft (WINS Registry) 
1099-53 • 51A 
Graft Patency Rates Among Patients Undergoing 
Minimally Invasive Coronary Artery Surgery 
1138-176.552A 
Impact of Minimally lnvasive Approach on Valvular 
Heart Surgery: A Case Controlled Study 842-6 
• 554A 
Intraoperative Echocardiography in Coronary Artery 
Bypass Graft Surgery Without Cardioptdmonary 
Bypass 866-6 •471A 
Left Internal Mammary Artery Graft Flow Reserve 
Is Related to Resting Diastolic Flow After 
Minimally Invasive Bypass 1025-61 •403A 
Local Bed Capacity Is Associated With Probability 
of Readmission: A Study of 6752 Coronary 
Artery Bypass Surgeries in New England 
1015-119°229A 
Long-Term Follow-Up of Conservatively Treated 
Prosthetic Valve Endocarditis: Low Rate of 
Reinfection or Death 871-6•563A 
Low Dose Sotalol Is Superior to Metoprolol in the 
Prevention of Supraventricular Ar hythmias 
After Cardiac Surgery 1144-156-132A 
Low-Term Morbidity and Mortality in Patients With 
Simple TGA, TGA, and VSD and Taus~ig-Bing 
Anomaly After Arterial Switch Repair 
1092-159 t 523A 
Mechanism of Improvement in Exercise Capacity 
After Maze Procedure Combined With Mitral 
Valve Surgery 1109-194•551A 
Mid-Term Clinical and Echocardiographic 
Follow-Up After Ross Procedure 842-2.554A 
Minimally lnvasive Direct Coronary Artery Bypass 
(M1DCAB): Have We Reached the Plateau of 
the Learning Curve? 1138-175•551A 
Mitral Annular Calcification Influences Clinical 
Outcomes Following Mitral Valve Replacement 
Independent ofCormorbidities 812-4•427A 
Multivessel Stenting Reduces In-Hospital 
Complication Compared With Repeat 
Aortocoronary Bypass Surgery 1099-55•51A 
Noninvasive Assessment of Left Internal Mammary 
Artery Graft Flow Reserve After Minimally 
lnvasive Coronary Bypass Using Supine Bicycle 
Doppler Echocardiography 862-6.562A 
Passive Ventricular Containment in the Treatment of 
Experimental Dilated Cardiomyopathy 870-3° 
208A 
Percutaneous Revascularization of Patients With 
Prior Coronary Bypass Surgery: Saphenous Vein 
Graft or Native Coronary Stenting? 1099-56o 
51A 
Percutaneous Transluminal Coronary Angioplasty of 
Left Main Stenosis: Results of the German 
PTCA Registry 1036-38-23A 
Periprucedural Myocardial Infarction After Vein 
Graft Stenting: Incidence and Predictive Factors 
8O7-3 • 37A 
Prediction of Coronary Artery Disease in Patients 
Undergoing Mitral Valve Prolapse Surgery 
842-4 •554A 
Preoperative Prediction of 30-Day Mortality After 
Cardiac Surgery: Registry of the ALKK 
1097 -139 • 349A 
Prognosis by Measures of lntraoperative 
Transesophageal Echocardiography in Patients 
Undergoing Cardiac Surgery 1148-61.442A 
Pulmonary Outflow Tract Reconstruction With 
Autololgous Tissue During the Ross Procedure: 
Right Ventricular Characteristics n Mid-Term 
Follow-Up 1152-161 o531A 
Rate Control Versus Conversion Strategy in Post 
Operative Atrial Fibrillation: A Prospective, 
Randomized Pilot Study 1022-150.103A 
Readmission Following Coronary Artery Bypass 
Graft Surgery in New Fngland: Magnitude anad 
Variability Across Institutions 808-6',249A 
Reparative Approach of Atrioventricular Valves 
Following Severe Blunt Cardiac Trauma 
1046-176o544A 
Results of a Randomized, Double Blind, 
Placebo Controlled Stndy of Local Perivascular 
Basic Fibroblast Growth Factor (bFGF) 
Treatment in Patients Undergoing Coronary 
Artery Bypass Surgery 874-2-383A 
Results of Dobutamine Stress Ecbocardiography at 
One Year Following Transmyocardial L ser 
Revascularization 879-4,,567A 
Role of Coumadin in Patients After Mitral Valve 
Repair: Analysis of 202 Patients Followed Up to 
12 Years After Surgery 1046-175 ° 544A 
Sensitivity, Specificity, and Predictive Accuracies of 
Noninvasive Tests. Singly and in Combination, 
for Diagnosis of Hibernating Myocardium 
821-6-438A 
Should We Routinely Repair Tetralogy of Fallol in 
Neonates and Very Young Infants? 1092-143• 
523A 
Stress Test in Detection of Functional Alterations in 
the Internal Thoracic Artery Flow Measured by 
Transcutaneous Doppler Echocardiograpby in 
Patients With Coronary Artery Disease 1025-63 
• 403A 
Succcsstul Palliation of Ebstein Anomaly on the 
First Day of Life Following Fetal Diagnosis 
1092-145 • 523A 
Surgery for Atrial Fibrillation Using lntraoperative 
Radiofrequency Catheter Ablation: Results at 
One Year in Mitral Patients 1203 151 *I50A 
Surgical Treatment of Valvular Heart Disease in 
Patients With Acromegaly and Cardiomyopathy 
1047-194- 545A 
The Relationship Between Coronary Disease, 
Baseline Clinical Variables, Revascularization 
Mode, and Mortality 879-3.567A 
Valvular Hemodynamics at Rest and Exercise 
Following Pulmonary Autograft Replacement of
the Aortic Valve CRoss Procedure) 1197-175. 
559A 
Wall Thickening of Saphenous Vein Bypass Grafts 
Begins in Relatively Early Stage After Surgery 
1159-51 o77A 
When ls a CABG Mortality Model Complete, 
Stable, and Reliable'? 1078-176.548A 
Cardiac tamponade 
Absence of Excess Bleeding Risks in Patients With 
Coagulation Abnormalities Undergoing 
Echo-Guided Pericardiocentesis 1087-32 • 
419A 
Consecutive 779 Therapeutic Echo Guided 
Pericardiocenteses for Large or Compressive 
Effusions: Risks and Outcomes 907 3.517A 
Coronary Perforation and Pericardial Tamponade 
Risk in the Abciximab Era 1157-41.72A 
Validation of Left Ventricular Volumes by Real-Time 
Three-Dimensional Echocardiography and 
Biplane Cineansiography I 119-81 "431A 
Cardiac volume 
A New Digital Method lor Estimating Left. 
Ventricular Vulume Using Real-Time 
Three-Dimensional Echocardiography: A 
Comparison With M;lgnetic Resonance Imaging 
829-4.441A 
Accuracy of Quantitating Three-Dimensional 
Reconstruction f Left Atrial Volume With 
Color Kinesis Imaging From Three Apical 
Views 1180-34.457A 
Accurate Measurement of Left Ventricular Stroke 
Volumes Using Real-Time, Three-Dimensional 
KEY." Abstract title, Session-abstract number ° page number 
Echo During Nonischemic and lschemic 
Conditions 914-4.486A 
Clinical Impact of Gating Errors on Visual 
Assessment of Myocardial Perfusion and 
Ventricular Function From SPECT Data 
1122-122.435A 
Differential Left Ventricular Remodeling in Volume 
Overload: A Quantitative Echocardiographic 
Study 8l 2-6. 428A 
Obesity Reduces Accuracy of Two-Dimensional 
Echocardiographic Measurement of Left 
Ventricular Volume and Ejection: Improvement 
With Three-Dimensional Echocardiography 
1119-84. 431A 
Relationship Between Left Ventricular Function and 
Recovery Time Dispersion in Patients With 
Previous Myocardial Infarction 1234-186- 
la0A 
The Relationship Between the Anterolx)sterior 
Measure of Left Atrial Size and Left Atrial 
Volume Derived From Biplane 
Echocardiography 1087-36.420A 
Three-Dimensional Echocardiography for Accurate 
Quantification fRight Ventricular Volume and 
Function: A Comparison With Magnetic 
Resonance Imaging 1206-63 -463A 
Tissue Harmonic Imaging Improves Endocardial 
Border Definition: An Insight From Quantitative 
Comparison of Videointensity Between 
Myocardial and Cavity With Digital Subtraction 
828-2+439A 
Validation Studies for Real-Time Three+Dimensional 
Echocardiographic Determination f Left 
Ventricular Diastolic and Systolic Cavity and 
Strt~ke Volumes: Comparisons of Digital 
Sonomicrometric Arrays, Conductance Catheter, 
and EM Flow Meter Measurements 1090-105. 
425A 
Ventricular Volumes Compared Among Three Gated 
SPECT Methods and Echocardiography 
1029-32 •409A 
Cardiology practice/management 
A Population-Based Study on Congestive Heart 
Failure Admissions in the Largest Italy Region 
1081-3.179A 
A Simple Prognostic Score Based on Clinical 
Parameters in Patients With Cardiac Symptoms 
and Normal Resting Electrocardiograms 
1215-141-393A 
Age and the Utilization of Cardiac Catheterization 
Post Myocardial Infarction: National Registry of 
Myocardial Infarction 2 (NRMI-2) 889-4° 
395A 
Cost-Effective Implications of a Cardiac Ultrasound 
Screening Strategy in Evaluation of Mitral Valve 
Prolapse 867- 1.472A 
Diuretic Usage as a Risk Factor fbr Increased 
Mortality in the Elderly With Acute Myocardial 
Infarction 1034-162. 332A 
Effect of a Clinical Pathway on Quality Indicators 
for Treatment of Acute Myocardial Infarction 
1095-199 ° 347A 
Effect of Race and Gender on Physician 
Recommendation f rCardiac Catheterization 
835 2o 266A 
Exercise Performance-Based Outcomes of Medically 
Treated Patients With Coronary Artery Disease 
and Profound ST Segment Depression 
1066-140° 341A 
First Acute Myocardial Infarction With ST Segment 
Depression: Prognostic Significance of 
Involvement of Lateral Leads 1125-132.360A 
High Variability in "Normal '+ Rates on Coronary 
Angiography Among Hospitals 808-5.249A 
Impact of On-Site lnterventional Facilities on 
Hospital Procedures and Outcomes: Canada 
Versus the United States in GUSTO lib 
1096-164o 348A 
Recidivism Rates Among Patients Presenting With 
Chest Pain and the Impact on Resource 
Utilization 1154-130.365A 
Regional Myocardial Perfusion Reserve on 
Cholesterol Lowering Therapy Compared With 
634A SUBJECT INDEX JACC February 1999 
Percutaneous Transluminal Coronary 
Angioplasty Assessed With Positron Emission 
Tomography 854-1.460A 
Secular Trends (1975-1995) in Incidence of Heart 
Block and Use of Pacing Devices During 
Hospitalization for Acute Myocardial Infarction: 
The Worchester Heart Attack Study 1154-131 * 
365A 
Secular Trends in the Management ofCongestive 
Heart Failure by Primary Care Physicians and 
Cardiovascular Specialist  1077-117• 247A 
Sudden Death in Grown-Up Congenital Heart 
(GUCH) Patients: A 26-Year Population-Based 
Study 885-1 •538A 
"[he ~mpertance of'i~ayer Case'M~x on "dos p'¢ta'J Cos~: 
Don't Contract Without It 1077-120•248A 
Variability of Myocardial Infarction Attack Rates, 
Case Fatality. and Medical Care in the Warsaw 
PoI-MONICA Register (1984-1994) 1031-171° 
329A 
Cardiomyopathies, dilated 
A Prolonged QRS Duration on a 12-Lead 
Electrocardiogram ls Associated With Increased 
Cardiac Fibrosis 1201-85*507A 
ACE Inhibition Limits Apoptosis in 
Cardiomyopathic Hamsters. and Improves 
Remodeling and Scar Tissue Material Properties 
1199-16•202A 
Altered Coronary Blood Flow Velocity Reserve in 
Dilated Cardiomyopathy Results From Both 
Increased Baseline Velocity and Inappropriate 
Intramyocardial Coronary Dilatory Capacity 
1201-87 * 507A 
Amindipine Improves Mortality and Function in a 
Murine Model of Myocarditis-Dilated 
Cardiomyopathy: The Role of Microvascular 
Blood Flow 1199-14*201A 
~ltventr/cu~r Pa~i~ fs ALso of  8eneft ict Less 
Severe Heart Failure 1115-157°125A 
Cardioprotective Myocardial Inflammation i
Myocarditis (MC) 1050-87•492A 
C)~a~S,e)n ~a~a) ~)se~)ave UontourX,~)~ G)ycery) 
Trinitrate as a Method to Assess Severity of Left 
Ventricular Failure 1228-4° 211A 
Chemokine Expression i  Human End-Stage 
Congestive Heart Failure Due to Dilated 
Cardiomyopathy and Ischemic Heart Disease 
1048-15 • 173A 
C)):0)ca) Prob)es o~ ~our L~rge I'e~)gTee.s',~)~ 
Familial Dilated Cardiomyopathy: Preliminary 
Recommendations for Clinical Practice 
1201-99 ° 508A 
Coronary Flow Reserve in Children With 
Duchenne's Disease 1121-790435A 
Diastolic Function Is Highly Predictive of Recovery 
of Left Ventricular Systolic Function in Patients 
With New Onset Dilated Cardiomyopatby 
837-1 •448A 
Does Patient Race Influence Utilization of Effective 
Medical Therapy for Heart Failure? 1081-2• 
179A 
Does Spherical Left Ventricular Shape Imply Worse 
Prognosis in Dilated Cardiomyopathy? 1140-7o 
191A 
Early Versus Medium Term Effects of Partial Left 
Ventriculectomy onLeft Ventricular Function: 
An lnvasive Study 1200-3 •203A 
Familial Dilated Cardiomyopathy: New 
Echocardiographic Diagnostic Criteria for 
Classification of Family Members as Affected 
1051-101 •493A 
Flow Cytometric Analysis of Cytokine Profiles in 
Patients With Idiopathic Dilated 
Cardiomyopathy and Their Asymptomatic 
Relatives 1051-98•492A 
High Serum Levels of Soluble lnterleukin 2 
Receptor, Neopterin and b-2 Microglobulin in 
Idiopathic Dilated Cardiomyopathy: Relation to 
Heart Failure Severity and Autoimmune 
Features 1018-15.169A 
Impairment of Myocardial Blood Flow Alters the 
Myocardial Stress-Strain Relations in Ischemic 
Cardiomyopathy 910-2.485A 
Importance of Temporal Variation in Quantifying 
Functional Mitral Regurgitation: Minimum 
blow Rate at Mid-Systole Rather Than 
Maximum Flow Rate Best Predict Overall 
Severity 1016-173.541A 
Improvement ofCardiac Neuronal Function Using 
123I-MIBG Scintigraphy in Dilated 
Cardiomyopathy After Carvedilol Therapy 
1091-107 o425A 
Independent Myocardial Substrate Utilization From 
Left Ventricular Regional Function in Dilated 
Cardiomyopathy 803-6 •495A 
Insulin Resistance in Patients With Idiopathic 
Dilated Cardiomyopathy Assessed by 
Fluorodeoxyglucose Positron Emission 
Tomography Imaging: Implications for 
Metabolic Intervention ? 1049-13• 177A 
ls Myocardial Na+Ca2+ Exchanger Gene 
Expression Altered in Chronic Heart Failure? 
1048-18° 174A 
Isolated Annular Dilatation Does Not Cause 
Important Mitral Regurgitation: Comparison 
Between Patients With Lone Atrial Fibrillation 
and Dilated Cardiomyopathy 852-1.557A 
Left Atrial Systolic Function During Dohutamine 
Stress in Coronary Artery Disease: The Effect of 
Left Ventricular Ischemia nd Left Ventricular 
Dysfunction 1088-62o420A 
Left Ventricular Energetics in Transgenic Mice With 
Dilated Cardiomyopathy 891-3•515A 
Less Spherical Smaller Ventricle, Increased Wall 
Thickness, and Mitral Competence Account for 
Benefits After Partial Left Ventriculectomy 
1200-5 • 204A 
Long-Term Results of Permanent Biventricular 
Pacing in Refractory Heart Failure: Comparison 
of Patients With Stable Sinus Rhythm and 
Chronic Atrial Fibrillation 1115-152 • 12,4A 
"LowN[yocarififft~etffmi~o"oenz~]tguatfii3me TJ_pteig  
Independently Predicts Adverse Clinical 
Outcome of Dilated Cardiomyopathy 1170-102 
• 504A 
~)1,'5c D~)t)e ~p~es ~rJyocart))~ D~yger~ 
Consumption Attenuating Contractile Response 
to b-Adrenergic Stimulation i  Patients With 
Idiopathic Dilated Cardiomyopathy 803-1- 
494A 
Outcome of Surgery for Functional Mitral 
Regurgitation in Congestive Cardiomyopathy 
8 5 2-b . 5.~$A 
Passive Ventricular Containment in the Treatment of 
Experimental Dilated Cardiomyopathy 870-3° 
208A 
Patients With Idiopathic Dilated Cardiomyopathy 
and Up-Regulated Major Histocompatibility 
Complex Antigens Respond Poorly to 
Conventional Therapy 1201-100.508A 
Prospective Clinical Evaluation of Transvenous 
Biventricular DDD Pacing in Refractory Heart 
Failure: Preliminary Results of the Insync 
Multicenter Study 1115-153.124A 
QT Interval Dynamicity for Risk Stratification i
Idiopathic Dilated Cardiomyopathy 1228-12. 
213A 
Quantitative Fatty Acid Myocardial Scintigraphy 
Predicts Responders for b-Blockade Therapy in 
Patients With Dilated Cardiomyopathy 
1209-124.468A 
Radial Artery Pulse Wave Analysis for Assessment 
of Left Ventricular Failure 1228-5•211A 
Reduced Exercise Capacity in Early Familial Dilated 
Cardiomyopathy in Spite of Normal Left 
Ventricular Function 1051-99°492A 
Regional and Global Hypoperfusion of the Left 
Ventricle in Congestive Heart Failure 1049-12* 
177A 
Removal of Cardiodepressant Factor(s) in Dilated 
Cardiomyopathy b  Immunoadsorption 
1018-19• 170A 
Reversal of Subendocardial Metallothionein 
Expression and Myocyte Diameter After 
Prolonged Left Ventricular Assist Device 
Support 909-2* 219A 
Right Ventricular Ejection Fraction in Idiopathic 
Dilated Cardiomyopathy Compare to Ischemic 
KEY." Abstract tide, Session-abstract number * page number 
Left Ventricular Dysfunction: Data From an 
Angiographic Study 1168-2* 196A 
The Detrimental Effect of Combined Aspirin and 
Angiotensin Converting Enzyme Inhibitor 
Therapy on Readmission Rates in Heart Failure 
881-3*214A 
The Different Strata of Left Ventricalar Remodeling 
After Aortic Valve Replacement With a 
Stentless Valve 1197-176*559A 
Time Course of Functional Changes in Long-Term 
Survivors With Idiopathic Dilated 
Cardiomyopathy: Effects of Metoprolol 
1083-100*497A 
Time Course of Left Ventricular Mass Regression 
~o'fiowing Le~t "4entficu'tar Ass'lst Device 
Implantation 870-4* 208A 
Usefulness of Brain Natriuretic Peptide for 
Predicting an Association of Diastolic 
Restriction i  Patients With Chronic Heart 
Failure: A Doppler Echocardiographic Study 
1140-14* 192A 
Cardiomyopathies, hypertrophic 
A New Mutation of the Cardiac Troponin T Gene 
Causing Familial Hypertrophic Cardiomyopathy 
Without Left Ventricular Hypertrophy 1082-86 
* 495A 
al a-Adrenergic Receptor and Protein Kinase C 
Stimulation Suppress Delayed 
Afterdepolarizations in Hypertrophic 
Cardiomyopathic Hamsters 913-2 •167A 
Assessment ofElderly Diastolic Left Ventricular 
Regional Myocardial Function in Patients With 
Hypertrophic Cardiomyopathy Using Tissue 
Doppler Imaging and Magnetic Resonance 
Myocardial Tagging 910-1*485A 
Cardiopulmonary Exercise ls a Useful Method for 
Differentiating Physiological Hypertrophy of the 
Athlete "s Heart From U~oertrqottic 
Cardiomyopathy With Mild Hypertrophy 
1230-100 * 510A 
Changes in Left Ventficular Diastolic Function Six 
NIont?os AIler ~onsur,~ca) Sept~ Ret~ucf~o~ 
Therapy for Hypertrophic Obstructive 
Cardiomyopathy 837-4•449A 
Clinical Correlates of Myocyte Disarray in Patients 
With Hypertrophic Cardiomyopathy 1020-99 • 
489A 
Comparison of Dual-Chamber Pacing Versus Septal 
),3yeclomy ~or Ihe'Yrealment ofPafie:ols WJth 
Hypertrophic Obstructive Cardiomyopathy: A 
Comparison of Objective Hem•dynamic and 
Exercise Endpoints 1142-99.501A 
Determinants and Clinical Significance of Atrial and 
Brain Natriuretic Peptides in Hypertrophic 
Cardiomyopathy 1201-101 o508A 
Diversity of Clinical and Genetic Patterns in a 
Family With Hypertrophic Cardiomyopathy 
1020-102*489A 
Eleclromechanical Left Ventricular Behavior 
Following Nonsurgical Septal Reduction in 
Patients With Hypertrophic Cardiomyopathy 
1142-100°502A 
Evaluation of Left Ventricular Myocardial Elasticity 
in Normal, Pressure-Overload Hypertrophic, and 
Amyloid Myocardium Based on Measurement 
of Myocardial Balk Modulus 888-4.514A 
Evaluation of Segmental Myocardial Strain Rate by 
Tissue Doppler Echocardiography in aFeline 
Model of Hypertrophic Cardiomyopathy 
1180-37 •458A 
Evidence of Myocardial Stunning in Patients With 
Nonobstructive Hypertrophic Cardiomyopathy 
and Exercise-lnduced Left Veotricular 
Dysfunction 1230-1020511A 
Exercise Capacity in Hypertrophic Cardiomyopathy: 
Relation to Intracavitary Gradient 1230-103• 
511A 
Expression of a Human Hypertrophic 
Cardiomyopathy Mutation in Transgenic Mice 
hnpairs Left Ventricular Systolic Function 
Detected by 178Ta Radionucleide Angiography 
Which Precedes Histological Changes 410-4. 
3A 
Expression of b-Myosin Heavy Chain-Gin403 in
Transgenic Rabbits Induces Myocyte Disarray 
JACC February 1999 SUBJECT INDEX 635A 
and Increased Interstitial Collagen Content 
1082-85 o 495A 
Genetic Polymorphism of the Renin Angiotensin 
AIdosteron System May Determine the Clinical 
Phenotype in Gene Carriers in a Family With 
Hypertrophic Cardiomyopathy 1020-101• 
489A 
Hypertrophic Cardiomyopathy in Pediatric Age: A 
20-Year Experience in a Pediatric Cardiology 
Center 1240-1600537A 
Identification of Hypertrophic Cardiomyopathy in 
the Muscular Dystrophy Mouse Model, dy/dy 
1229-87 • 509A 
Magnetic Resonance Imaging Reliably Detects the 
Area of Left Ventricular Outflow Tract in 
Patients With Hypertrophic Obstructive 
Cardiomyopathy asa Parameter to Characterize 
Clinical Outcome 1020-100°489A 
Noninvasive Assessment of Left Ventricular 
Diastolic Function Using Doppler Tissue 
Imaging in Patients With Hypertrophic 
Cardiomyopathy 1112-87o498A 
Nonsargical Septal Reduction Therapy for 
Hypertrophic Obstructive Cardiomyopathy: 
One-Year Follow-Up 1142-1030502A 
Novel Missense Mutations in the Cardiac b-Myosin 
Heavy Chain Gene in Hypertrophic 
Cardiomyopathy: Genotype/Phenotype 
Relationship 818-6•262A 
Percutaneous Transluminal Septal Myocardial 
Ablation for Hypertrophic Obstructive 
Cardiomyopathy Eliminates Resting 
Obstruction, Not Provocable Obstruction. While 
Improving Quality of Life 1142-1020502A 
QT Abnormalities in Genetically Affected Subjects 
Without Left Ventricular Hypertrophy: A Study 
on 201 Subjects With Familial Hypertrophic 
Cardiomyopathy 1230-101 •511A 
QT Dispersion Is Not a Predictor of Sudden Cardiac 
Death in Hypertrophic Cardiomyopathy as
Assessed in an Unselected Patient Population 
830- I • 128A 
QT Interval and Cardiac Cycle Length in Normal 
Subjects, Myocardial Infarction. and 
Hypertrophic Cardiomyopathy: New Insight 
Into Mechanisms of Arrhythmogenesis? 
1024-186 • 107A 
Remodeling After Percutaneous Transluminal Septal 
Myocardial Ablation in Hypertrophic 
Obstructive Cardiomyopathy Results in 
Ongoing Outflow Tract Gradient Reduction 
1020-103 • 490A 
Response to Left Ventricular Systolic Wall Motion 
Velocity During Low-Dose Angiotensin I1 
Stress Tissue Doppler Imaging in Patients With 
Hypertrophic Cardiomyopathy 1207-83 •465A 
Subclinical Skeletal Muscle Abnormalities in 
Patients With Hypertrophic Cardiomyopathy 
and Their Relation to Clinical Characteristics 
1020-98 • 489A 
The ECG in Hypertrophic Cardiomyopathy 
Revisited: Do ECG Voltages Reflect Left 
Hypertrophy? 1234-187• 161A 
The Influence of Age and Gender on the 
Histopathology of Patients With Hypertrophic 
Cardiomyopathy 1229-86o509A 
The TGF Beta-Activated Kinase, TAKI, ls Activated 
in the Myocardium by Pressure-Overload nd ls 
Sufficient o Trigger Heart Failure in Transgeoic 
Mice 410-5•3A 
Cardiomyopathies, other 
Arrested Progression of Cardiac Amyloidosis in 
Patients Undergoing Intravenous Melphalan 
Therapy With Autologlous Stem Cell 
Transplantation 888-2• 513A 
Arrhythmogenic Right Ventricular Cardiomyopathy: 
Long-Term Follow-Up of 37 Families 
1083-103 • 497A 
Cardiac Troponin T (cTnT) as a Biomarker for 
Monitoring Chronic Doxorubicin (DXR) 
Cardiomyopathy 1019-6• 171A 
Cell Death in Acromegalic Cardiomyopathy 
1141-88o501A 
Chronic Chagas's Heart Disease Does Not Recur Up 
to 13 Year Follow-Up After Heart 
Transplantation 1169-12-198A 
Clinical Course and Prognosis in Naxos 
Arrhythmogenic Right Ventricular 
Cardiomyopathy 1083-990496A 
Contractile Dysfunction Very Early in Chagas" 
Cardiomyopathy 1050-880492A 
Detection of Left Atrial Myopathy in Heritable 
Cardiac Conduction and Myocardial Disease 
1051-100.493A 
Does Sports Activity Enhance the Risk of Sudden 
Death in Young People? 1085-181 • 119A 
Does the Blood How/Metabolism Mismatch Pattern 
Represent Hibernating Myocardium, Repetitive 
Stunning, or Both? 854-5•461A 
Evaluation of Left Ventricular Myocardial Elasticity 
in Normal, Pressure-Overload Hypertrophic. and 
Amyloid Myocardium Based on Measurement 
of Myocardial Bulk Modulus 888-4•514A 
Incidence and Outcome of Childhood 
Cardiomyopathy in Australia: Results of a 
Ten- Year Population-Based Study 1083-98o 
496A 
Influence of PET Viability Studies on Clinical 
Decision-Making in CHF Patients 1049-4- 
175A 
Localization of a Gene Responsible for 
Arrhythmogenic Right Ventricular Dysplasia to 
Chromosome 3p23 410-1•2A 
Long-Tern1 Follow-Up of 34 Adults With Isolated 
Ventricular Noncompaction: Poor Prognosis 
Due to Sudden Death or Heart Failure 1229-88 
•510A 
One-Hundred Fifty Patients With Cardiac Biopsy 
Proven Amyloidosis: A Correlative Study of 
Clinical, Pathologic, and Echocardiographic 
Findings 888-3•513A 
Predictive Value of QT Dispersion for Sudden 
Cardiac Death in Patients With Arrhythmogenic 
Right Ventricular Dysplasia 1055-1840 l13A 
Quantitative Analysis of Coronary Vasculopathy in
Patients With Fabry Disease by Contrast Echo 
Myocardial Perfnsion 1179-1270456A 
Reduced Cardiotoxicity of Lipososomal 
Doxorubicin (D99): A Phase Ill Single Agent 
Study in Patients With Metastatic Breast Cancer 
1091-109•426A 
Reversal of Myocyte [njury With Chelation Therapy 
in Patients With Thalassemia 1240-143•536A 
Reversible Left Ventricular Dysfunction Mimicking 
Acute Myocardial Infiaretion: Clinical 
Characteristics and Speculation on the 
Mechanisms I113-980499A 
Right Bundle Branch Block. Right Precordial ST 
Segment Elevation. and Sudden Death: A 
Variant of Arrhythmogenic Right Ventricular 
Cardiomyopathy? 1085-180• l I9A 
Surgical Treatment of Valvular Heart Disease in 
Patients With Acromegaly and Cardiomyopathy 
1047 - 194 • 545A 
The Clinical Features of lie 122 Amyloidosis: A 
Cardiomyopalhy Found Exclusively in Patients 
of African Origin 888-1 •513A 
The Neglected Cardiomynpathy: AF-lnduced 
Diastolic Dysfunction and Its Improvement 
After Sustained Sinus Rhythm 1083-102.497A 
Cardiomyoplasty 
Accelerating Angiogenesis and Capillarization 
Between Skeletal Mu:~cle and Myocardium in 
Experimental Model of an Ischemic Heart 
1093-169o344A 
Cardiomyoplasty: Compromised Right Ventricular 
Function ls Dependent on Latissimus Dorsi 
Muscle Stimulation 1200-20203A 
The Role of TCRab+ T Ct.qls in Viral Myocarditis: 
Dissection Through TCRb-/- Transgenic 
Knockont Models 1050-86•491A 
Cardioplegia 
Bradykinin Pretreatrnent Protects lschemic Rabbit 
Heart: Role of Potassium Channels 1124-166 ° 
357A 
Cardiopulmonary resuscitation 
Biphasic Waveform Transthoracic Defibrillation 
Thresholds for Spontaneous Ventricular 
Fibrillation in a Porcine Model of Acute 
Ischemia 1156-199o370A 
Cardiopulmonary Cerebral Resuscitation Using 
Emergency Cardiopulmonary Support: Coronary 
Repeffusion Therapy and Hypothermia 
Increases Patient Survival 905~o402A 
Cardiopulmonary Resuscitation for In-Hospital 
Cardiac Arrest: Prospective Results From 415 
Patients 905-3 • 402A 
Epinephrine Plasma Levels and Hem•dynamic 
Effects After Airway and Central Venous 
Epinephrine Administration i  Patients 
Predisposed for Cardiac Arrest 1156-198o 
370A 
Intra-Aortic Balloon Counterpulsation Venus 
Dobutamine in the Treatment of 
Postresuscitation Left Ventricular Stunning 
1156-197 o369A 
Long-Term Adaption of Cardiac Arrest Survivors 
905-2 • 402A 
Optimizing Ventilation With Phased Chest and 
Abdominal Compression-Decompression 
(Lifestick) CPR 115b-195o369A 
Recurrence of Out-of-Hospital VF Following 
Low-Energy Biphasic and High-Energy 
Monopha.sic Defibrillation Shocks 1116-183o 
127A 
Cardiovascular disease 
A Multicenter Clinical Evaluation of the Safety and 
Efficacy of BRI (SonoVue) as a Contrast 
Enhancing Agent for LV Endocardial Border 
Delineation 1058-106 • 413A 
Accuracy of a Pretest Questionnaire in Exercise Test 
Protocol Selection 1109-1910550A 
Baseline Levels of Cell Adhesion Molecules 
P-Selectin and ICAM-t Predict Five Year 
Survival in Patients With Coronary" Artery 
Disease 1220-24 • 300A 
Black Patients Presenting With Acute Coronary 
Syndromes Have Better Outcomes Due to Less 
Extent of Disease 1154-129•365A 
Cardiac Involvement in Wegener's Granulomatosis: 
Mayo Clinic Experience 1976-1997 1201-102o 
508A 
Cardiovascular Safety of SiIdenafil in the Treatment 
of Erectile Dysfunction (ED) 877-5o309A 
Carotid Arterial Wave Intensity Measured 
Noninvasively in Humans 1237-820477A 
Coronary Anatomy of Diabetic Patients Being 
Assessed for Renal Transplantation 1097-138o 
349A 
Depreasion and Risks of Coronary' Heart Disease, 
Stroke and Death in 2,722 Elderly Women: A 
Six-Year Prospective Study 1021-850490A 
Determinants of Progression of Aortic Dilatation in 
Marfan Syndrome 1074-690243A 
Diuretic Usage as a Risk Factor for Increased 
Mortality in the Elderly With Acute Myocardial 
Infarction 1034-162 • 332A 
Endotoxemia-A Potential Path•physiological Link in 
the Association of Smoking. Chronic Infection, 
and Atherosclerosis 817-4 • 260A 
Minimally lnvasive Coronary Artery Bypass Surgery 
as a Treatment for Restenosis 1138-174•551A 
Object Virtual Reality Display of Congenital 
Cardiovascular Path•logic Specimens 1502-20 
7A 
Platelet GPlIla Receptor PLA Polymorphism and 
Cardiovascular Disease: The Framingham Heart 
Study 818-5 •262A 
ProCOR: A Global Electronic Conference for 
Promoting Cardiovascular Health in Developing 
Countries 865-6• 6A 
Pulse Inversion Harmonic Imaging Consistently 
Achieves Myocardial •pacification Which Is 
Visually Apparent, But Nonuniform Following 
Intravenous •prison in Patients 1058-107- 
413A 
Radiodermatitis Following Coronary Angioplasty 
1157-58072A 
Serotonin-lnduced Proliferation in Cardiac Valve 
Tissue 1079-194 • 550A 
KEY." Abstract itle, Session-abstract number •page number 
636A SUBJECT INDEX JACC February 1999 
Systolic and Diastolic Heart Failure Have Similar 
Impact on Hospital Cost 1081-9o181A 
The Plasminogen Activator lnhibitor-I Gene4G/5G 
Polymorphism and Cardiovascular Disease: The 
Framingham Heart Study 1191-21.288A 
Cardiovascular disease prevention 
A New Method of Long-Term Preventive 
Cardioprotection Using Lactobacillus 1124-172 
• 358A 
A Simplified Cardiovascular Event Reduction Tool 
(CERT) Developed From the West of Scotland 
Coronary Prevention Trial 0NOSCOPS) 
1095-197 * 347A 
Accelerating the Improvement i  Community 
Cardiovascular Health Using Web-Enhanced 
Project Development 1503-1•7A 
Accurate Noninvasive Quantitation of 
Atherosclerosis by Wavefront Analysis and 
Transthoracic Echocardiography 411-2•4A 
Air Force/Texas Coronary Atherosclerosis 
Prevention Study: Lipid Modification and Risk 
Associated With Nonlipid Risk Factors 
1075-73 • 244A 
Cardiac Physiologic Characteristics A sociated With 
Development of Atrial Fibrillation in Older 
Adults With Normal Left Ventricular Systolic 
Function 1171-99o505A 
Clinical Profiles of Four Large Pedigrees With 
Familial Dilated Cardiomyopathy: Preliminary 
Recommendations forClinical Practice 
1201-99 •508A 
Dietary Treatment in Dyslipidemia: Do Dietitians 
Do It Better? A Prospective, Randomized 
Clinical Trial 860-4° 297A 
Factor VII and Factor XI1 Plasma Levels Are 
Elevated in Healthy Offspring of Men With 
Premature Myocardial In fraction 1137-119* 
274A 
Motivation to Change Smoking Behavior in Patients 
With Coronary Artery Disease in Europe: The 
Euroaspire Survey 1137-120.275A 
Predicting Risk of First Acute Major Coronary 
Events (AMCEs) in the Air Force/Texas 
Coronary Atherosclerosis Prevention Study 
(AFCAPS/TexCAPS) 824-3 • 263A 
ProCOR: A Global Electronic Conference for 
Promoting Cardiovascular Health in Developing 
Countries 865-6•6A 
Purple Grape Juice Protects LDL From Oxidation in 
Coronary Artery Disease Patients Taking 
Vitamin E 1164-68•282A 
Randomized Trial of Cholesterol-Lowering Therapy 
and Antioxidant Vitamin Supplementation in 
6,000 People With Diabetes Mellitus 1164-72° 
283A 
Randomized Trial of Cholesterol-Lowering Therapy 
and Antioxidant Vitamin Supplementation in 
Over 20,000 Higher Risk Patients 824-2•263A 
Reduced Cardiotoxicity of Lipososomal 
Doxorubicin (D99): A Phase III Single Agent 
Study in Patients With Metastatic Breast Cancer 
1091-109.426A 
The Effects of Crystalline and Extended-Release 
Niacin, Niaspan, on HDL Lip•protein-Mediated 
Cellular Cholesterol Efflux as Compared to 
Placebo 1075-78 •245A 
The Effects of Vitamin E on Chronic aod Acute 
Endothelial Dysfunction in Smokers 836-2• 
275A 
The Prevalence of Aspirin Resistance in Cardiac 
Patients as Measured by Platelet Aggregation 
and the PFA-100 1104-68-254A 
Carotid arteries 
A Rat Carotid Artery Model of In Stent Restenosis 
1101-136•55A 
Aden•viral Gene Transfer to Mouse Carotid 
Arteries: Limited Role of Antigen-Specific 
Immunity in Elimination of Transgene 
Expression 10l 1-26•222A 
Angioplasty and Stenting of Extracranial Carotid 
Arteries in High-Risk Patients 1130-47 *65A 
Association Between Mitral Annulus Calcification 
and Carotid Atherosclerotic Disease 1103-29- 
253A 
Carotid Arterial Wave Intensity Measured 
Noninvasively in Humans 1237-82•477A 
Clinical Impact of Angiotensin-Converting Enzyme 
Genotype on Intergrated Backscatter of Carotid 
Artery 1237-81.477A 
Comparison of Results With the Palmaz Stent and 
Wallstent for Carotid Stem Supported 
Angioplasty 1008-95.15A 
Elective Carotid Artery Stenting for 
Radiation-Induced E×tracranial Carotid Artery 
Occlusive Disease 1069-96 •42A 
Endotoxemia-A Potential Path•physiological Link in 
the Association of Smoking, Chronic Infection, 
and Atherosclerosis 817-4.260A 
Evaluation of a New Self Expanding Micorporous 
Multilayered Stent: Improved Vessel Expansion 
With Minimal VesselTranma 1069-95•42A 
Failure to Detect Chlamydia Pueumoniae in
Coronary and Carotid Atherosclerotic Plaques 
876-5 • 394A 
Four-Year Experience With Carotid Stenting 78-1 • 
21A 
Humanized Platelet-Derived Growth Factor-b 
Receptor Antibodies Decrease Neointima 
Formation at 30 Days in Baboon Stented 
Carotids 1039-57..30A 
Incidence and Outcomes of Prolonged Hypotension 
Following Carotid Artery Stenting 1130-45• 
65A 
ls Carotid Artery lntimaI-Medial Thickness aMarker 
of Diffuse Atherosclerosis? 1137-I 18•274A 
ls Carotid Stenting the Preferred Treatment in 
High-Risk Surgical Carotid Endarterectomy 
Patients'? 1130-43•64A 
Novel Model of Arterial Calcification by Direct 
Intranmral Hydroxyapatite Injection 1130-39. 
64A 
One-Year Outcome Following Carotid Stent 
Supported Angioplasty (CSSA) 78-2.21A 
Postproeedural Hypotension After Carotid Stem 
Implantation: Incidence and Clinical Sequelae 
1008-96 • 16A 
Protection Against Shear-Dependent Ar erial 
Thrombosis by Local Expression of Human 
Tissue Factor Pathway Inhibitor in 
Balloon-Injured Porcine Carotid Arteries 
1103-31 "253A 
Recurrent Restenos~s After Carotid Artery Stenting 
(CASt Versus Operative Management of 
Neointimal Hyperplasia Following Carotid 
Endarterectomy 1130-42.64A 
Relationship Between lntima-Media Complex of 
Comnnm Carotid Artery, Leptin Serum Levels, 
and Insulin Activity in Obese and Non-Obese 
Subjects 1103-28-253A 
The Benefits of Intravascular Ultrasound During 
Carotid Artery Stenting 1219-49•100A 
The Impact of Impaired Glucose Tolerance and 
Diabetes Mellitus on Large Artery Structare and 
Function: The Strong Heart Study 1137-117- 
274A 
The Role of Apoptosis, t~roliferation, and Migration 
as Regulators of lntimal Cell Density in Human 
Carotid Arteries 1103-27.252A 
The Role of Carotid Atherosclerosis in the 
Distinction Between Ischemic and Nonischemic 
Cardiomyopathy 1049-11 • 177A 
Treatment of Hyperhomocyste(e)inemia Halts 
Atherosclerotic Plaque Progression 1163-27. 
281A 
Vascular Hypertrophy and Distensibility of the 
Carotid Arteries in Patients With Hypertension: 
ICARUS, a LIFE Substudy 1103-26•252A 
Cell physiology 
a la-Adrenergic Receptor and Protein Kinase C 
Stimulation Suppress Delayed 
Afterdepolarizations i  Hypertrophic 
Cardiomyopathic Hamsters 913-2" 167A 
Changes in the the Insulin-Like Growth Factor Axis 
in Cardiac Tissue Following Myocardial 
Infarction 1093-167.343A 
Chronic Aortic Regurgitation Causes Fibrosis 
Featuring Hyperprocluction f Noncollagen, 
Glucnsamine-Containing Matrix Elements 
871 - I • 562A 
Cocaine Increases Total Protein and Fetal B-Myosin 
Heavy Chain Protein Expression in Cultured 
Adult Cardiac Myocytes 1141-86•500A 
Coregulation of Nkx2-5 and Serum Response Factor 
Transcriptional Activation of the Cardiac 
Sodium-Calcium Exchanger Promoter 811-2o 
182A 
Decorin Antagonizes Transforming Growth 
Factor-b l-Induced Effects in Cardiac 
Fibroblasts: Evidence for a New Antifibrotic 
Therapeutic Principal 1195-77o294A 
Differential Apoptotic Effects of Hypoxia and 
Reoxygenation i  Cardiac Fibroblasts and 
Myocytes 1 t 82-199 •372A 
Functional Excitation-Contraction Coupling in the 
Absence of Calcium-lnduced Calcium Release 
868-5.155A 
Left Ventricular Hypertrophy in Mitral Regurgitation 
Is Not Driven by Abnormal Myocardial Protein 
Synthesis Rates 1225-176*564A 
Regulation of Ryanodine Receptor by Cyclic ADP 
RJbose in Guinea Pig Isolated Ventricular 
Myocytes: Possible In•tropic and 
Arrhythmogenic Actions 1052-149 • 109A 
Ticlopidine Inhibits Hypoxia-lnduced Collagen 
Types I and 11I Expression in Cardiac 
Fibroblasts 1043-77 • 234A 
Vitamin E Counterbalances the Action of the 
Phosphatase Inhibitor Cyclosporine A (CsA) on 
the Na+-K+ Pump 1043-73.233A 
Cells 
C Reactive Protein in Unstable Angina: Marker or 
Culprit? 875-2 o385A 
Constitutive Properties of Cardiac Muscle Cells 
Measured Under Physiologic Conditions Which 
Parallel In Vivo Cell Lengthening 1082-87* 
496A 
Effect of y-Irradiation on the Cell Cycle of Rat 
Smooth Muscle Cells 1101-134*55A 
Failure to Detect Chlamydia Pneumoniae in
Coronary and Carotid Atherosclerotie Plaques 
876-5- 394A 
lnduclion of Tenascin in Cardiomyocytes by 
Mechanical Strain: Role of Reactive Oxygen 
Species 811-1 *182A 
Initial Characterization fRetinoblastoma Control 
Element and Sp3 Protein in Smooth Muscle 
Differentiation 1040-23 *230A 
Mechanisms Causing Alterations in Cardiac Muscle 
Cell Relaxation Rate in Pressure Overload 
Hypertrophy (POH) 803-4o494A 
Rapamycin Inhibits Vascular Endothelial Cell 
Proliferation Via Induction of a 
Cyclin-Dependent Kinase Inhibitor 809-5o 
250A 
Role of Inflammatory Mediators in Oxygen-Free 
Species Production by Polymorphonuclear 
Leukocytes in Unstable Angina 875-3 •385A 
Serotonin-lnduced Proliferation in Cardiac Valve 
Tissue 1079-194o550A 
The Effects of Cyclosporine-A on Apoptosis and 
p53 Expression in Human Cardiomyocytes 
1043-74- 234A 
Tissue Factor Expression Is Increased by bFGF 
Infusion in Rabbits 1102-21 •251A 
Central nervous ystem 
Congestive Heart Failure and Depression: Frequency 
and Impact of Depression on Functional Status 
1228-1 •210A 
Prognostic Value of Central Chemoreflex Sensitivity 
in Patients with Chronic Heart Failure 1140-1 * 
189A 
Vasopressin Modulates Sympathetic Nerve Activity 
in Various Models of Hypertension 1107-121 • 
259A 
Cerebrovascular circulation 
Coronary Stent Diameters Are Systematically 
Overestimated 1217-91 •96A 
Intracranial Arteries of Human Fetuses Are More 
Resistant to Oxidative Damage and 
Hypercholesterolemia-lnduced Fatty Streak 
Formation Than Extracranial Arteries 809-6• 
251A 
Transcatheter Closure of Patent Foramen Ovale 
(PFO) in 86 Patients With Five Different 
KEY: Abstract itle. Session-abstract number •page number 
JACC February 1999 SUBJECT INDEX 637A 
Occlusion Systems: A Report of 127 
Patient-Years 827-3 o528A 
Cholesterol 
A Nutritional Product Designed to Enhance Nitric 
Oxide Activity Restores 
Endothelium-Dependent Function in 
Hypercholesterolemia 1164-69.282A 
Apolipoprotein E Polymorphism Influences the 
Remnant-Like Particle-Cholesterol Metabolism 
1105-76o256A 
Dietary L-Arginine Reverses the Inhibitory. Effect of 
Asymmetric Dimethylarginine on Angiogenesis 
in Hypercholesterolemia 407-2-1A 
Genetic Determination ofthe Early Onset of 
Myocardial Infarction 1106-111 • 257A 
Impact of Clinical Judgment on Number of Patients 
Requiring Lipid-Lowering Therapy Based on 
Adult Treatment Panel 11 Guidelines and New 
National Health and Nutrition Examination 
Survey I11 Data 1196-119.296A 
Mechanism of Action of Probucol on Cholesteryl 
Ester Transfer Protein (CETP) mRNA in a CHO 
Cell Line That had Been Stably Transfected 
With a Human CETP Gene 111 I 1-21 ° 221A 
Myocardial Perfusion Imaging and Coronary 
Angiography in Children With Homozygous 
Familial Hypercbolesterolemia 1240-158 • 
537A 
Plasma and Red Blood Cell Membrane Cholesterol 
Impacts Red Blood Cell Oxygen Transport and 
Myocardial Oxygenation 1062-171 *336A 
Pyruvate Prevents Oxidative Stress 1192-30•291A 
Relationship of Plasma Lipids to Reductions in 
Cardiovascular Risk: A POSCH Report 824-4° 
263A 
Smoking, High Serum Cholesterol, and the Presence 
of Coronary Artery Disease Are Associated 
With Progression of Calcific Aortic Stenosis 
(AS): Implications for Secondary Prevention 
1139-192• 553A 
The Effects of Crystalline and Extended-Release 
Niacin. Niaspan, on HDL Lip*protein-Mediated 
Cellular Cholesterol Efflux as Compared to 
Placebo 1075-78o245A 
Tissue Factor Expression Is Increased by bFGF 
Infusion in Rabbits 1102-21 •251A 
Unfiltered Coffee Raises Plasma Homocysteine 
Levels in Healthy Volunteers 860-2•297A 
Vascular Responsiveness to Angiotensin I1 Is 
Correlated With LDL-Cbolesterol in 
Normocholesterolemic Humans 912-4° 320A 
Cholesterol-lowering drugs 
A Simplified Cardiovascular Event Reduction Tool 
(CERT) Developed From the West of Scotland 
Coronary Prevention Trial (WOSCOPS) 
1095-197 •347A 
Aggressive Lipid Lowering Versus Coronary 
Angioplasty in Patients With Inducible 
Myocardial Ischemia: An AVERT Substudy 
1066-141 •341A 
Are Cholesterol-Lowering Drugs Antiarrhythmic n
High Risk Patients? 824-5°264A 
Atorvastatin Downregulates ATI-Receptor Gone 
Expression in Cell Proliferation in Vascular 
Smooth Muscle Cells 1011-28°222A 
Endothetium-Dependent Response in 
Hypercholesterolemic Coronary Artery Disease 
Patients Under the Effects of Simvastatin and 
Enalapril, Either Separately or Combined 
1135-68 • 271A 
HMG-Co A Reductase lnhibitors Are Modifying the 
Inflammatory Response of Human Macrophages 
Infected by Chlamydia Pneumoniae 817-3• 
260A 
HMG-CoA Reductase Pravastatin Restored the 
Infarct Size-Limiting Effect of lschemic 
Preconditioning Blunted by 
Hypercholesterolemia 1211-166•386A 
Impact of Clinical Judgment on Number of Patients 
Requiring Lipid-Lowering Therapy Based on 
Adult Treatment Panel 11 Guidelines and New 
National Health and Nutrition Examination 
Survey III Data 1196-119•296A 
Large, Dose-Dependent Effects of Simvastatin 40 
and 80 mg/day in Combined Hyperlipidemia 
1075-74 • 244A 
Lipid Lowering Therapy Does Not Affect the Acute 
Fibrinolytic Capacity of Hypercholesterolemic 
Patients 1220-25 °300A 
Massive Cholesterol Lowering Acutely Improves 
Myocardial Vascular Responsiveness in Fanailial 
Hypercholesterolemia 1194-113.293A 
Mechanism of Action of Probucnl on Cholesteryl 
Ester Transfer Protein (CETP) mRNA in a CHO 
Cell Line That had Been Stably Translqected 
With a Hunmn CETP Gene 1011-21 °221A 
Pravastatin Reduces Both Clinical and Angiographic 
Restenosis Two Years After Percutaneous 
Transluminal Coronary Angioplasty: An 
Analysis of the PTCA Stratum of the REGRESS 
Trial 846- I • 79A 
Predicting Future Mortality From Acute Myocardial 
Infarction m a Westero Society Considering 
Population Shift, Present Trends, and Risk 
Factor Intervention 1224-119 • 307A 
Randomized Trial of Cholesterol-Lowering Therapy 
and Antioxidant Vitamin Supplementation in 
6,000 People With Diabetes Mellitus 1164-72o 
283A 
Randomized Tnal of Cholesterol-Lowering Therapy 
and Antioxidant Vitamin Supplementation in 
Over 20,000Higher Risk Patients 824-2•263A 
Regional Myocardial Perfusion Reserve on 
Cholesterol Lowering Therapy Counpared With 
Percutaneous Transluminal Coronary 
Angioplasty Assessed With Positron Emission 
Tomography 854-1 •460A 
Relation of Apo E Genotype to Response to 
Lipid-Lowering Therapy and Progression of 
Coronary Artery Disease 1075-77 • 244A 
Simplified Coronary Risk Stratification for Clinical 
Use 824-I •263A 
Simvastatin Improves In V~tro Large and Small 
Vessel Endothelial Function Independent of
Lipid Lowering Effects 1192-27. 290A 
Simvastatin I creases Nitric Oxide Induced 
Coronary Vasodilation and Nitric Oxide 
Production in Catqne Coronary Microvessels 
1011-29o 223A 
Circadian rhythm 
Circadian Regulation of Heart Rate Variability in 
Primary Pulmonary Hypertension: An 
Unappreciated Risk Marker? 1086-184 • 120A 
Differences in Heart Rate Variability Between 
African-Americans and Whites With Coronary 
Artery. Disease and lschemia 1086-188 • 121A 
Clinical trials 
A Multicenler Randomized Trial Comparing by 
Intravascular Ultrasound, the Acute and 
Subacute Recoil of 4 Stents 1217-90•96A 
A New Precedent in Percutaneous Coronary 
Intervention: Less than 9% Subsequent Target 
Vessel Revascularization in a Large Scale, 
Diverse Patient, Randomized Trial of Stenting 
1188-51 •83A 
Aggressive Lipid Lowering Versus Coronary 
Angioplasty in Patients With Inducible 
Myocardial [schemia: An AVERT Substudy 
1066-141 •341A 
Antihyperglycemic Treatment in Noninsullin 
Dependent Diabetics With Coronary Disease: 
Increased Metfonnin-Associated Mortality Over 
a Five-Year Follow-Up 1196-118.295A 
Argentine Randomized Study Optimal Coronary 
Balloon Angioplasty aud Stenfing Versus 
Coronary' Bypass Surgery in Multiple Vessel 
Disease (ERACt 11): In-Hospital and 30-Day 
Results 81-9~33A 
Balloon Dilatation Guided by Intravascular 
Ultrasound: Acute and Long-Term Results of 
the UPSIZE Pilot Trial 810-1 •46A 
Beraprost Sodium, an Effective Treatment lbr 
Peripheral Arterial Disease: Results of BERC1 
2, a Randomized, Placebo-Conm~lled, Double 
Blind Study 840-2,277A 
Cardiovascular Safety of Sildenafil in the Treatment 
of Erectile Dysfunction tED) 877-5o309A 
KEY." Abstract itle. Session-abstract number • page number 
Clinical Events and Angiographic Results of the 
First 142 Patients Randomized in The 
BESMART Study 1217-56e95A 
Comparison of the Protection Against Restenosis 
Afforded by Stenting or Abciximab 1006-39 • 
I1A 
Critical Event Pathways for Progression of Heart 
Failure and Mortality: Insights From the ATLAS 
Study 1228-8 -212A 
Cutting Balloon Versus Conventional Balloon 
Angioplasty: Subgroup Analysis of a 
Prospective and Randomized Trial 1098-41• 
48A 
Do Pert-Procedure Creatine Kinase Elevations in 
Trials of Percutaneous Intervention Reflect 
Those Observed in Clinical Practice? 1036-39• 
23A 
Does Ticlopidine Reduce Reocclusion After 
Successful Balloon Angioplasty of Coronary 
Occlusions? lnsights From TOSCA 1068-55o 
40A 
Dofetilide a New Class II1 Antiarrhythmic Drug 
Prevents Atrial Fibrillation in Patients With 
Congestive Heart Failure in Normal Sinus 
Rhythm: Results of the DIAMOND-CHF Study 
1144-152.,132A 
Double Blind. Placebo-Controlled Trial of 
Recmnbinant Human Vascular Endothelial 
Growth Factor: The VIVA Trial 874-4°384A 
Durability of Treatment Effect of Thrombolysis for 
Acute Myocardial Infarction: The GUSTO 
Trials 858-5 o3g0A 
Early Clinical Evaluation of rNAPc2, a Novel 
Inhibitor of Blood Quantitafion Factor 
Vlla/Tissue Factor (fVIlafrF) 1 I04-74.255A 
Early Outcome in Elderly Patients With Acute 
Myocardial Infarction: The 60-Minute 
Myocardial Infarction Project 832-2•356A 
Echocardiographic Findings of Shock Complicating 
Acute Myocardial Infarction and the Effects of 
Early Revascularization Left Ventricular 
Structure and Function: The SHOCK Trial 
898-5 • 399A 
Effect of Amlodipine on Cardiovascular Events and 
Procedures 892-5 •314A 
Effect of Avocado-Enriched Diets on Serum Lipids: 
A Meta-Analysis 860-5•297A 
Effect of Estrogen + Progestin on Progression of 
Carotid Atbeu'osclerosis in Postmenopausal 
Women With Documented Heart Disease: 
HERS B-Mode Substudy 831-5t265A 
Efficacy and Safety of Dofetilide in the Prevention 
of Sylnptomatic Attacks of Paroxysmal 
S upraventricular Tachycardia 123b148•156A 
Efficacy and Safety of Oral d,l-Sotalol in Patients 
Witb Implanted Defibrillators: Results of a 
Prospective. Double Blind, Randomized. 
Placebo-Controlled Multicenter Trial 801-3• 
lISA 
EP1STENT: A Large-Scale Randomized Trial of 
Primary Versus Provisional Corona]3, Stenting 
With Background Platelet Glycoprotein llb/llla 
Blockade 81-4°32A 
Eplerenone, a Novel Selective Aldosterone Receptor 
Antagonist (SARA): Dose Finding Study in 
Patients With Heart Failure 825-4° 188A 
Factors Determining Implantation of Defibrillators 
Following Trial Termination in Patients 
Randomized to Drug Therapy in the 
Antiarrhythmics Versus Implantable 
Defibrillators (AVID) Trial 801-1 • I14A 
Heart and Estrogen/Progestin Replacement S udy 
(HERS): A Study of Postmenopausal Women 
With Coronary Heart Disease 878-6o513A 
High Dose ACE Inhibitor Strategy Is More Effective 
Than Low Dose in Diabetic Patients With 
Congestive Heart Failure 825-3 ° 188A 
Importance of ECG -ST Elevation in Patients With 
Acute Myocardial Infarction Treated With 
ACE-lnhibitors 1095-200 • 347A 
In-Hospital Mortality of Elderly Patients Following 
Acute Myocardial Infarction 878-2-512A 
Incomplete Infarction Trial of European Research 
Collaborators Evaluating Prognosis 
Post-Thrombolysis (INTERCEPT Trial): A 
638A SUBJECT INDEX JACC February 1999 
Randomized, Placebo-Controlled Study of 
Adjunctive Diltiazem + Aspirin Versus Aspirin 
Alone in Patients With ST Segment Elevation 
My 858-1.379A 
Initial Results of the CURE Safety Trial: Coronary 
Brachytherapy With Radioactive Liquid-Filled 
Balloons 1216-59•94A 
lntracoronary Administration of Recombinant 
Fibroblast Growth Factor-2 (rFGF-2) in Patients 
With Severe Coronary Artery Disease: Results 
of Phase 1 874-1-383A 
Is a Patient Care Facilitated or Impeded by 
Participation i  an Acute Myocardial Infarction 
Research Trial? 1095-195 •346A 
Long-Term Beneficial Hem•dynamic and 
Neurohormonal Effects of Vasopeptidase 
Inhibition With Omapatrilat in Heart Failure 
l 110-18.185A 
Marked Benefit in Diabetic Patients Treated With 
Stent and Abciximab Combination: Six-Month 
Outcome of the EP1STENT Trial 82-4•34A 
Method•logic Drift in the Assessment of the TIMI 
Flow Grades and Its Impact on Angiographic 
Trial Results ll26-200o362A 
Nesiritide (Human B-Type Natriuretic Peptide) 
Improves Symptoms and Hem•dynamics n 
NYHA Class 111 and IV Heart Failure 825-2- 
188A 
Nondrug Therapy of Hypertension: Persistence of 
Effect After Discontinuation of Intervention 
804- I • 238A 
Nonsurgical Septal Reduction Therapy for 
Hypertrophic Obstructive Cardiomyopathy: 
One-Year Follow-Up 1142-103*502A 
One-Year Clinical and Three-Mmlth Angiographic 
Follow-Up of Cutting Balloon Angioplasty 
Versus Plain Old Balloon Angioplasty 
Randomized Study in Small Coronary Artery 
(CAPAS) 810-5 *47A 
One-Year Clinical Follow-Up Results of Stent 
Versus Atherectomy Randomized Trial 1007-93 
• 15A 
Patient Motivation and Reaction to Participating in
Clinical Heart Failure Trials 1228-2. 210A 
Patients With Longer QT (QTc) Interval Are More 
Likely to Remain in Sinus Rhythm After 
One-Year Treatment on Dofetilide: The 
EMERALD (European and Australian 
Mulficenter Evaluative Research on Atrial 
Fibrillation Dofetilide) Study 1144-153* 132A 
Phase 2 Trial of a Novel Prostacyclin Analogue, 
UT-15, in Patients With Severe Intermittent 
Claudication 840-3 o277A 
Phase 1 Trial of the Selectin Inhibitor CY-1503 
(Cylexin) in Infants Undergoing 
Cardiopulmonary Bypass Surgery 859-6• 536A 
Pravastatin Reduces Both Clinical and Angiographic 
Restenosis Two Years After Percutaneous 
Transluminal Coronary Angioplasty: An 
Analysis of the VI'CA Stratum of the REGRESS 
Trial 846-1 •79A 
Prediction of Functional Recovery in Patients With 
Acute Myocardial Infarction as Assessed by 
Myocardial Contrast Echocardiography and 
Coronary Flow Reserve Measurement 882-1 *
480A 
Prophylactic ICD Implantation After Prospective 
Risk Stratification i Posfinfarction Patients 
801-2 • 114A 
Randomized Trial Comparing aHigh Fat, Low 
Carbohydrate Diet to the National Cholesterol 
Education Program Step II Diet 850-3,, 297A 
Randomized Trial of Oral Anticoagulafion Therapy 
in Patients With Acute lschemic Syndromes 
Without ST Elevation: Importance of Good 
Compliance 896-2•396A 
Relation of APO E Genotype to Response to 
Lipid-Lowering Therapy and Progression of 
Coronary Artery Disease 1075-77.244A 
Relationship of Coronary Peffusion and Stenosis to 
Arrhythmic Events in the Anfiarrhythmics 
Versus Implantable Defibrillators (AVIDI Trial 
1085-182. l19A 
Relationship of Plasma Lipids to Reductions in 
Cardiovascular Risk: A POSCH Report 824-4• 
263A 
Responsiveness to Angiotensin II (A 11) Predicts 
Left Ventricular (LV) Mass in Hypertensive 
Subjects 872-2,,298A 
Restenosis I  Not Reduced by Antithrombofic 
Therapy After PTCA: A Randomized 
Angiographic Follow-Up Study 1158-94•74A 
Results of a Multidose F'base I Trial With Tumor 
Necrosis Factor Receptor (p75) Fusion Protein 
(Etanercept) inPatients With Heart Failure 
1110-14.184A 
Safety of Platelet Glycoprotein Ilb/llla Inhibitor and 
Stents in Multivessel Coronary Intervention 
1006-43 • 12A 
Should All Patients With Acute Myocardial 
Infarction be Treated at Tertiary Hospitals 
Rather Than at Community Hospitals? 
1096-163.348A 
Substantial Number of Patients With Acute 
Coronary Syndromes at Risk for Stroke Each 
Year: Results From the PURSUIT Trial 
1154-132-366A 
T Wave AItemans in Postmyocardial Infarction 
Patients (ACES Pilot Study) 847- l • 144A 
The Bezafibrate Infarction Prevention (BIP) Stod~. 
CHD and Cancer Death in 9.050 Male Coronary 
Patients During 5.1 Years:Significance of Trends 
in Tertiles of Lipids and Fibrinogen Levels 
1137-116" 274A 
The Bezalibrate Infarction Prevention (BIP) Study, 
Israel: HDL Subclasses (HDL2 & HDL3. LpAI, 
& LpAI:All), in CHD Patients Compared to 
Healthy Individuals 1135-71o271A 
The Effect of Chronic Nocturnal Oxygen on Sleep 
Disordered Breathing Associated With 
Congestive Heart Failure (CI-IF) 1199-l 8 • 
202A 
The Medicine, Angioplasty, and Surgery Study 
(MASS), a Prospective Randomized Trial of 
Medical Therapy, Balloon Angioplasty or 
Bypass Surgery for Single Proximal Left 
Anterior Descending Artery Stenosis: Five Years 
of Follow-Up 1097-141 °349A 
The Value of Epicardial Mapping of Ventricular 
Tachycardia From the Coronary Venous System: 
A Prospective Multicenter Study 816-1 *121A 
Tolerance and Responses to Tamoxifen and 
Toremifene in Male Patients With Coronary 
Artery Disease 1164-67,,282A 
Transfer From Commanity Hospitals to Tertiary 
Hospitals After Thrombolytic Therapy for Acute 
Myocardial Infarction: Insights From GUSTO-I 
t 096- 162 • 348A 
Unfiltered Coffee Raises Plasma Homocysteine 
Levels in Healthy Volunteers 860-2• 297A 
Valsartan (Diovan): Effect on Micrnalbuminuria n
Patients With Type I1 Diabetes and Nephropathy 
872-5 ° 299A 
Ventricular Arrhythmias Are Closely Related to Left 
Venlricular Size and Mass in Patients 
Post-Infarction: Experience From the Survival 
and Ventricular Enlargement (SAVE) Study 
898-2•398A 
VIAGRA (Sildenafil Citrate) Potentiates the 
Hypotensive Effects of Nitrates in Men With 
Stable Angina 877-6•309A 
Cocaine 
Cocaine Increases Total Protein and Fetal B-Myosin 
Heavy Chain Protein Expression in Cultured 
Adult Cardiac Myocytes 1141 86°500A 
Collagen 
17b-Estradiol Decreases Collagen Deposition in the 
Noninfarcted Myocardium After Large 
Myocardial Infarction in the Rat 1001-170• 
322A 
Angiotensin Converting Enzyme 1(ACE) 
Insertion/Deletion Polymorphism in Chilean 
Normotensive Population: Effect on Plasma 
ACE Activity. Left Ventricular Mass in Cardiac 
Fihrogenesis 1136-112•273A 
Impact of Basic Fibroblast Growth Factor Treatment 
on Left Ventricular Ejection Fraction, 
Remodeling. and Collagen Content After Acute 
Anterior Myocardial Infarction 826-3e354A 
Increase in Interstitial Collagen of Left Ventricular 
Wall in Insulin-Resistant S age of Otsuka 
Long-Evans Tokushima Fatty (OLETF) Rats 
1201-86 * 507A 
Increased Collagen Synthesis and Content in Stented 
Versus Balloon Treated Arteries 845-4"70A 
Protective Effects of Carvedilol in Pressure-Induced 
Left Ventricular Hypertrophy and Diabetes 
1229-85 •509A 
Serum Urate Is Related to Circulating Matrix 
Metalloproteinases in Chronic Heart Failure 
895-3•217A 
Stimulation of Fibrotic Remodeling by Exogeneous 
Endothelin-1 in the Rabbit Double Injury Model 
ofRestenosis 1160-136•79A 
Collateral circulation 
A New Method to Determine Risk Region in 
Experimental Myocardial Infarction 1155-141 * 
367A 
Antiadhesion Monoclonal Antibodies Against 
ICAM lnhibit Arteriogenesis 911-1 *318A 
Basic Fibroblast Growth Factor ls Produced From 
the lschemic Myocardium of Patients With 
Stable Effort Angina 1186-141 •378A 
Clinical Determinants ofCoronary Steal Induced by 
Intravenous Dipyridamole 897-3°482A 
Clinical Presentation ofReocclusion of the Infarct 
Related Artery After Successful Thrombolytic 
Therapy: Impact of Collateral Filling 1004-164 
.326A 
Does Channel Depth Affect Angiogenesis After 
Catheter-Based Myocardial Revascularization? 
A Histologic and 3-D Micro Computed 
Tomography Study 1035-137. 333A 
Efti~ct of Basic Fibroblast Growth Factor on 
Myocardial Necrosis and Perfusion After Acute 
Anterior Myocardial Infarction 1155-169• 
368A 
Feasibility Study of Percutaneous Transmyocardial 
Revaseularization With Forward-Looking 
A-Mode Ultrasound for Real-Time Wall 
Thickness Measurements 886-6•101A 
Measurement ofCoronary Flow Velocity Using 
Contrast-Enhanced Transthoracic Doppler: 
Validation by Intracoronary Doppler Guide Wire 
1179-125o456A 
Myocardial Contrast Echocardiography Compared 
With Dobutamine Echocardiography to Predict 
Myocardial Viability Shortly After Reperfusion 
of Acute Myocardial Infarction With Direct 
Angioplasty 1057-64*412A 
Viability Threshold Determination by Collateral 
Flow Estimation Using Tc 99m Sestamibi 
Imaging During Acute Infarction 1060-126o 
417A 
Computer communication etworks 
A Three-Year Experience With Real-Time Remote 
Pediatric Echocardiography Using Low-Cost, 
PC-Based Telemedicine 814-2o524A 
Accelerating the Improvement i  Community 
Cardiovascular Health Using Web-Enhanced 
Project Development 1503-1.7A 
First Experiences With DICOM Images and 
Waveforms lntergration 1504-2•8A 
lntemet Tele-Echocardiography: Transmission of 
Echocardiograms a E-Mail 1176-61 •451A 
lnteroperable Cardiological Data Cards: Italian 
Nationwide hnplementation Phase G7 
CARDIO-ANMCO Project 865-2-5A 
Is Atrial Fibrillation an Independent Predictor of 
One-Year Mortality and Hospitalization i
Patients With Congestive Heart Failure? Data 
From Italian Network on Congestive Heart 
Failure (1N-CHF) 1140-8-191A 
Long-Term (13-Year) Results After Pulmonary 
Balloon Valvuloplasty in Adolescent and Adult 
Patients 1181-160.532A 
ProCOR: A Global Electronic Conference for 
Promoting Cardiovascular Health in Developing 
Countries 865-6"6A 
The Integrated Paperless Multimedia Electronic 
Patient Record: Coming of Age in a 
Multicentered Hospital Environment 865-1-5A 
KEY: Abstract itle, Session-abstract number •page number 
JACC February 1999 SUBJECT INDEX 639A 
Computer-assisted instruction 
A Computer-Based Heart Sounds Tutorial and Self 
Assessment Program for Students and House 
Officers 1503-2•8A 
Acute Mechanical Traosmyocardial Channelling 
Provides Protection for ischemia gl3-1.341A 
Graphical Plotting of Framingham Risk Scores for 
Office Use 865-4•6A 
Identification of Circulatory Parameters by Use of a 
Computer Model Coupled With a Nonlinear 
Optimization Algorithm 1505-2 * 9A 
Impact of a Novel Blood Noise Reduction Algorithm 
on lnterobserver Variability for Morphometric 
Measurements 1159-49076A 
Object Virtual Reality Display of Congenital 
Cardiovascular Path•logic Specimens 1502-2 •
7A 
Tissue Harmonic Imaging Improves Endocardial 
Border Definition: An Insight From Quantitative 
Comparison of Vide•intensity Between 
Myocardial and Cavity With Digital Subtraction 
828-2 •439A 
Contractile proteins 
Human Cardiac Troponin Function: An In Vitro 
Motifity Analysis 1019-5• 171A 
Noninvasive Assessment ofLeft Ventricular 
lso,,~lumic Contraction and Relaxation Using 
Continuous Wave Doppler Aortic Regurgitant 
Velocity Signals: An In Vivo Validation Study 
1150-107o446A 
Plasma Troponin T Level in Patients With Unstable 
Angina Pectofis: Association With Myocardial 
Perfusion and Functional Abnormalities on 
Gated SPECT Imaging and Angiographic 
Morphology 1094-130•345A 
Contracti l i~- 
Abnormal Doppler-Derived Myocardial Systolic 
Strain Rate Is a Strong Index of LV Contractility 
815-1 •428A 
Altered Force Frequency Relationship of Human 
Myocardium in Mitral Valve Incompetence 
852-5 •558A 
Analysis of the Interval Force Relation in the 
Presence of Coronary Artery Disease and/or 
Cardiomyopathy in Atrial Fibrillation 1049-7• 
176A 
Assessment of Regional Left Ventricular 
Contractility: Comparison Between NOGA 
Electromechanical Mapping and 
Echocardiography 1147-33..442A 
Atrial Stunning: Increased Myocardial 
Na+/Ca2+-Exchanger but Unchanged SR Ca2+ 
Transport Protein Expression 868-30155A 
Changes in Ejection Fraction Three Months After 
First Myocardial Infarction Are Related to 
Intramural Mechanics 1093-166 • 343A 
Contractile Dysfunction Very Early in Chagas' 
Cardiomyopathy 1050-88• 492A 
Correlation Between Systolic Wall Thickening and 
the Cyclic Variation of Integrated Backscatter in 
Ischemic Myocardium 1237-80•476A 
Dantrolene Sodium Restores the Altered 
Force-Frequency Relationship n Failing Human 
Myocardium 1227-160209A 
Distinctive Deviation From Normal Strain Patterns 
in Left Ventricular Hypertrophy: Observations 
From The LIFE Study 910-30485A 
Evaluation of Segmental Myocardial Strain Rate by 
Tissue Doppler Echocardiography in a Feline 
Model of Hypertrophic Cardiomyopathy 
1180-37 • 458A 
Human Cardiac Troponin Function: An In Vitro 
Motility Analysis 1019-5•171A 
Impaired Atrial b-Adrenergic Responsiveness 
Contributes to Atrial Stunning 868-2• 154A 
Impaired Cardiac Function in Mice Overexpressing 
Bovine Growth Hormone Gene 1048-14 * 173A 
Mechanical Restitution Reflects Impaired Calcium 
Handling in Pacing Induced Heart Failure in 
Immature Goats 891-6 •516A 
Myocardial Strain Rate Imaging: Validation of a 
New Doppler Method to Quantify Regional 
Myocardial Function 815-2°428A 
Nitric Oxide Spares Myocardial Oxygen 
Consumption Attenuating Contractile Response 
to b-Adrenergic Stimulation i  Patients With 
Idiopathic Dilated Cardiomyopathy 803-I • 
494A 
Papillary Muscle Myocardial Velocity Gradient: A
New Indicator for Assessing Papillary Muscle 
Contractility by Tissue Doppler Imaging 815-6 
•429A 
Potentiation of the B-Adrenergic Responsiveness in 
Failing Human Myocardium by Dantrolene 
Sodium 1227-150209A 
Pyruvate Prevents Oxidative Stress 1192-30•291A 
Regulation of Atrial Contractility in the Human 
Heart 1019-70171A 
Regulation of Ryanodine Receptor by Cyclic ADP 
Ribose in Guinea Pig Isolated Ventricular 
Myocytes: Possible In•tropic and 
Arrhythmogenic A tions 1052-149 • 109A 
Response to Left Ventricul~ Systolic Wall Motion 
Velocity During Low-I)ose Angiotensin lI 
Stress Tissue Doppler Imaging in Patients With 
Hypertrophic Cardiom yopat hy 1207-83 •465A 
Contrast echocardiagraphy 
A Multicenter Clinical Evaluation of the Safety and 
Efficacy of BRI (SonoVue) as a Contrast 
Enhancing Agent for LV Endocardial Border 
Delineation 1058-106•413A 
Abnormal Intraventricular Filling Pattern During 
Myocardial lschemia: A Consequence of 
Regional Systolic Dys function 1118-32.429A 
Advantages of Doppler Tissue Energy-Harmonic 
Modality for Contrast Peffusion Imaging: A 
Comparative In Vitro Study 1236-66•476A 
Assessment ofMyocardial Perfusion With 
Intravenous lnfusion of Micrnhubbles Using 
Intermittent Harmonic Imaging in Patients With 
Acute Myocardial Infarction: Comparison With 
99mTc-Sestamibi Single-Photon Emission 
Computed Tomography and Myocardial Contra 
1236-61 •475A 
Assessment of Refill Kinetics of Microbubbles for 
Quantification f Myocardial Perfusion: Is a 
Single Frame Enough to Destroy All Myocardial 
Contrast? 1208-109•467A 
Automatic Three-Dimensional Mapping of Entire 
Left Ventricular Myocardial Perfusion Without 
the Need for Manually Delineating Perfusion 
Zones: An Experimental Study 829-2o440A 
Can Timing and Quantitative Analysis Improve the 
Accuracy of Contrast Echocardiography in 
Detection of Myocardial Viability? 1057-61 *
412A 
Capillary Derecruitment Causes Pet-fusion Defects 
on Myocardial Contrast Ecbocardiography 
During Pharmacologic Stress 841-1*450A 
Combined Evaluation of Functional Peffusion by 
Myocardial Contrast Echocardiography in the 
Clinical Setting 1208-105 •466A 
Contrast Dnbutamine Stress Echocardiography in 
100 Consecutive Patients: Improvement in 
Image Quality, Wall Segment Visualization, and 
Confidence of lnlerpretatiou 1089-123 •422A 
Contrast-Enhanced Transthoracic Second Harmonic 
Echo Doppler With Adenosine: A Noninvasive, 
Rapid, and Effective Method for Coronary Flow 
Reserve Assessment 1179-123•455A 
Definition of Normal and Abnormal Human 
Myocardial Perfusion at Rest by Venous 
Contrast Echocardiography 1236-62 -475A 
Diagnosis of Arrhythmogenic Right Ventricular 
Dysplasia by Contrast Echocardiography 
1028-127 •408A 
Differential Contractile Response of Asynergic 
Myocardium to Pairecl Pacing and Dobutamine 
1057-63 • 412A 
Effect of a Novel a Na+/H+ Exchange Inhibitor, 
KB-R9032, on Myocardial 
lschemia/Repeffusion Injury in Rats in Dogs 
1124-168 °358A 
Endocardial Definition by Real-Time 
Three-Dimensional Echocardiography: 
Improved Delineation With Contrast 
Enhancement 829-5°441A 
Endothelial and Smooth Muscle Cell Migration 
Induced by Vascular Endothelial Growth Factor 
KEY." Abstract title, Session-abstract number ° page number  
With Ultrasound After Systemic Administration 
1028-125 • 408A 
Evaluation of Coronary Reserve in the Left Anterior 
Descending Coronary Artery by 
Contrast-Enhanced Transthoracic Harmonic 
Echo Doppler: Validation Versus lntracoronary 
Doppler Flow Wire 1179-122.455A 
Flow Kinetics of Perfluoropropane-Containing 
Albumin Ultrasound Contrast Microspheres in
Normal and Inflamed Rat Microcirculation 
1028-124o408A 
Improved Endocardial Border Delineation During 
Dobntamine-Atropine Echocardiography Using 
Perfluorocarbon Containing Microbubbles 
1207-80 • 465A 
Increased Detection of Viable Myocardium Using 
Myocardial Perfusion Analysis With 
Dobutamine Stress Echocardiography in 
Patients With Resting Wall Motion 
Abnormalities 882-6o 481A 
Increased Myocardial Perfusioo in Patients With 
Acute Myocardial Infarction and Recent 
Angina: An Acute Myocardial Contrast 
Echocardiography Study 882-30481A 
lnterinstitutional Variability in Detecting Myocardial 
Perfusion Abnormalities With Accelerated 
Intermittent Harmonic Imaging I057-62.412A 
ls Intravenous Myocardial Contrast 
Echocardiography Preferable to Nuclear 
Scintigraphy in the Assessment of Myocardial 
Perfusion? Comparison i Patients With 
Suspected Coronary Artery Disease 1089-127o 
423A 
Is the Technically Limited Echo Study an 
Endangered Species? Endocardial Border 
Definition With Native Tissue Harmonic 
Imaging and Optison Contrast: A Review of 200 
Cases I f158-1040413A 
Left Ventricular Volume Measurements in Cardiac 
Patients Using Contrast Enhanced Real-Time 
Three-Dimensional Echocardiography: 
Feasibility and Accuracy Compared With 
Magnetic Resonance Imaging 914-1..486A 
Microbubble Persistence in the Microcirculation 
During Inflammation ls Due to Their Adherence 
to Activated Leukocytes 1 fl28-123 o40"/A 
Myocardial Contrast Echocardiography Compared 
With Dobutamine Echocardiography to Predict 
Myocardial Viability Shortly After Reperfusion 
of Acute Myocardial Infarction With Direct 
Angioplasty 1057-64o412A 
Myocardial Contrast Echocardiography in Acute 
Myocardial Infarction and Unstable Angina: 
Correlation With Nuclear Medicine Preliminary 
Study 1236-63 -475A 
Myocardial Contrast Echocardiography Is aHighly 
Sensitive Tool for the Detection and 
Localization of Microvascular Injury 1236-65 • 
476A 
Myocardial Contrast Echocardiography Perfusion 
Imaging for the Evaluation of Chest Pain in the 
Emergency Department 1208-104o466A 
Myocardial Perfusion Studied by Power Doppler 
Imaging in Patients With a Recent Myocardial 
Infarction 882-2 °480A 
Neither Myocardial Perfusion Nor Regional Wall 
Motion Closely Predict Angiographic Findings 
in Chronically Ischemic Myocardium 882-5• 
481A 
New Insights Into Mechanisms of Albumin 
Microbubble Adhesion to Coronary 
Endothelium Using Chemically Modified 
Microbubbles 1028-122•407A 
New Technique for Quantifying Spatial Dispersion 
of Ventricular Repolarization Morphology in 
Digitized ECGs l 117-188•351A 
Nonperfused Versus Perfused Myocardium: Feature 
Extraction of Digital Myocardial Contrast 
Echocardiographic Images 841-2 •450A 
Phasic Changes in Video Intensity Can Be Used to 
Detect Coronary Stenosis at Rest Without Need 
for Stress 841-3 •450A 
Pulse Inversion Harmonic Imaging Consistently 
Achieves Myocardial •pacification Which Is 
640A SUBJECT INDEX JACC February 1999 
Visually Apparent, But Nonuniform Following 
Intravenous Optison in Patients 1058-107- 
413A 
Quantitative Analysis of Coronary Vasculopathy in
Patients With Fabry Disease by Contrast Echo 
Myocardial Perfusion 1179-L27*456A 
Real-Time Detection of Myocardial Perfusion 
Defects With Power Harmonic Imaging 
1058-108.414A 
Real-Time Three-Dimensional Contrast 
Echocardiography for Left Ventricular Cavity 
Visualization: Animal and Clinical Studies 
1119-83 • 431A 
Regional Variation in Acoustic Density of 
Normokinetic Myocardium During Dobutamine 
Stress-Contrast Echocardiography 1236-64- 
475A 
Size of Myocardial Contrast Defect After Primary" 
PTCA in Patients With First Myocardial 
Infarction Predicts Subsequent Left Ventricular 
Dysfunction at Four Weeks Follow-Up 882-4• 
481A 
Studies of Laser Transmyocardial Revascularization 
(TMR) in Pigs: Using Wall Motion Evaluation 
and Intravenous Echo Contrast Myocardial 
Perfusion 1089-125°422A 
Tenfold Augmentation of Myocardial Uptake of 
Vascular Endothelial Growth Factor With 
Ultrasound After Systemic Administration 
41 I-3*4A 
The Combination of Blood and Agitated Saline 
Contrast Enhances the Doppler 
Echocardiographic Assessment of Tricuspid 
Regurgitation Flow and Estimation of 
Pulmonary Artery Pressure in Patients With 
Emphysema 1222-74. 304A 
The Effect of Opfison on Sensitivity and Specificity 
of Dobutamine Contrast Echocardiography in 
Technically Difficult Pafients 1056-35 o411A 
The Usefulness of Second-Generation Ultrasound 
Contrast Agent o Identify Intracardiac 
Thrombus 1028-126= 408A 
Transesophageal Echocardiography Adds 
Incremental Information in the Evaluation of 
Cardiac Source of Embolus 867-6=473A 
Transpulmonary Passage of Albune× as a Predictor 
of Clinical Outcome in Patients With Chronic 
Congestive Heart Failure 1179-124°456A 
Validation of Myocardial Perfusion Assessed by 
Digitally Subtracted, Dual Gated, Power 
Doppler Harmonic Contrast Echocardiography 
841-5*451A 
Contrast media 
A Randomized Trial of Contrast Media Utilization in 
High-Risk PTCA (The COURT Trial) 1006-38 
- l lA  
Acute and Subacute Stent Occlusion: 
Risk-Reduction by Combined Use of Nonionic 
and Ionic Contrast Media 1188-91085A 
Benefit of IV Contrast and Harmonic Imaging 
During Dobutamine Stress Echocardiography 
1089-1240422A 
Does Nonionic Contrast Medium Still Modify 
Angioplasty Results in the Stent Era? 1188-93o 
85A 
Flow Kinetics of Perfluornpropane-Containing 
Albumin Ultrasound Contrast Microspheres in 
Normal and Inflamed Rat Microcirculation 
1028 124•408A 
Impact of Ionic (loxaglate) and Nonionic (lovers•l) 
Contrast Media on PTCA-Related 
Complications 1188-92-85A 
Interinstitutional Variability in Detecting Myocardial 
Perfusion Abnormalities With Accelerated 
Intermittent Harmonic Imaging 1057-62 •412A 
The Effect of •prison on Sensitivity and Specificity 
of Dobutamine Contrast Echocardiography in 
Technically Difficult Patients 1056-350411A 
The Relationship Between Intramyocardial 
Microbubble Cavitational Activity at Different 
Mechanical Indices and Myocardial Contrast 
During Intermittent Imaging 841~0450A 
Coronary artery disease 
"Optimal" Instead of "High'' Balloon Pressure 
Dilatation During Coronary Stent Placement 
833-3058A 
16-Interval Gating Improves Thallium-201 Gated 
SPECT LVEF Measurement i  Patients With 
Large Myocardial Infarction 1122-127•436A 
A Comparison of Diabetics With Restenosis to 
Diabetics Without Restenosis 1187-42•82A 
A New Approach to Improve Detection of Coronary 
Artery Disease in Patients With Left Bundle 
Branch Block Using Dobutamine Stress 
Echocardiography 1056-36*411A 
A Phantom Model for Detection of Coronary 
Stennsis by Three-Dimensional Magnetic 
Resonance Coronary Angiography 1121-62* 
434A 
A Randmnized Comparison of Cilostazol Versus to 
Ticlopidine Therapy After Elective Coronary 
Stent Placement 1104-700255A 
A Randomized Comparison of the Effects of 
Gradual Inflation at Optimum Pressure Versus 
Steut Implantation on Early and Late Outcome 
1189-48 • 87A 
A Randomized Trial of Contrast Media Utilization in 
High-Risk PTCA (The COURT Trial) 1006-38 
• l lA 
A Simple Prognostic Score Based on Clinical 
Parameters inPatients With Cardiac Symptoms 
and Normal Resting Electrocardiograms 
1215-1410393A 
A Simplified Cardiovascular Event Reduction Tool 
(CERT) Developed From the West of Scotland 
Coronary Prevention Trial (WOSCOPS) 
1095-197 •347A 
Acute and Six-Month Follow-Up Results of 32P 
Radioactive b-Emitting Stem Implantation i  
Patients With CAD: The Milan BX 
Dose- Response Study 77-6 • 20A 
Acute Effects of Nicotine Gum on Coronary Artery 
Dimensions in Patients With Coronary Artery' 
Disease 1044-115° 236A 
Acute Lmnen Gain After Cutting Balloon 
Angioplasty in Calcified and Noncalcified 
Lesions: lntravasctdar Ultrasound Analysis of 
the REDUCE Study 886-30101A 
Acute Mechanical Transmyocardial Channelling 
Provides Protection for lschemia 813-1-341A 
Age as a Risk Factor for Major and Minor Adverse 
Clinical Events in PTCA: A Report From the 
NHLBI Dynamic Registry 1216-43.93A 
Analysis of the Interval Force Relation in the 
Presence of Coronary Artery Disease and/or 
Cardiomyopathy in Atrial Fibrillation 1049-7 * 
176A 
Angiographic Characteristics and Management of 
Occluded Infarct Related Artery Following 
Acute Myocardial Infarction: Findings From 
Regist~ of the Open Artery Trial 858-2•379A 
Apolipoprotein E Polymorphism Influences the 
Renmant-Like Particle-Cholesterol Metabolism 
1105-76 •256A 
Apoptolysis: A Novel Mechanism for Plaque 
Ulceration and Rupture 1161-112.278A 
Apoptosis Mediated Regional Myocyte Loss and 
Compensatory Hypertrophy in Pigs With 
Hibenrating Myocardium 1182-200°372A 
Are Acute Outcomes Worse for "All Arterial" 
Coronary Bypass Surgery? A Comparison 
Based on the Number of Arterial Conduits Used 
1097-1370348A 
Are There Clinical and Procedural Outcome 
Differences Between African and White 
Americans Undergoing Percutaneous Coronary 
Interventions? 1187-43•82A 
Assessment ofSerial Changes of the Coronary 
Arterial Remodeling From the Mechanical 
Viewpoint, in Acquisition of Initial Luminal 
Gain 1010-50.19A 
Association Between Atherosclerotic Plaque 
Temperature and Risk Factors of Coronary 
Atherosclerosis 903-4•400A 
Attenuation Corrected Thallium Scintigraphy 
Accurately Predicts the Invasively Measured 
Fractional Flow Reserve 802-2°417A 
KEY." Abstract i tie, Session-abstract number ° page number 
Automatic Quanfitation of Wall Motion and 
Thickening by Gated SPECT: Validation and 
Application in Identifying Severe Coronary 
Artery Disease 802-6o418A 
Availability of Coronary Stems ls Associated With a 
Reduction in Abrupt Vessel Closure Rates 
873-3o91A 
Bailout Stenting in Small Vessels: Preliminary 
In-Hospital Results of the ULTRA Acute or 
Threatened Closure Registry 843-3- 68A 
Biphasic Increases in Vessel Wall Thickness of 
Grafted Saphenous Vein: Evidence From 
Intravaseular Ultrasound 1159-46.75A 
Black Patients Presenting With Acute Coronary 
Syndromes Have Better Outcomes Due to Less 
Extent of Disease I 154-129 * 365A 
C-Reactive Protein Levels in Acute Coronary 
Syndromes Are Unrelated to the Extension of 
Coronary Atherosclerosis 1183-133 • 374A 
Can Magnesium Sulfate Suppress 
Acetylcholine-lnduced Coronary Spasm in 
Patients With Vasospastic Angina? 1042-72* 
233A 
Capillary Derecrnitment Causes Perfusion Defects 
on Myocardial Contrast Echocardiography 
During Pharmacologic Stress 841-1 e450A 
Cardiovascular Responses to Dobutamine and 
Exercise Stress Testing in Patients Taking 
Beta-Adrenevgic Blocking Agents 1226-191 ° 
565A 
Chlamydia Pneumoniae and Helicobacter Pylori in 
Human Coronary Atherosclerosis 817-5o260A 
Chlamydia Pneumoniae Seropositivity Predicts the 
Risk of Restenosis After Per'cutaneous 
Transluminal Coronary Angioplasty 846-3. 
80A 
Chronotropic Incompetence Predicts Long-Term 
Mortality Better Than Coronary Angiography 
862-1 °561A 
Circadian Variations in Right and Left Coronary 
Artery Involvement During Acute Myocardial 
Infarction 1062-167 =335A 
Clinical Evaluation of a Novel Dual-Simultaneous 
SPECT Myocardial Perfusion Protocol: Blinded 
Comparison to Dual-Sequential Images 802-5° 
418A 
Clinical, Angiographic, and Physiologic Predictors 
of Major Adverse Cardiac Events (MACE) After 
Stent Implantation 1007-51o12A 
Comparison of Coronary Bypass Surgery Venus 
Coronary Angioplasty in Patients With Chronic 
Renal Failure 1187-39-81A 
Comparison of Coronary Remodeling in the Culprit 
Lesion in the Acute Coronary Syndrome and 
Stable Angina Pectoris 1010-45.18A 
Comparison of Coronary Stenting in Hemodialysis 
and Nonhemodialysis Patients 873-5.92A 
Comparison of Deferral Versus Performance of 
PTCA Based Upon Fractional Flow Reserve: 
The DEFER Study 864-1 *89A 
Contemporat2,, Coronary. Intervention for Unstable 
Angina: A Report From the NHLBI Dynamic 
Registry 806-2°35A 
Contrast Dobutamine Stress Echocardiography in 
100 Consecutive Patients: Improvement i  
Image Quality, Wall Segment Visualization, and 
Confidence of Interpretation 1089-123 • 422A 
Coronary Arterial Remodeling at the Sites of Focal 
Vasospasmin Variant Angina 1073-26•241A 
Coronary Artery Disease Revascularizalion With the 
Joined Jostent: A Two Center Experience 
1037-92 ° 28A 
Coronary' Flow Reserve Assessment Using 
Transthoracic Color Doppler Echocardiography 
Detects Functional Status of Internal Mamaria 
Artery Bypass 1025-64°403A 
Coronary, Interventions: Is Being a Woman a Risk 
Factor? 1036-46.25A 
Coronary Plaque Progression: Evidence for the Role 
of Repetitive Plaque Ruptures and Erosions 
876-1 •393A 
Coronary Revascularization in the Elderly: 
Contemporary Experience 1216-60o94A 
JACC February 1999 SUBJECT INDEX 641A 
Correlation Between Coronary Artery Calcification 
and Impaired Peripheral Endothelial Function 
1220-2l o300A 
Cross-Sectional Measurements After Treatment of In 
Stent Restenosis: An lntravascular Ultrasound 
Guide for Intracoronary Radiation Dosimetry 
1100-45 •53A 
Cutting Balloon Versus Conventional Balloon 
Angioplasty: Subgroup Analysis of a 
Prospective and Randomized Trial 1098-41 ° 
48A 
Debunking the Yuppie Habit: Cigars and Endothelial 
Function 1042-71,233A 
Defect Extent and Severity Are Underestimated 
With Dobutamine Stress Using Technetium-99m 
Tetrofosmin Single-Photon Emission Computed 
Tom•graphic Myocardial Perfusion Imaging 
802-3°418A 
Definition of Normal and Abnormal Human 
Myocardial Perfusion at Rest by Venous 
Contrast Echoeardiography 1236-62 °475A 
Delayed Systolic Blood Pressure Recovery After 
Graded Exercise: No Advantage Over Exercise 
Blood Pressure Increase for Predicting 
Angiographic Coronary Disease 1017-193° 
543A 
Detection of Coronary Atherosclerosis Using 
High-Resolution, Two-Dimensional 
Transthoracic Echocardiography 901-3•484A 
Determination ofMenopausal Status in Women: The 
NHLBl-Sponsored WISE Study 835-4° 266A 
Difference in Security of Stent Jail Among 
Palmaz-Schatz Stent, NIR Stent, and Multilink 
Stent: Effect of Balloon Inflation Through Stent 
Struts 1188-89,84A 
Differences in Heart Rate Variability Between 
African-Americans and Whites With Coronary 
Artery Disease and lschemia 1086-188+121A 
Direct Comparison of lntracoronary Pressure and 
Doppler-Derived Parameters of Intermediate 
Lesions in Multivessel Disease 1071-50•46A 
Direct lntramyocardial Injection of Vascular 
Endothelial Growth Factor Results in Effective 
Gene Transfer for Patients With Chronic 
Myocardial Ischemia 874-3•384A 
Do We Still Need High-Pressure Stent Implantation 
With the New Less Rigid Second Generation 
Stents Mounted on Noncompliant Balloons? 
1217-89°96A 
Dobutamine Echocardiography Predicts Success of 
Revascularization a d Extent of Myocardial 
Viability After Bypass Surgery in Chronic 
lschemic Cardiomyopathy 1149-81-4.44A 
Does Type of Prior Revascularization Predict Mode 
of Presentation With Malignant Ventricular 
Arrbythmias? 1085-i83 •120A 
Doppler and QCA Guided Aggressive PTCA Has 
the Same Target Lesion Revascularization f 
Stent Implantation: Six-Month Results of the 
DESTIN1 Study 810-2•47A 
Echocardiography Accurately Measures Left 
Ventricular Function and Infarct Size in 
Closed-Chest Rat 1237-84o477A 
Effect of Andodipine on Cardiovascular Events and 
Procedures 892-5 *314A 
Effect of Coronary Risk Factors on Arterial 
Remodeling in Japanese Patients With De Nov• 
Atherosclerotic Lesions 1128-137o363A 
Effect of Different Estrogen-Progestin Replacement 
Therapy Schemes Upon Exercise-lnduced 
Myocardial lschemia in Female Menopausal 
Patients With Coronary Artery Disease 
1005-139,327A 
Effect of Negative Residual Stenosis Following 
Stenting on Angiographic Restenosis 1158-93• 
74A 
Effect of Residual Dissection After Coronary Stent 
Implantation on Early and Late Results 
1188-56* 84A 
ERects of L Arginine Administration on the 
Endothelium-Dependent Dilation in 
Atherosclerotic Coronary Arteries and Stenoses 
1062-165 - 334A 
Endocardial Flow Reserve Determines Resting 
Myocardial Function in Chronic Coronary 
Disease When Resting Flow Is Normal 821-1D 
437A 
Estimation of Operating Room Costs for Coronary 
Artery Bypass Graft Surgery 1015-121 #229A 
Ethnic Differences in Coronary Calcium Prevalence 
in a Symptomatic Population 1059-66,414A 
Evaluation of ACC/AHA Guidelines for Exercise 
Testing: What Is the Appropriate Indication for 
Each Pretest Probability Group? 862-3 * 561A 
Evaluation of ACC/AHA Guidelines for Exercise 
Electrocardiography in Patients Older Than 65 
Years 1198-192°560A 
Evidence for Variable Platelet Response to 
Low-Dose ASA in Patients With Coronary 
Artery Disease 1104-69*254A 
Excimer Laser Coronary Angioplasty in ln-Stent 
Restenosis: Acute and Long-Term Clinical 
Outcomes t 129.92°63A 
Exercise and Dobntamine Stress Echocardiography 
in Patients With Single Vessel Disease: Factors 
Influencing Ontcome 1027-105 *406A 
Exercise Pertbrmance-Based Outcomes of Medically 
Treated Palients With Coronary Artery Disease 
and Profound ST Segment Depression 
1066-140• 341A 
Experience With the PTFE Covered Stem in 
Percutaneous Coronary Interventional 
Proeedures: Indications and Outcome 1217-92* 
96A 
Failure to Detect Chlamydia Pneumoniae in
Coronary and Carotid Atherosclcrotic Plaques 
876-5 • 394A 
Final Results of thc Randomized Wallstent 
Endoprt>sthesis in Saphenous Vein Graft Trial 
(WINS) 807-4.37A 
Final Results of the Wallstent Endoprosthesis in 
Large Saphenous Vein Graft (WINS Registry) 
1099-53°51A 
Fractional Flow Reserve, Absolute and Relative 
Coronary Blood Flow Velocity Reserve in 
Relation to 99mTc-MlBl Spect Scintigraphy in 
Intermediate Coronar~ Lesions 1219-46)99A 
Frequency Dependency of Ultrasonic Backscatter 
From Coronary Plaque and Adventitia Relative 
to Blood, Measured in Humans Using 
lntravasc ular Ultrasound 901-2-483A 
Functional Significance of Coronary Artery Stenosis 
Evaluated by lntravascular Ultrasound: Relation 
With T1-201 Scintigram 1239-125-479A 
Gender Remains a Powerful Predictor of Increased 
Mortality in Acute Myocardial Infarction in a 
Defined Community Population 1154-128• 
365A 
Grafting Strategies in Minimally lnvasive CABG 
With EndoCPB 1138-173o551A 
High Variability in "Normal" Rates on Coronary 
Angiography Among Hospitals 808-5 °249A 
Histologic and Ecboc~diographic Features of 
Reperfused Versus Nonreperfused Chronic 
Hibernating Myocardium 849-2 •371A 
Holmium: YAG Laser Transmyocardial 
Revascularization 863-4-381A 
How Safe and Effective ls Percutaneous Treatment 
of ln-Stent Restenosis? 1129-58)62A 
Immediate and Long-Term Results: "T" Stenting in 
BifurcationalCoronary Lesions 873-4*91A 
Impact of a Novel Blood Noise Reduction Algorithm 
on lnterobserver Variability for Morphometric 
Measurements 1159-49,76A 
Impact of Cilostazol on Restenosis Following 
Percutaneous Coronary Angioplasty fur 
Diabetics 833 1°57A 
Impact of Glucagon Administration on Dobutamine 
Stress Testing Using Tc99m Sestamibi Single 
Photon Emission Computed Tomographic 
~SPECT) Imaging in Patients Receiving Acute 
Beta Adrenergie Receptor Btockade 802-1* 
417A 
Impact of On-Site lnterventional Facilities on 
Hospital Procedures and Outcomes: Canada 
Versus the United States in GUSTO lib 
1096-164 • 348A 
Impact of Smoking on Outcomes With Unstable 
Angina/Non Q Myocardial Infarction: Report 
From the T1M1-3 Registry 1154-133,366A 
Impaired Detection of Coronary Disease Due to 
Inconsistent Vasodilator Response to 
Dipyridamole in The NHLBI Women's l chemia 
Syndrome Evaluation (WISE) Study 854-3 • 
460A 
Impairment ofMyocardial Blood Flow Alters the 
Myocardial Stress-Strain Relations in Ischemic 
Cardiomyopathy 910-2•485A 
Importance of Gender in Predicting Long-Term 
Clinical Outcome in African-Americans 
Undergoing Coronary Intervention 1036-49• 
26A 
Improved Endocardial Border Delineation During 
Dobutamine-Atropine Echocardiography Using 
Perfluorocarbon Containing Microbubblcs 
1207 -80 • 465A 
Improved Washout Profiles With an 
Aden•sine/Exercise Protocol in Thallium-201 
Myocardial Perfusion Imaging 1029-36 • 410A 
In Vivo Gene Transfer of Fibroblast Growth Factor-2 
(FGF-2) Improves Myocardial Dysfunction 
Induced by Mieroembolization i Rabbit Heart 
1001-168*321A 
Increase in Global Left Ventricular Ejection Fraction 
With Low Dose Dobutamine Infusion: A 
Powerful Predictor of Response to Surgical 
Revascularization 821-2•437A 
Increased Level of Advanced Oxidation Protein 
Products in Patients With Coronary. Artery 
Disease 900-2 •317A 
Increased Myocardial Glucose Uptake After 
Percutaneous Myocardial Laser 
Revascularization in Patients With End-Stage 
Coronary Artery Disease 11162-168*335A 
Incremental Prognostic Value of 
Dobutamine-Atropine T chnetium-99m 
Sestamibi SPECT Imaging in Patients With 
Resting Perfusion Abnormalities Late After Q 
Wave Myocardial Infarction I060-122,416A 
Incremental Value of Electron Beam Computed 
Tom•graphic S anning in the Evaluation of 
Patients With Chest Pain 1059-84,415A 
Influence of Nonlipid and Lipid Risk Factors on 
Coronary Artery Disease Progression 1135-74, 
272A 
Influence of Parcutaneous Coronary Intervention at 
the Time of Diagnostic Catheterization  
Hospital Cost 1187-59,82A 
Influence of Residual Stenosis After PTCA and 
Stent Implantation on Stent Thrombosis Rate 
and Restenosis Rate 1158-91 +73A 
Integrated Backscatter Heterogeneity Index: A New 
Tool to Evaluate Subendocardial lschemia 
1088-6l *420A 
lntraoperative Echocardiograpby in Coronary Artery 
Bypass Graft Surgery Without Cardiopulmonary 
Bypass 866-6 D471A 
Intraoperative Troponin T Release in Coronary Sinus 
and Arterial Blood During Beating Heart 
Coronary Artery Surgery Using the "Octopus" 
Myocardial Stabilization Device 1138-177o 
552A 
Is Intravenous Myocardial Contrast 
Echocardiography Preferable to Nuclear 
Scintigraphy in the Assessment of Myocardial 
Perfnsion? Comparison in Patients With 
Suspected Coronary Artery Disease 1089-127* 
423A 
ls Remodeling Different Among Major Coronary 
Artery Branches? 1013-72o225A 
ls There Clinical Value in Measuring LVEF Both 
Post-Stress and at Rest During ECG-Gated 
Myocardial Perfusion SPECT Scintigraphy? 
897-4 • 482A 
Isolated Coronary Artery Ectasia Does Not Have a 
Benign Long-Term Prognosis 1128-140•363A 
Lecithinized Cu, Zn-Superoxide Dismutase Reduces 
lschemic Myocardial Damage Through 
Inhibiting Apoptosis In Vivo and In Vitro 
1124-169°358A 
Left Atrial Systolic Function During Dobutamine 
Stress in Coronary Artery Disease: The Effect of 
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a Five-Year Follow-Up 1196-118,295A 
Aspirin Reduces C Reacti'.~ Protein Plasma Levels 
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Cytokine Plasma Levels 1066-139..341A 
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Echocardiography 1147-33,442A 
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Association of Helicobacter Pylori Infection and 
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Baseline Levels of Cell Adhesion Molecules 
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Beneficial Effects of Enhanced External 
Counterpulsation (EECP) Are Independent of
the Severity of Angina Pectofis: Results of the 
MUST-EECP Trial 1097-140,349A 
C-Reactive Prolein and Cytomegalovirus Antibody 
Levels Predicl Mortality in Patients With 
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Disease 900-1 •317A 
Characteristics of the Culprit Coronary Lesions and 
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Patients With Acute Myocardial Infarction by 
Coronary Angioscopy 1100-48,54A 
Circadian Variations in Right and Left Coronary 
Artery Involvement During Acute Myocardial 
Infarction 1062-167 * 335A 
Clinical Outcome After Rescue Stenting in Patients 
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Coronary Artery Calcium Scores on Electron Beam 
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Determination f Menopausal Status in Women: The 
NHLBI-Sponsored WISE Study 835-4.. 266A 
Differential Contractile Response of Asynergic 
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Exercise Treadmill Testing in Women With 
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Related Coronary Artery 1067-41 *38A 
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With Coronary Heart Disease 878-6•513A 
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Scores to Predict Events? 1059-65•414A 
HPA-3 Polymorphism of the Platelet Fibrinogen 
Receptor ls Not Associated With an Increased 
Risk of Thrombosis or Restenosis After 
Coronary Stenl Placement 1068-93,41A 
Hyperglycemia. but Not Hyperinsulineamia. 
Increases the Risk of Premature Death in 
Patients With Coronary Artery Disease 1220-28 
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Impact of BMIPP SPECT in the Diagnosis of 
Unstable Coronary Artery Disease: A
Comparison With ECG Changes and Troponin T
Levels 1209-123,467A 
Importance of Brain Natriuretic Peptide and Doppler 
Diastolic Variables in Postinfarction Myocardial 
Remodeling 1205-37 •463A 
Improved Clinical Outcomes in Patients Undergoing 
Coronary Artery Bypass Grafting With 
Coronary Endarterectomy 879-6•567A 
In Vivo Gene Transfer of Fibroblast Growth Factor-2 
(FGF-2) Improves Myocardial Dysfunction 
Induced by Microembolization in Rabbit Heart 
1001-168,321A 
Incomplete Revascularization: Long-Term Outcome. 
and Functional Status in Patients Undergoing 
Percutaneous Coronary Interventions 846-2 •
79A 
Increased Detection of Viable Myocardium Using 
Myocardial Perfusion Analysis With 
Dobutamine Stress Echocardiography in 
Patients With Resting Wall Motion 
Abnormalities 882-6,481A 
Influence of PET Viability Studies on Clinical 
Decision-Making in CHF Patients 1049~-0 
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Intracoronary Radiation to Prevent Restenosis n 
Native Coronary Lesions: The Result of the 
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ls There a Benefit o Lowering Low-Density 
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ls There an Ongoing Myocyte Apoptosis in Chronic 
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Less Vigorous Treatment and Older Age at 
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Women Following Acute Myocardial Infarction 
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Long-Term Prognostic Value of Tissue Viability 
Assessed by Dobutamine Stress Echo Following 
Acute Myocardial Infarction 853-2-459A 
Management Decisions in Post-CABG Patients 
Referred for SPECT Myocardial Perfusion 
Scintigraphy 1151-127,448A 
Massive Cholesterol Lowering Aculely Improves 
Myocardial Vascular Responsiveness in Familial 
Hypercholesterolemia 1194-1130293A 
Mutation in the Promoter Region of 
Thrombomodulin Gene Is an Independent Risk 
Factor of Coronary. Artery Disease 900-60 
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Myocardial Perfusion Reserve for the Detection of 
Myocardial Ischemia Using Magnetic 
Resonance Imaging 854-2,460A 
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Direct Current Shock Injury t 192-28-290A 
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Myocardial Perfusion Studied by Power Doppler 
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Prediction of Functional Recovery in Patients With 
Acute Myocardial Infarction as Assessed by 
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Quantifying Coronary' Blood Flow: A Comparison 
of the TIMI Frame Count Method With 
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Ultrasound 1071-44 • 45A 
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Myocardial Perfusion 1179-127,456A 
Real-Time Detection of Myocardial Perfusion 
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Reduced Coronary Flow Reserve in Women With 
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Reduced Early Diastolic Coronary Flow and 
Coronary Flow Reserve in Patients With Left 
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Perfusion Defect. and Normal Coronary Arteries 
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Reserve Measurement With Positron Emission 
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Simvaslatin Improves In Vitro Large and Small 
Vessel Endothelial Function Independent of
Lipid Lowering Effects 1192-27•290A 
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Coronary vasospasm 
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Clinical Events and Angiographic Results of the 
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BESMART Study 1217-56-95A 
Coronary Arterial Remodeling at the Sites of Focal 
Vasospasmin Variant Angina 1073-26*241A 
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ls QT Dispersion Heart Rate Dependent? What Are 
the Values of Correction Formulas for QT 
Interval? 1055-187o l13A 
ls T Wave AIternans Related to Delayed Myocardial 
Activation or Inhomogeneity ofVentricular 
Repolarization? 1055-185 •I13A 
Measurement ofRims of Atrial Septal Defects 
During Device Closure by Three-Dimensional 
Transesophageal Echocardiography 1061-143 • 
521A 
Mechanism of the Difference of Defibrillation 
Efficacy of Anodal Versus Cathodal Monophasie 
Wave forn/s 1023-179,, 106A 
Microvolt Level T Wave Altemans Is Prevalent in 
Subjects With Congenital Long QT Syndrome 
830-6 • 130A 
Noninvasive Assessment of Atrial Electrophysiology 
in AF-Influence of Posture Change 1175-188• 
144A 
P Wave Duration Predicts the Risk of Early 
Recurrence of Atrial Fibrillation After 
Cardioversion 1175-184* 143A 
Performance of Classical ECG Criteria for LVH in 
Black Individuals 1045-116-236A 
Poor Correlation of Automated and Manual QT 
Dispersion Measurements in Patients and 
Normal Subjects 1117-186 • 350A 
Predictive Value of QT Dispersion for Sudden 
Cardiac Death in Patients With Arrhythmogenic 
Right Ventricalar Dysplasia 1055-184• I13A 
Prognostic Value of Admission Electrocardiogram of 
1,072 Patients With Unstable Angina and 
Non-Q-Wave Myocardial Infarction I 125-129 • 
359A 
QT Dispersion Has No Impact on Mortality in 
Patients With Moderate and Severe Left 
Ventrieular Dysfunction: Results From a Cohort 
of 2.263 Patients 1024-184,107A 
Relation of ECG Left Ventricular Hypertrophy to 
Obesity in Hypertensive Patients: The LIFE 
Study 1045-117•236A 
Relation of Echocardiographic Left Ventricular Mass 
and Hypertrophy to Electrocardiographic Left 
Ventrieular Hypertrophy in Hypertensive 
Patients: The LIFE Echocardiographic Substudy 
1045-118•237A 
Relationship Between Left Ventricular Function and 
Recovery Time Dispersion in Patients With 
Previous Myocardial Infarction 1234-186• 
160A 
Reproducibility of the ST Depression Measurement 
During Exercise Electrocardiographic Test in 
Asymplomatic Middle-Aged Women 1198-193 
• 560A 
Right Bundle Branch Block and ST Segment 
Elevation in Lead V1 -V3: Prevalence in an 
Apparently Healthy Population 839-4• 138A 
Stability of the Recorded ECG in a New Insertable 
Loop Recorder During a Follow-Up of Three 
Months 1117-187•350A 
T Wave Alternans and Late Potential as Predictors of 
Ventricular Tachyarrbythmias n Patients With 
Post-Myocardial Infarction 1234-185 • 160A 
T Wave Atternans in Postmyocardial Infarction 
Patients (ACES Pilot Study) 847- I • 144A 
The Duration of Paroxysmal Atrial Fibrillation 
Episodes Conelates With the Frequency of 
Fibrillatory Activity on the Surface ECG 
1022-149 • 103A 
Usefulness of Admission Electrocardiogram for 
Prediction of Q-wave or Posterior Acute 
Myocardial Infarction in Patients Without 
ST-Segment Elevation 1125-133*360A 
Ventricular Septal Defect in Anterior Acute 
Myocardial Infarction in the Thrombolytic Era: 
Electrocardiographic and Clinical Variables 
Associated With Increased Risk 1031-165• 
328A 
Electron beam CT 
Ambulatory Follow-Up of Aortic Dissection: 
Comparison Bet ~'een Computed Tomography 
and Biplane Transesophageal Echocardiography 
1148-62 • 443A 
Comparison of Echocardiography and Electron 
Beam Computed Tornography in Differentiating 
the Etiology of Heart Failure 1049-5• 175A 
Coronary Calcification in African-American and 
White Women in The Women's Health Initiative 
Observational Study 1059-81 •415A 
Correlation Between Coronary Artery Calcification 
and Impaired Peripheral Endothelial Function 
1220-21 •300A 
Ethnic Differences in Coronary Calcium Prevalence 
in a Symptomatic Population 1059-6fi• 414A 
Incremental Value of Electron Beam Computed 
Tom,graphic Scanning in the Evaluation of 
Patients With Chest Pain 1059-84•415A 
Sudden Coronary Death as the First Manifestation of 
Ischemic Heart Disease in Persons Under Age 
50: Can Extent of Calcification Predict Presence 
of Plaque Rupture'? 1220-29 • 301A 
The hnportanee of the Interval Between Preoperative 
Neurologic Events and Valve Operation in 
Patients With Acute Infective Endocarditis 
842-5*554A 
The Use of Electron Beam Computed Tonmgraphy 
to Predict Clinical Significance of Coronary 
Calcification in Diabetics 1059-80•415A 
Eleetropharmaeology 
Are There Differential Effects of the New lks 
Blocking Agent Chromanol 293b in Normal and 
Infarcted Canine Hearts? 1204-186• 152A 
Beta Adrenergic Blockade Decreases T Wave 
Alternans 1024-188o 108A 
Electrophysiologic and Antiarrhythmic Effects of 
KB 130 015. A New Thyroid Hormone Receptor 
Blocker. in the Mammalian Heart 1143-146* 
130A 
Sota]ol Effects Are Exaggerated inCHF: Action 
Potential Duratkm and Reverse 
Use-Dependence In Vivo 1143-150• 131A 
The Upper Limit of Vulnerability Predicts Biphasic 
Waver, tin Defibrillation Energy Requirements 
Better Than Mouophasic 1145-182• IMA 
Tmie-Dependence and Pattern of Atrial Fibrillation 
Recurrences After Single and Dual Site Right 
Atrial Pacing 1173-153.140A 
Electrophysiology 
A Comparison of T Wave Alternans. Signal 
Averaged Electrocardiography. and 
Electrophysiology Study to Predict Arrhythmia 
Vulnerability 847-2 • 145A 
A New Computer Model to Simulate ECG Based on 
Ionic Channels 1501-2•7A 
a la-Adrenergic Receptor and Protein Kinase C 
Stimulation Suppress Delayed 
Afterdepolarizations i  Hypertrophic 
Cardiomyopathic Hamsters 913-2•167A 
Ablation of Isthmus-Dependent Atrial Flutter Using 
the CARTO Nonfluoroscopic Mapping System 
887-5 • 164A 
Accuracy of Geometric Localization Using 
Noncontact Multielectrode Mapping Array in 
the Right Atrium 1114-146• 123A 
Approximate Entropy as an Index for Ventricular 
Fibrillation Stratification: Implications for 
Mechanism 1116-180o126A 
Atypical Patterns of Reentry. in Patients With 
Atrioventricular Nodal Tachycardia 906-4• 
166A 
Can Extensive Right Atrial Ablation in Atrial 
Fibrillation Patients Decrease Atrial 
Defibrillation Thresholds'? 1233-178•158A 
Characteristics ofConduction Within Nonincisional 
Atypical Atrial Flutter Circuits 1084-147• 
I I6A 
Characterization f the Configuration and 
Dimensions of the HIS Bundle Region Using the 
CARTO System: Defining the H1S Cloud 
1114-147 •123A 
Clinical and Pathologic Characteristics ofa Unique 
Fornr of Heritable Atrioventricular Node 
Dysfunction 1232-154,158A 
Detection of Concealed lnteratrial Conduction Delay 
From Morphology of the "Unfiltered" 
Signal-Averaged P-Wave 1175-189 • 144A 
Different Pattern Related to Anatomical Site in 
Atrial Cycle Length Before Spontaneous 
Termination of Atrial Fibrillation 1052-148• 
109A 
Discordant Recovery of Electrophysiologic 
Parameters After Conversion of Lone Atrial 
Fibrillation in Humans 1114-151 •124A 
Dose-Dependent Protection of Atrial 
Tacbycardia-lnduced Electrical Remodeling by 
Mibefradil 1143-147o 130A 
Dynamic Patterns of High and Low Frequency Atrial 
Activation Potentials Recorded at the Posterior 
Input to the AV Node Using a Split-Tip 
Electrode Catheter and a Long Stabilizing 
Sheath 906-3 • 166A 
Effect of Aging on Nitrous Oxide-Mediated 
Antiadrenergic Actions of Adenosine in the Rat 
Heart In Vivo 913-3,167A 
Electroanatomic Mapping of Chronic Porcine 
Anterior Infarction: Correlation With Pathology 
and lntracardiac Echo 816-5•122A 
Electromechanical Characterization fChronic 
Experimental Myocardial lschemia in a Pig 
Model 849-5 •371A 
Electrophysiologic and Antiarrhythmic Effects of 
KBI30 015, A New Thyroid Hormone Receptor 
Blocker, in the Mammalian Heart 1143-146• 
130A 
Electrophysiologic Effects of Long-Term Treatment 
With SR33589B on Rabbit Atrial Muscle: 
Comparison With Amiodarone 1143-148• 
131A 
Electrophysiological Heterogeneity of
Atrioventricular Node Cells 1202-182-149A 
Endocardial Mapping of Induced Atrial Fibrillation 
Initiated by Premature Atrial Extrastimuli 
Delivered at Different Right Atrial Sites in 
Patients With Recurrent Sustained Atrial 
Fibrillation 890-5'q65A 
Feasibility Study of In Vivo Real-Time 
Three-Dimensional lntracardiac Ultrasound 
1026-84 •405A 
Identification of Left Atrial Tract (Marshall) 
Potential From Left Pulmonary Vein 1053-152• 
110A 
Increased QT Interval Dispersion ls Associated With 
Malignant Ventricular Arrhythmias in Patients 
With Syncope 1055-188 • 114A 
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Kinetics of Defibrillation Shock-Induced Response: 
Implications to Design of the Optimal 
Defibrillation Waveform 1023-180o106A 
Left Atrium Is the Critical Area of Atrial Fibrillation: 
Evidence From Regional Differences in 
Recovery Course of Tachycardia-lnduced 
Electrical Remodeling 1202-183• 149A 
Localization of the Site of Conduction Abnormality 
in a Mouse Model of My*tonic Dystrophy 
868-6 • 155A 
Maturational Dual Atrioventricular Nodal 
Physiology in the Mouse 1202-156-148A 
Multisite Mapping of lnteratrial Septal Activation in 
Canine 1202-155• 148A 
New Technique for Vagai Nerve Stimulation 
1232-157 • 158A 
Nonfluoroscopic Catheter-Based Electroanatomical 
Mapping Predicts Regional Wail Motion 
Improvement After Successful Myocardial 
Revascularization 1035-141 •334A 
Optimal Energy Field Distribution Determined by 
Catheter Mapping 1023-18l •106A 
Predictors of Low Atrial Defibrillation Thresholds, 
Early and Late Recurrences of Atrial Fibrillation 
After Internal Atrial Defibrillation 1174-183• 
142A 
Progressive Isthmus Delay During Atrial Flutter 
Ablation: The Critical Importance of 
Isthmus-Spanning Electrodes for Distinguishing 
Conduction Delay From Block 1084-149• 
l l6A 
Prospective Study of Diagnostic Pacing Maneuvers 
During Paroxysmal Supraventricualr 
Tachycardia 1231-149•156A 
Radiofrequency Catheter Ablation of Common and 
Reverse Common Atrial Flutter: A New 
Algorithm to Determine Complete Isthmus 
Conduction Block 890-40165A 
Regulation of Ryanodine Receptor by Cyclic ADP 
Ribose in Guinea Pig Isolated Ventricular 
Myocytes: Possible In*tropic and 
Arrhythmogenic Actions 1052-149•109A 
Right Atrial Activation With Coronary Sinus Pacing: 
Insight Into Patterns of lnteratrial Conduction 
1204-180•151A 
Safety and Performance of a New Dual-Chamber 
Implantable Cardioverter-Defibrillator (ICD): 
Results From a European Multicenter Study 
801-60 lISA 
Sotalol Effects Are Exaggerated inCHF: Action 
Potential Duration and Reverse 
Use-Dependence In Vivo 1143-1500131A 
Stimulus-An+l : A New Measure for Entrainment 
Mapping for Atrial Flutter 890-2• 164A 
Temporal Stability of the Spatial Distribution of 
Dominant Frequencies During Acute Atrial 
Fibrillation in the Isolated Sheep Heart 
1052-147 • 109A 
The Cardiac Glycoside Ouabain Enhances 
Inducibility of Atrial Tachycardia n Dogs With 
Pacing-Induced Heart Faiture 1143-149• 131A 
Thermometry Predicts Electrode Orientation During 
Ablation of Ventricular Myocardium With a 
New Dual Thermocouple 8-mm Tip Catheter 
816-2 • 122A 
Transvenous Internal Atrial Cardioversion: A 
Randomized Study on Asymmetrical Versus 
Symmetrical Biphasic Shocks 1023-I 83• 106A 
Usefulness of a Score System in Predicting the 
Outcome of Electrophysiologic Studies in 
Noninvasively Unexplained Syncope 884-4• 
162A 
Usefulness of Unipolar Electrograms to Confirm 
Isthmus Block After Radiofrequency Ablation 
of Typical Atrial Flutter 1084-151 • l17A 
Emergency care 
C-Reactive Protein and Troponin T Independently 
Predict Mortality in Patients With Unstable 
Angina: Results From the CAPTURE Trial 
896-6-397A 
Can Emergency Room Nurses Perform a Screening 
Cardiac Ultrasound Exam? Assessment of 
Quality and Diagnostic Impact 867-3•472A 
Intra-Aortic Balloon Counterpulsation Versus 
Dobutamine in the Treatment of
Postresuscitation Left Ventricular Stunning 
1156-197 o369A 
Myocardial Contrast Echocardiography Perfusion 
Imaging for the Evaluation of Chest Pain in the 
Emergency Department 1208-104•466A 
Recurrence of Out-of-Hospital VF Following 
Low-Energy Biphasic and High-Energy 
Monophasic Defibrillation Shocks 1116-183 • 
127A 
The Utility of a Clinical Algorithm and Influences in 
Its Use to Triage Chest Pain Patients in the 
Emergency Department 892-1o313A 
Endocarditis 
AI-700, a New Ultrasound Contrast Agent Allows 
Reliable Detection of Hypoperfused Zones in 
Acute lscbemia nd Infarction Not Only in 
Triggered Mode but Also in Continuous 
Imaging Mode 1208-107 •466A 
Bacterial Endocarditis Prophylaxis in Patients With 
Recent Transthoracic Echocardiography: Use, 
Misuse, and Uncertainty 812-3•427A 
Clinical and Echocardiographic Predictors of 
Embolic Events in Patients With Infective 
Endocarditis 871-50563A 
Harmonic Power Doppler Imaging in Conjunction 
With Contrast Agent SHU 563A Allows 
Recognition of Viable Myocardium: 
Experimental Contrast Echocardiographic 
Studies of Reperfused Myocardium 1058-109.. 
414A 
Hypoperfused Myocardial Mass Estimated From 
Three-Dimensional Contrast Echocardiography 
Using a Novel Contrast Agent, AI-700, Aids in 
Accurate Quantitation of Infarct Mass 
1208- t08.467A 
Improved Structure Identification by Tissue Doppler 
Echocardiography: An Experimental nd 
Clinical Classification of Motion Patterns 901-5 
-484A 
Long-Term Follow -Up of Conservatively Treated 
Prosthetic Valve Endocarditis: Low Rate of 
Reinfection or Death 871-6•563A 
Perivalvular Abscesses Due to Staphylococcus 
Aureus Endocarditis: Comparison With 
Streptococcus Viridans Endocarditis and 
Incremental Value of Transesophageal 
Echocardiography 866-3.471A 
Quantitative Three-Dimemsional Contrast 
Echocardiography Can Estimate Myocardial 
Mass at Risk. Infarct Mass, and Efficacy of 
Reperfusion: Experimental Canine Studies With 
a Transvenous Contrast Agent. NC 100100 
1235-32 • 473A 
Quantitative Two-Dimensional Regional Curvature 
Analysis of the Right Ventricle in Patients With 
Arrhythmogenic Right Ventricular Dysplasia 
1176-64•452A 
Survival of Infective Endocarditis: The Information 
Brought by "Usual" Statistical Techniques May 
Be Misleading 871-40563A 
Endothelin 
1 I b Hydroxysteroid Dehydrogenase Deficiency 
Regulates Endotbelins, Angiotensins, and Nitric 
Oxide: A Novel Mechanism in Hypertension? 
1165-117..284A 
Acute Volume Load in Patients After Heart 
Transplantation-Hem*dynamic Effects and 
Endothelin Response 1169-9• 197A 
Aden*virus-Based Antisense Phospholamban s
Potential Gene Therapy Approach for 
Improvement of Diastolic Dysfunction 894-3- 
215A 
Agthg, a Cardiovascular Risk Factor, Markedly 
Increases Expression of Endothelin- 1In Vivo 
Independent ofBlood Pressure and 
Endothelin-One Clearance 1013-71 • 225A 
Altered Activation of c-Jun N-Terminal Kinase in 
the Hypertrophied and Failing Rat Myocardium 
811-5 • 183A 
Attenuation of Myocardial and Endothelial Injury 
During Reperfusion by Endothelin A and B 
Receptor Antagonists I 111-4• 186A 
Chronic Endothelia Receptor Antagonism Preserves 
Coronary Endothelial Function In Vivo in 
Experimental Hypereholesterolemia 1041-27 • 
231A 
Comparison of Amino-Terminal Pro-Brain 
Natriuretic Peptide and "Big" Endothelin 1 as 
Prognostic Indicators After Myocardial 
Infarction 1140-19•194A 
Correction of Endothelial Dysfunction in Rats With 
Chronic Myocardial Infarction by Treatment 
With Endothelin Receptor Antagonists 1080-18 
• 178A 
Early, Long-Teml Therapy With Bosentan Prevents 
Progressive Left Ventricular Dysfunction and 
Dilation in Dogs With Moderate Heart Failure 
1080-15 • 178A 
Effect of Chronic Activation of Angiotensin I1, 
Endothelin, and Catecholamines in the Absence 
of Cardiac Volume or Pressure Overload on Left 
Ventricular Mass In Vivo 1107- I 160258A 
Endothelin A Antagonist Reduces No Reflow and 
Infarct Size in Dogs 869-3.382A 
Endothelin Is Activated Prior to the 
Renin-Angiotensin-Aldosterone System During 
the Evolution of Congestive Heart Failure 
1080-14 • 177A 
Endothelin Type A Receptor-Dependent Signaling 
Pathways Inhibit b-Adrenergie Agonist-lnduced 
Apoptosis in Cardiac Myocytes 1080-17o 178A 
Endothelin-1 Has a Unique Oxygen-Saving Effect 
by Increasing Contractile Efficiency in the 
Isolated Rat Heart 803-3•494A 
Endothelin-1 Induces Mitogen-Activated Protein 
Kinases in Smooth Muscle Cells Through a 
Radical Sensitive Mechanism 1040-220230A 
Endothelin-I Potentiates Human Vascular Smooth 
Muscle Cell Grnwth Mainly Through ET-A 
Receptor 1072-240240A 
Impact of Myocardial Endothelin Expression on 
Functional and Morphological Coronary 
Alterations During Follow-Up in Cardiac 
Transplant Recipients 1111-3" 186A 
Impaired Intravascular Conversion and Clearance of 
Big Endothelin-I in Experimental Heart Failure 
1080-16 • 178A 
Lack of Apoptosis in Cardiomyocytes and Increased 
Myocardial Endothelin-1 Levels in a Commonly 
Used Model*f Myocardial Stunning 849-3. 
371A 
Oxidant Stress Stimulates the Activity of the 
Endothelin- l Promotor in Cultivated Endothelial 
Cells 1012-76•224A 
Sequential Evaluation of Big Endotbelin Plasma 
Concentration i Patients With Advanced Heart 
Failure: Effects of Therapy 1199-19•202A 
Stimulation of Fibrotic Remodeling by Exogeneous 
Endothelin-I in the Rabbit Double Injury Model 
of Restenosis 1160-136•79A 
The ETA Receptor Antagonist LU 135252 Prevents 
the Progression of Established Pulmonary 
Hypertension I duced by Monocrotaline in Rats 
1041-28 • 231A 
Endothelium 
A Nutritional Product Designed to Enhance Nitric 
Oxide Activity Restores 
Endothelium-Dependent Function in 
Hypercholesterolemia 1164-69•282A 
Acetylsalicylic Acid Inhibits the Cytokine-lnduced 
Up-Regulation of Pro Inflammatory Adhesion 
Molecules on Vascular Endothelial Cells 
1161-115 •279A 
Aden*viral Gene Transfer to Mouse Carotid 
Arteries: Limited Role of Antigen-Specific 
Immunity in Elimination of Transgene 
Expression 101 t-26•222A 
Advanced Glycation End Products Inhibit the 
Stimulation of Nitric Oxide Synthase by 
Histamine in a Human Endothelial Cell Model 
1041-29 •231A 
Aging, a Cardiovascular Risk Factor, Markedly 
Increases Expression of Endothelin-1 In Vivo 
Independent ofBlood Pressure and 
Endotbelin-One Clearance 1013-71 •225A 
Alteration in Coronary Epicardial and Microvascular 
Endothelial Function in Experimental 
Renovascular Hypertension 1223-70..305A 
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Angioscopic Evaluation of Coronary Endothelial 
Lesions by Staining With Evans Blue in Patients 
With Acute Myoeardial Infarction 1131-134• 
67A 
Angiotensin Converting Enzyme Inhibition 
Improves Endothelial Dysfunction in Chronic 
Cigarette Smokers 1044-111 •235A 
Antiadhesion Monoclonal Antibodies Against 
ICAM Inhibit Arteriogenesis 911-1 o318A 
Antioxidant Therapy With Vitamin E Does Not 
Improve Fibrinolysis in Postmenopausal Women 
831-3 • 265A 
Baseline Levels of Cell Adhesion Molecules 
P-Selectin and ICAM-1 Predict Five Year 
Survival in Patients With Coronary Artery 
Disease 1220-24.300A 
Beneficial Effects of Troglitazone on Endothelial 
Dysfunction.f Coronary Artery 1220-27- 
301A 
Bone Marrow Transplantation f Endothelial Cells 
410-2-2A 
Cellular Hypoxia, Cyclooxygenase-2. and Spl: 
Potential Cofactors in Heart Failure 1019-8. 
172A 
Chronic Endothelia Receptor Antagonism Preserves 
Coronary Endothelial Function In Vivo in 
Experimental Hypereholesterolemia 1041-27- 
231A 
Comparison of the Assessment of Brachial Artery 
Flow-Mediated Artery Vasodilation Using 
Upper and Lower Arm Occlusion in Subjects 
With and Without Risk Factors 1220-20• 299A 
Coronary Endothelial Dysfunction Predicts 
Progression of All.graft Vasculopathy After 
Heart Transplantation I II I-7 • 187A 
Coronary Endothelial Function and Angiotensin 
Converting Enzyme Polymorphism: The 
Intervention Cardiology Risk Stratification 
Study (ICARIS) 883-3-312A 
Coronary Vascular Dysunction Associated With 
Direct Current Shock Injury 1192-28-290A 
Correction of Endothelial Dysfunction in Chronic 
Heart Failure: Additive Effects of Oral 
L-Arginine Supplementation a d Exercise 
Training 1221-114-303A 
Correction of Endothelial Dysfunction in Rats With 
Chronic Myocardial Infarction by Treatment 
With Endothelin Receptor Antagonists 1080-18 
• 178A 
Correlation Between Coronary Artery Calcification 
and Impaired Peripheral Endothelial Function 
1220-21 •300A 
Cytomegalovirus Antigenemia After Cardiac 
Transplantation Is Associated With Endothelial 
Dysfunction 855-4*205A 
Damages of Coronary Endothelial Cells Are Easily 
Caused Even by Floppy Guidewire: In Vivo 
Staining Angioscopic Study 1131-96•67A 
Debunking the Yuppie Habit: Cigars and Endothelial 
Function 1042-71 •233A 
Differential Effect of a Local Paclitaxel Release 
From a Biodegradable Stent Coating on 
Vascular Smooth Muscle Cells and Endothelial 
Cells in a Coculture Model 1011-24- 222A 
Digoxin Impairs Endothelium-Dependent a d 
-Independent Relaxations in Isolated Arteries 
1044-114• 236A 
Do Serum Urate Levels in Heart Failure Reflect 
Chronic Vascular Inflammation? 895-2•217A 
Does Blood Pressure Influence the Hypercoagulable 
State in Atrial Fibrillation? 1223-71-306A 
Effects of Estrogen and Vitamin E on Nitric Oxide 
Bioactivity and Markers of Inflammation i
Postmenopausal Women 831-6•265A 
Effects of Estrogen Versus Droloxifene on Adhesion 
Molecules and Cytokines in Healthy 
Postmenopausal Women 911-2-318A 
Effects of Hyperoxia on Flow-Related Endothelial 
Function and Hemodynamics n Patients With 
Heart Failure 1013-70*225A 
Effects of Soluble Cell Adhesion Molecules and 
Proinflammatory C tokines on Coronary 
Vasomotor Function in Chronic Rejection After 
Heart Transplantation in Humans 1111-6•187A 
Endothelial Cell Dysfunction and Elevation of 
Circulating Smooth Muscle Cell 
Chemoattractants and Mitogens in Congestive 
Heart Failure Patients: Potential Role of avb3 
lntegrin 856-3- 206A 
Endothelial Dysfunction After Acute Chlamydia 
Pneumoniae Infection in ApoE-Knock-Out 
Mice 1072-21 •239A 
Endothelium Dependent Response in 
Hypercholesterolemic Coronary Artery Disease 
Patients Under the Effects of Simvastatin and 
Enalapril, Either Separately or Combined 
1135-68•271A 
Enhanced Endothetium-Dependent Vasodilation i  
Older Endurance Trained Men I 113-100•499A 
Glucose Tolerance Dnes Not Influence Large Vessel 
Endothelial Function or Carotid Artery 
Distensibility: The Whitehall 1I Study 1162-25 
•280A 
Hormone Replacement Therapy and Levels of 
Soluble Adhesion Molecules in Postmenopausal 
Women 1221-11 -302A 
Hyperglycemia R pidly Suppresses Flow-Mediated 
Endothelium-Dependent Vasodilation of 
Bracfiial Artery 899-1-315A 
Impact of Myocardial Endothelin Expression on 
Functional and Morphological Coronary 
Alterations During Follow-Up in Cardiac 
Transplant Recipients 1111-3•186A 
Intracoronary 17b-Estradiol Reduces Plasma 
Endothelin-1 Levels in Postmenopausal Women 
With Coronary Artery Disease 899-2,,316A 
Is Isolated Office Hypertension I nocent? A Study 
of the Flow-Related Endothelial Function 
1162-22 • 279A 
Lack of Long-Term Beneficial Effects of Ascorbic 
Acid on Endothelial Vasomotor Dysfunction in 
Patients With Insulin-Dependent Diabetes 
Mellitus 1163-30•281A 
Lipid Lowering Tberapy Does Not Aflect the Acute 
Fibrinolytie Capacity of Hypercholesterolemic 
Patients 1220-25- 300A 
Long-Term Estrogen Therapy Improves 
Acetylcholine.lnduced Nitric Oxide Mediated 
Vasodilation but Not Metabolic-Induced 
Vasodilation i  the Skeletal Resistance Vessels 
of Biological Males 912-1•319A 
Long-Term Raraipril Treatment Prevents Nitrate 
Tolerance by an Antioxidant Mechanism 
I 133-78 •269A 
Mechanisms of Reduction Restenosis After 
Coronary Balloon Angioplasty by Cilostazol 
1068-94- 42A 
Muscarinic and Bradykinin Receptor Function in the 
Human Coronary Circulation: What Predicts 
Physiologic Coronary Vasomotion? 1162-20. 
279A 
New Insights Into Mechanisms of Albumin 
Microbubble Adhesion to Coronary 
Endothelium Using Chemically Modified 
Microbubbles 1028-122 • 407A 
One.genie Ras Induces Premature Senescence in
Primary Vascular Endothelial Ceils: In Vitro 
Model for Cardi<wascular Aging 1195-76• 
294A 
Overexpression fEndothelium Nitric Oxide 
Restores Relaxation in the Hindlimb Vasculature 
After Myocardial Infarction 1080-19• 179A 
Oxidant Stress Stimulates the Activity of the 
Endothelin-I Promotor in Cultivated Endothelial 
Cells 1012-76-224A 
Peripheral Vascular Endothelial Function Is 
Abnormal After Cardiac Transplant in lschemic 
but Not in Nonischemic Cardiomyopathy 
1049-8 * 176A 
Polymorphism of Angiotensin Converting Enzyme 
Gene Affects Unfavorably Transforming Growth 
Factor and Von Willebrand Factor in 
Hypertensive Patients 1136-11 .273A 
Polymorphism of Angiotensin Converting Enzyme 
Gene ls Associated With Hem.static Parameters 
Disturbances inPatients With Essential 
Hypertension 1165-121 •285A 
Post-Prandial Lipaemia Is Associated With 
Augmented Free Radical Release and 
Endothelial Dysfunction in Diabetics Compared 
With Healthy Controls 900-5-318A 
Protein Kinase Cd Mediates Hypoxia-lnduced 
Nonapoptotic Cell Death in Endothelial Cells: 
Roles of Heat Shock Proteins 809-1.249A 
Raloxifene Acutely Relaxes Rabbit and Human 
Coronary Arteries In Vitro by an 
Endothelium-Dependent Mechanism 1041-30• 
231A 
Rapamycin Inhibits Vascular Endothelial Cell 
Proliferation Via Induction of a 
Cyclin-Dependent Kinase Inhibitor 809-5 • 
250A 
Relation of Inflammation to Vascular Function in 
Patients With Coronary Heart Disease 836-5• 
276A 
Role of Hepatocyte Growth Factor in Patients With 
Coronary Artery Disease 1185-196•377A 
Role of Hepatocyte Growth Factor in Percutaneous 
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The Effects of Withdrawal of Chronic Estrogen 
Therapy on Brachial Artery Vasoreaefivity in
Women With Coronary Artery Disease 836-3• 
276A 
The Genetic Control of Coronary Vasomotor Tone: 
Role of Angiotensin Converting Enzyme Gene 
Polymorphism 883-4•312A 
The Importance of Changes in Conduit and 
Peripheral Arteries for Coronary Flow Reserve 
in Patients With Hypertension: A LIFE 
Substudy 1162-21 •279A 
The Role of Lipids and Fibrinogen in Coronary 
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Sharp Contrast Wiith Streptokinase and rt-PA 
1003-132. 325A 
Financial incentives/disincentives 
Efficiency and Cost Saving of Seven Day Per Week 
Exercise Testing Utilizing Electrocardiography 
Technologists 1077 118,,247A 
Save Me the Money: A Cost Comparison of 
Inpatient Versus Outpatient Care of Left 
Ventricular Assist Device Patients 1200-6• 
204A 
The Importance of Payer Case Mix on Hospital Cost: 
Don't Contract Without It 1077 120•248A 
Followup studies 
Angina Normal Coronary Arteries Normal and 
Abnormal Coronary Sinus Lactates: 20 Year 
Follow Up 1186 139 • 378A 
Angiographic No Reflow Predicts LongTerm 
Cardiac Complications and Mortality in Patients 
With Acute Myocardial Infarction 1004-163• 
326A 
Are CholesterolLowering Drugs Antiarrhythmic n
High Risk Patients? 824 5•264A 
Arrhythmogenic Right Ventricular Cardiomyopathy: 
LongTerm FollowUp of 37 Families 
1083 103 • 497A 
Clinical Presentation ofRestenosis l  Associated 
With the Extent of Atherosclerotic Inflammation 
of the Initial Coronary Lesions 1039 59o31A 
Complex Pulmonary Atresia: Outcome of Hospital 
Survivors Alter Radical Repair 885 4•538A 
ContrastEnhanced Doppler Echocardiography 
Allows a Complete Hem•dynamic Assessment 
in Patients With Congestive Heart Failure 
1179126.456A 
Depressed Coronary Disease Patients Derive More 
Improvement i  Quality of Life From Coronary 
Revasculari~ation 1015 116.228A 
Diastolic IN Dysfunction Is a Major Predictor of 
Symptom Persistence Nine Years After Aortic 
Valve Replacement 805 5•547A 
Free Fatty Acid Imaging Besides Sestamibi 
Scintigraphy for Predicting Resting and 
Dobutamine Induced Contractile Improvement 
After Revascularization: ToDo or Not to Do? 
1060 127 • 417A 
Hyperhomocysteinemia and Progression of 
Coronary Atherosclerosis i128 141.364A 
In Stent Restenosis: Predictors of Subsequent Target 
Lesion Revascularization After Repeat 
Intervention 1129 56o61A 
Intravascular Ultrasound Predictors of Angiographic 
Restenosis n Lesions Treated With Directional 
Coronary Atherectomy 1189 47,,86A 
Lead Related Complications in 340 Patients With an 
lmplantable Cardioverter/Defibrillator Over a 
Period of Seven Years 1054 183. I I2A 
LongTerm FollowUp After Multicoil Occlusion of 
Patent Ductus Aretriosus: Prospective 
Evaluation Using Angiography Intravascular 
Ultrasound Imaging and Lung Perfusion Scan 
1123 145,,526A 
LongTerm FollowUp of 344 Diabetic Patients: 
Predictive Factors for the Occurrence of 
Cardiovascular Events 1215 140o393A 
LowTerm Morbidity and Mortality in Patients With 
Simple TGA TGA and VSD and Taussig Bing 
Anomaly After Arterial Switch Repair 
1092 159•523A 
Microcatheter Ablation Technique in Paroxysmal 
Atrial Fibrillation: Results of Clinical 
Follow Up in a Pilot Study 1203 150.150A 
Modified Fontan Operation With Autologous Atrial 
Tissue: Reduced Incidence of Postoperative 
Atrial Dysrhythmias During Medium Term 
FollowUp 902 3.540A 
Myocardial Infarction in Young Women: Risk Factor 
Analysis and Long Term Follow Up 1031168- 
328A 
OneYear Clinical and ThreeMonth Angiographic 
FollowUp of Cutting Balloon Angioplasty 
Versus Plain Old Balloon Angioplasty 
Randomized Study in Small Coronary Artery 
(CAPAS) 810 5•47A 
Prediction of Death and Nonfatal Myocardial 
Infarction by Combined Myocardial Perfusion 
and Radionuclide Ventricular Function (RNA) 
Studies During Pharmacologic Stress Testing 
857 5o470A 
Prediction of LongTerm Outcome With 
Simultaneous Stress Tc 99m Sestamibi SPECT 
and FirstPass Radionuclide Angiography 
857-4. 469A 
Predictors of Recurrent Restenosis Aiier Balloon 
Angioplasty for Stent Restenosis: Statistical 
Analysis 1037 53e27A 
Reduced Reintervention for Restenosis: The Major 
Clinical Benefit of Increased Stent Usage in the 
RealWorld 115890-73A 
Risk of Development of Delayed AV Block After 
Slow Pathway Modification in Patients With 
Atrioventricular Nodal Reentrant Tachycardia 
and Preexisting Prolonged AH Interval 
1231146.156A 
Side Branch Evaluation After Stent Implantation 
I 158-96 • 74A 
Superiority of Brain Natriuretic Peptide in Assessing 
Efficacy of Therapy to Improve Symptoms of 
Congestive Heart Failure in the Outpatient 
Setting 1140 15-193A 
Survival in Cardiac Amyloidosis: Role of Exercise 
Capacity 1140 11 - 192A 
The Fortran Procedure for Tricuspid Atresia: Early 
and Late Results of a 25 Year Experience With 
216 Patients 859 2.535A 
Triglycerides HDLc  and Diabetes: Prediction of 
Postcoronary Artery Bypass Grafting Survival in 
Women 1135 72-272A 
Free radicals/scavengers 
Aflopurinol Improves Endothelial Dysfunction in 
Patients With Chronic Heart Failure 895-1 *
216A 
Cytotoxic Aldehydes in Patients With Congestive 
Heart Failure 895 4*217A 
Effects of Chronic Exercise in Patients With Chronic 
Heart Failure on Markers of Oxidative Stress 
1019 10.172A 
Function and Gene Expression of Antioxidative 
Enzymes in Human Hearts With EndStage 
Heart Failure 1048 19-174A 
Hyperglycemia R pidly Suppresses FiowMediated 
Endothelium Dependent Vasodilation of 
Brachial Arteu, 899 1*315A 
Oxidant Stress Stimulates the Activity of the 
Endothelin I Promotor in Cultivated Endothelial 
Cells Ifll2 76-224A 
PostPrandial Lipaemia Is Associated With 
Augmented Free Radical Release and 
Endothelial Dysfunction in Diabetics Compared 
With Healthy Controls 900-5 • 318A 
Reduced Antioxidant Capacity Is Associated With 
Elevated Levels of Ceruloplasmin and 
KEY: Abstract itle, Session-abstract number •page number 
JACC February 1999 SUBJECT INDEX 663A 
C-Reactive Protein and With Prognosis in 
Unstable Angina 876-3-394A 
Reversal of Subendocardial Metallothionein 
Expression and Myocyte Diameter After 
Prolonged Left Ventricular Assist Device 
Support 909-2*219A 
Role of Peroxynitrite in the Modulation of Redox 
State and Oxidative Stress in Bovine Coronary 
Artery 1011-20•221A 
The Balance Between Nitric Oxide and Free 
Radicals Affects the Coronary Vasodilator 
Reserve 1192-290290A 
The NO Synthase Inhibitor L-NNA Decreases 
Defibrillation-Induced Free Radical Generation 
1156-196•369A 
Vitamin C Improves the Coronary Vasodilator 
Reserves in Asymptomatic Smokers 1013-680 
225A 
G proteins 
Activation of the Jak/STAT Signaling Pathway by 
Blocking G Protein-Coupled Receptor Kinases 
in Cardiomyocytes 1195-110*295A 
Comparison of Early Invasive Versus Early Medical 
Management of Acute Coronary Syndrome: A
Meta-Analysis 1063-130.337A 
Gap junctions 
Elevated Circulating Levels of CXC-Chemokines. a 
New Group of Cytokines Involved in the 
Path•genesis of Congestive Heart Failure 
1018-18• 170A 
Intra-Atrial Conduction Disturbances in Cx40 
Deficiency Are Associated With an Increased 
Atrial Vulnerability 868-1 •154A 
Gender 
Acute Myocardial Infarction in Women: 
Epidemiological Variables From a Low Risk 
Mediterranean Population 1224-121.308A 
Are Women With Acute Myocardial Infarction Less 
Well Managed Than Men? A Study in 2,519 
Consecutive Patients 1064-200•339A 
Cardiovascular Risk and Lip•protein(a): A Gender 
and LDL-C Interaction 1135-70•271A 
Community Presentation a d Management ofNew 
Onset Chest Pain in Women Compared to Men 
Assessed Through aRapid Access Chest Pain 
Clinic (RACPC) 1005-137 °326A 
Comparison of Exercise ECG, Rest/Stress 
99m-Technetium Sestamibi SPECT, 
Dipyridamole and Dobutamine Stress 
Echocardiography in Detecting Coronary Artery 
Disease in Female Hypertensive Patients 
1027-104•406A 
Coronary Interventions: Is Being a Woman a Risk 
Factor? 1036-46• 25A 
Effect of Gender on Transradial nd Transfemoral 
Access for Coronary Procedures 1187-60•83A 
Effect of Race and Gender on Physician 
Recommendation f rCardiac Catheterization 
835-2.266A 
Effects of Aging on the Left Ventricle in 
Hypertension: Influence of Gender 1076-1150 
246A 
Elevated Flbrinogen Negates Gender Advantage for 
Cardiovascular Risk 1194-114 • 293A 
Estrogen Receptor-Mediated Gender-Specific 
Vascular Effects of 17h-Estradiol 1107-119o 
259A 
Exercise Treadmill Testing in Women With 
Suspected Myocardial Ischemia. New Findings 
Using ACIP Protocol: NHLB! Women's 
lschemia Syndrome Evaluation (WISE) 
1005-141 ,,327A 
Gender Differences in Coronary Artery Size 
Assessed by Intravascular Ultrasound 1159-52- 
77A 
Gender Related Differences in Thrombogenic 
Factors Associated With Recurrent Cardiac 
Events 1031-167 o328A 
Gender Remains a Powerful Predictor of Increased 
Mortality in Acute Myocardial Infarction in a 
Defined Community Population 1154-128• 
365A 
Gender-Dependent Relation Between QT Interval 
and Its Components and Cardiac Cycle Length 
in Apparently Normal Population 1146-184 • 
134A 
Gender-Related Prognostic Difference in Myocardial 
lschemia Induced by Pharmacologic Stress 
Echocardiography 1178-1070454A 
Growth Factor Components in Human Pericardial 
Fluid: Diminished Angiogenic Potential in Aged 
and Female Populations 891-4o515A 
Heart Failure Is Due to Diastolic Dysfunction i  
Women More Often Than in Men 1081-8. 
180A 
lnsulin Treatment of Diabetic Women Predicts a
Worse Outcome After Intracoronary Stenting: 
Clinical Results of 564 Consecutive Patients 
1218-97.97A 
ls There a Gender Bias in Selection of Dual 
Chamber and Rate Responsive Pacemakers? 
861-6 •154A 
Less Vigorous Treatment and Older Age at 
Presentation Explain the Worse Outcome for 
Women Following Acute Myocardial Infarction 
1031-169o 329A 
Long-Term Estrogen Therapy Does Not Alter 
Systemic Arterial Compliance and 
Hem•dynamics in Biological Males 1163-31 •
281A 
Older Women Benefit From Balloon PTCA Rather 
Than Stenting When Combined With IIb/llla 
Antiplatelet Therapy: A Gender Specific 
Treatment Interaction From EPISTENT 
1006-41 *12A 
QT Dispersion Should Be Adjusted for Age: 
Observations From 1,096 Normal Subjects 
830-2 •129A 
Reduced Coronary Flow Reserve in Women With 
Chest Pain and Normal Coronary Arteries: Role 
of Left Ventricular Hypertrophy in The NHLBI 
Women's Ischemia Syndrome Evaluation 
(WISE) Study 1005-140.327A 
Refusal of Catheterization During Acute Myocardial 
Infarction: Influence of Patient Characteristics 
832-3 • 356A 
Sex Differences in Short-Term Mortality After 
Myocardial Infarction: A New Perspective 
835-3 • 266A 
Similar Reduction in Thrombotic Risk With 
Pravastatin Therapy in Hyperlipidemic Men and 
Women: A Prospective Study 824-6*264A 
The Effects of Withdrawal of Chronic Estrogen 
Therapy on Brachial Artery Vasoreactivity in 
Women With Coronary Artery Disease 836-3° 
276A 
The Influence of Age and Gender on the 
Histopathology of Patients With Hypertrophic 
Cardiomyopathy 1229-86.509A 
The Influence of Race and Gender on Reperfusion 
Therapy Use Among Medicare Beneficiaries 
With Myocardial Infarction 832-4 •356A 
Tubular Slotted Stents, a "Breakthrough T erapy" 
for Women Undergoing Coronary Interventions: 
Pooled Results From the STARS, ACSENT, 
SMART, and NIRVANA Randomized Clinical 
Trials 833-5 • 5gA 
Under Utilization of Invasive Procedures for 
Medicaid Patients With Acute Myocardial 
Infarction Is Independent of Race and Gender 
Bias 1063-128.336A 
Use of Thrombolytic Therapy in Females, Diabetics, 
and the Elderly: Trial Selection Bias or a Real 
Problem? 1003-133 o325A 
Gene expression 
Activation of c-Jan NH2-Terminai Kinases, AP- 1, 
and NF-kB in Left Ventdcular Remodeling 
After Myocardial Infarction 1001-172.322A 
An Adenovirns Minivector With High Cloning 
Capacity Suitable for Expression of SERCA and 
Phospholamban-Antisense-mRNA to Improve 
Cardiac Myocyte Function In Vitro and In Vivo 
894-4o216A 
Angiotensin II Subtype 1Receptors Contribute to 
Iscbemic Contracture and Regulate 
Chemomechanical Energy Transduction i
Isolated Transgenic Rat Hearts I 153-137 • 364A 
Angiotensin-Converting E zyme (ACE) Gene 
Polymorphism Does Not Account for the 
Variable Level of ACE Inhibition (ACE-I) 
Observed in Heart Failure During Chronic ACE 
Inhibition Therapy 881-6o215A 
Augmented Ventricular Gene Expression and 
Secretion of Adrenomedullin i  Experimental 
Congestive Heart Failurc 1227-17.209A 
Continuous Administration f Prostacycin Analogue 
Improves Vascular Remodeling and Survial in 
Pulmonary Hypertensive Rats 1199-15*201A 
Coregulation of Nkx2-5 and Serum Response Factor 
Transcriptional Activation of the Cardiac 
Sodium-Calcium Exchanger Promoter 811-2o 
182A 
Coronary Endothelial Function and Angiotensin 
Converting Enzyme Polymorphism: The 
Intervention Cardiology Risk Stratification 
Study (ICARIS) 883-3•312A 
Decorin Antagonizes Transforming Growth 
Factor-b 1-Induced Effects in Cardiac 
Fibroblasts: Evidence for a New Antifihrotic 
Therapeutic Principal 1195-77-294A 
Dexamethasone Activates Heat Shock Factor and 
Increases Heat Shock Protein 72 Expression 
1124-171.358A 
Downregulation f L-Type Calcium Channel and 
Sarcoplasmic Reticular Ca2+-ATPase mRNA in 
Human Atrial Fibrillation: An Insight Into the 
Mechanism of Atrial Electrical Remodeling 
820-6o 128A 
Effects of Changes in Cardiac Adrenergic Activity 
on Gene Expression i  the Intact Failing Human 
Heart 1227-19t 210A 
Estrogen Prevents Fas-Ligand Production: Evidence 
for a Apoptosis-Protective Effect From a 
Population-Based Study 856-1o206A 
Expression of b-Myosin Heavy Chain-Gin403 in
Transgenic Rabbits Induces Myocyte Disarray 
and Increased Interstitial Collagen Content 
1082-85 • 495A 
Expression of Human Cytomegalovirns Immediate 
Early Genes Increases Rat Smooth Muscle Cell 
Proliferation 883-2e311A 
Function and Gene Expression of Antioxidative 
Enzymes in Human Hearts With End-Stage 
Heart Failure 1048-19° 174A 
Gene Structure and Expression of Phospholemman 
in Mouse 1106-113•257A 
Genetic ACE Underexpressioo Affects Pattern of 
Hypertrophy but Does Not Prevent Cardiac 
Hypertrophy Due to Aorto-Caval Fistula 
1019-4o 171A 
Genetic Determination f the Early Onset of 
Myocardial Infarction 1106-111.257A 
Heat Shock Protein 60, Apoptosis, and Myocardial 
Injury 1062-172*336A 
Identification of Hypertrophic Cardiomyopathy in 
the Muscular Dystrophy Mouse Model, dy/dy 
1229-87 •509A 
Implication of Angiotensin II in the Expression of 
Na+-HCO-3 Symporter and Na+-H+ Exchanger 
in Rat Myocardium After Myocardial Infarction 
1153-166•365A 
improvement ofDiastolic Function After 
Transcoronary Ablation for Septal Hypertrophy 
(TASH) Is Accompanied by Changes in Gene 
Expression of the Regulatory b-Subunit of the 
Cardiac Calcium Channel 1082-88•496A 
Increase of Metalloproteinase-2 and -9 Activity 
During Flow Induced Remodeling Is Regulated 
at the Posttranscriptional Level 1132-23o268A 
Mechanism of Action of Probucol on Cholesteryl 
Ester Transfer Protein (CETP) mRNA in a CHO 
Cell Line That had Been Stably Transfected 
With a Human CETP Gene 1011-21.221A 
Midkine (MK) Plays a Crucial Role in Neointimal 
Formation 1040-21 o229A 
Myocardial Expression of Proinflammatory 
Cytokines and Mitogen-Activated Protein 
Kinases During Atrial Fibrillation 868-4o155A 
Myostatin. aTransforming Growth Factor-b 
Superfamily Gene, Is Expressed in Heart 
Muscle 1195-111 o295A 
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Paracrine Effects of Stretch on Expression of 
Immediate Early Genes and Atrial Natriuretic 
Peptide in Cardiomyocytes 1195-75,294A 
Polymorphisru of the Plasminogen Activator 
Inhibitor-1 Gene Is Not Associated With an 
Increased Risk of Coronary Artery Disease or 
Myocardial Infarction in a Caucasian Population 
1106-115,258A 
Regional and Highly Efficient Myocardial Gene 
Transfer by Selective Pressure-Regulated 
Retroinfusion of Coronary Veins 1012-75. 
223A 
Seeding of Novel Covered Stems With Transfected 
Autologous Smooth Muscle Cells 1009-58, 
17A 
Successful Gene Transfer in a Porcine Ischemia 
Model Using the Biosense Guided 
Transendocardial Injection Catheter 826-4) 
355A 
Testosterone Causes Dilatation of Rat Coronary 
Arteries by a Novel Non-Genomic Mechanism 
1132-25,268A 
Transcription and Transregulation f the Human 
Sarcomeric Creatine Kinase Gene 1106-114- 
258A 
U-74, A 21 Aminosteroid-Lazaroid Selectively 
Inhibits the Transcription of iNOS in Cultured 
Endo- and Myocardial Cells 894-6.216A 
Gene-based therapy 
Adenoviral Gene Transfer to Mouse Carotid 
Arteries: Limited Role ofAntigen-Specific 
Immunity in Elimination of Transgene 
Expression I01 [-26.222A 
Adenoviral Mediated NOS3 Gene Transfi-~r in
Porcine Coronary Arteries Reduces In Stem 
Restenosis 834-3.59A 
Adenovirus-Based Anfisense Phospholaruban s
Potential Gene Therapy Approach for 
Improvement of Dimstolic Dysfunction 894-3,, 
215A 
An Adenovirus Minivectnr With High Cloning 
Capacity Suitable for Expression of SERCA and 
PhosphoIamban-Antisense-mRNA to Improve 
Cardiac Myocyte Function In Vitro and In Vivo 
894-4-216A 
Direct lntraruyocardial Injection of Vascular 
Endothelial Growth Factor Results in Effective 
Gene Transfer for Patients With Chronic 
Myocardial lschemia 874-3 °384A 
Efficacy of the Prophylactic Use of Vascular 
Endothelial Growth Factor (VEGF 121 ) in 
Animal Models of Hindlimb Ischemia: A 
Functional Assessment 80%2* 250A 
Efficient Retrovirus-Mediated Gene Transfer Into 
the Healing Rat Heart After Myocardial 
Cryoinjury 1106-112.257A 
Expression of Adenovirus Receptors CAR and avb3 
Integfin in Different Organs and Species Does 
Not Correlate With Adenoviral Vector Targeting 
In Vivo Indicating Anatomical Vector Barriers 
894-2,215A 
Gene Transfer of Tissue Inhibitor of 
Metalloproteinase-2 Does Not Prevent 
Restenosis n an Atherosclerotic Model 834-4* 
59A 
Locally Delivered Adenovims Stimulates 
Neointirual Formation and Negates the Potential 
Benefit of Adenovirus Hirudin Construct in a 
Rabbit Arterial Injury Model 845-3.70A 
Overexpression fEndothelium Nitric Oxide 
Restores Relaxation in the Hindlimb Vasculature 
After Myocardial Infarction 1080-19.179A 
Pereutaneous Endocardial Gene Therapy: In Vivo 
Gene Transfer and Expression 818-3°262A 
Regional and Highly Efficient Myocardial Gene 
Transfer by Selective Pressure-Regulated 
Retroinfusion of Coronary, Veins 1012-75. 
223A 
Spatial Distribution and Clearance of VEGF-CDNA 
Following lntramyocardial Injection 826-1, 
354A 
Successful Gene Transfer in a Porcine Ischenfia 
Model Using the Biosense Guided 
Transendocardial Injection Catheter 826-4, 
355A 
Successful Gene Transfer to the Arterial Wall Using 
a DNA-Eluting Polyruer-Coated lntracoronary 
Stent in Swine 834-5.60A 
The Effects of Tissue Inhibitor of 
Metalloproteinase-2 Gene Transt?r on Arterial 
Remodeling 1190-97.88A 
Transmyocardiat Laser Revascularization (TMR) 
Limits In Vivo Adenoviral-Mediated Gene 
Transferin Porcine Myocardium 826-6o355A 
Genetic techniques 
An Adenovirus Minivector With High Cloning 
Capacity Suitable for Expression of SERCA and 
Phospholamban-Antisense-mRNA to Improve 
Cardiac Myocyte Function In Vitro and In Vivo 
894-4. 216A 
b-Adrenergic SubsensitMty and Decreased Cardiac 
Function After Prolonged Cardioselective 
Norepinephrine Stimulation in Transgenic Mice 
Overexpressing Nerve Growth Factor 893-3. 
314A 
The Role of TCRab+ T Cells in Viral Myocarditis: 
Dissection Through TCRb-/- Transgenic 
Knockout Models ~050-86.491A 
Genetics 
A New Mutation of the Cardiac Troponin T Gene 
Causing Familial Hypertrophic Cardiomyopathy 
Without Left Ventricular Hypertrophy 1082-86 
°495A 
A Novel Polymorphisru in the Gene Coding for the 
bl -Receptor Associated With Survival in 
Patients With Heart Failure 818-2.261A 
ACE Genotype Predicts Valve Damage in Acute 
Rheumatic Fever 1225-177o565A 
Angiotensin Converting Enzyme I (ACE) 
Insertion/Deletion Polymorphism in Chilean 
Nonnotensive Population: Effect on Plasma 
ACE Activity, Left Ventricular Mass in Cardiac 
Fibrogenesis 1136-112Q273A 
Angiotensin-Couverting Enzyme Genotype Predicts 
Prognosis in Patients With Congestive Heart 
Failure 1140-2= 189A 
Arrhythruogenic Right Ventricular Cardiomyopathy: 
Long-Term Follow-Up of 37 Families 
1083-103 • 497A 
Diversity of Clinical and Genetic Patterns in a 
Family With Hypertrophic Cardiomyopathy 
1020-102 • 489A 
Effect of the Factor V Leiden Mutation on Stroke 
Associated With Atrial Fibrillation in The 
Framingham Study 1201-88.507A 
Expression of b-Myosin Heavy Chain-Gin403 in 
Transgenic Rabbits Induces Myocyte Disarray 
and Increased Interstitial Collagen Content 
1082-85 * 495A 
Familial Dilated Cardiomyopathy: New 
Echocardiographic Diagnostic Criteria for 
Classification of Family Members as Affected 
1051-101.493A 
Genetic Polymorphism of the Renin Angiotensin 
Aldosteron System May Determine the Clinical 
Phenotype in Gene Carriers in a Family With 
Hy pert rophic Cardimnyopathy 1020-101- 
489A 
Heritable Atrial Fibrillation in Human Conduction 
System and Myocardial Disease 1022-147o 
I03A 
I/D Polymorphism of the Angiotensin Converting 
Enzyme Gene and Ventricular Remodeling After 
Myocardial Infarction in Patients With 
Mechanical Revascularization 1001 - 165 * 321A 
Increased Prevalence of Prothrombin Mutated Allele 
G20210A in Patients With Famifial Acute 
Coronary Syndromes 1073-28° 241A 
Interaction of b Fibrinogen Gene Polymorphism 
With Diabetes Mellitus: The Framingham 
Offspring Study 883-5.312A 
Is Aortic Atherosclemsis Heritable? Familial 
Aggregation of Lumbar Aortic Calcification in 
The Framingharu Study 880-1.310A 
LCAT OK: A Novel GC Deletion and the LCAT 
Gene Associated With a Dominant Effect on 
HDL-C 1105-75.256A 
Left Ventricular Function After Primary Angioplasty 
and Genetic Polymorphisms of the 
Angiotensin-Converting Enzyme and the 
Angiotensin-ll Type 1ReceptorGenes 898-6* 
399A 
Localization of a Gene Responsible for 
Arrhythmogenic Right Ventricular Dysplasia to 
Chromosome 3p23 410-1.2A 
Localization of the Site of Conduction Abnormality 
in a Mouse Model of Myotonic Dystrophy 
868-6.155A 
Methytene-Tetrahydrofolate Reductase 
Polymorphism and Allografl Vascular Disease 
Aft er Heart Transplantation 855-5.205A 
Mitochondrial DNA Defects Associated With 
Dilated Cardioruyopathy 818-4a262A 
Mutation in the Promoter Region of 
Thrombomodulin Gene Is an Independent Risk 
Factor of Coronary Artery Disease 900-6. 
318A 
Novel Missense Mutations in the Cardiac b-Myosin 
Heavy Chain Gene in Hypertrophic 
Cardiomyopathy: Genotype/Phenotype 
Relationship 818-6. 262A 
PAI-I Gene Polymorphism in Patients With 
Coronary Artery Disease and Malignant 
Ventricular Arrhythmias 1204-/88* 152A 
Platelet GPIIIa Receptor PLA Polyruorphism and 
Cardiovascular Disease: The Framingham Heart 
Study 818-5.262A 
Polynmrphism of Angiotensin Converting Enzyme 
Gene Affects Unfavorably Transforming Growth 
Factor and Von Willebrand Factor in 
Hypertensive Patients 1136-11 .273A 
Polymorphism of Angiotensin Converting Enzyme 
Gene Is Associated With Hemostatie Parameters 
Disturbances in Patients With Essential 
Hypertension 1165-121.285A 
Polymorphisru of Angiotensin-Converting Enzyme 
Gene Affects Unfavorably Fibrinogen Plasma 
Levels in Healthy Offspring of Men With 
Premature Coronary Artery Disease 1137-121 * 
275A 
Principal Component Analysis of Spatial Dispersion 
of Repolarization i  LQT1 and LQT3 Gene 
Carriers 1055-189. l14A 
QT Abnormalities in Genetically Affected Subjects 
Without Left Ventricular Hypertrophy: A Study 
on 201 Subjects With Familial Hypertrophic 
Cardiomyopathy 1230-101 *511A 
Significance of Methylenetetrahydrofolate 
Reductase Gene Polymorphisru as a Risk Factor 
for Early Myocardial Infarction 818-1 • 261A 
The Clinical Features of lie 122 Amyloidosis: A 
Cardiomyopathy Found Exclusively in Patients 
of African Origin 888-I.513A 
The Contribution of Genetic (4G/5G Polymorphism) 
and Environmental Factors to Plasminogen 
Activator lnhibitor-I Antigen Levels: The 
Framingham Offspring Study 883-6-312A 
The Genetic Control of Coronary Vasomotor Tone: 
Role of Angiotensin Converting Enzyme Gene 
Polymorphism 883-4. 312A 
The Plasminogen Activator Inhibitor-I Gene4G/5G 
Polymorphism and Cardiovascular Disease: The 
Fraruingham Heart Study 1191-21 =288A 
Geographic variation (small area analysis) 
Improvement i  Treatment Quality Indicators for 
Elderly Patients With Acute Myocardial 
Infarction: The Cooperative Cardiovascular 
Project in Maryland and the District of 
Columbia 835-5 • 266A 
Local Bed Capacity Is Associated With Probability 
of Readmission: A Study of 6752 Coronary 
Artery Bypass Surgeries in New England 
1015-119.229A 
Readmission Following Coronary Artery Bypass 
Graft Surgery in New England: Magnitude and 
Variability Across Institutions 808-6¢249A 
KEY: Abstract itle, Session-abstract number * page number 
JACC February 1999 SUBJECT INDEX 665A 
Glucose 
Hyperglycemia R pidly Suppresses Flow-Mediated 
Endothelium-Dependent Vasodilation of 
Brachial Artery 899-1 °315A 
Insulin Resistance in Patients With Idiopathic 
Dilated Cardiomyopathy Assessed by 
Fluorodeoxyglucose Positron Emission 
Tomography Imaging: Implications tor 
Metabolic Intervention? 1049-13• 177A 
Relation Between Plasma Leptin and Insulin 
Metabolism 1164-71°283A 
Serial Changes in Wall Motion Abnormality, 
Glucose Utilization, and Free Fatty Acid 
Utilization in Successfully Reperfused 
Myocardium 1209-122-467A 
Growth factors 
A Growth Factor Mixture That Significantly 
Enhances Angiogenesis 826-2 °354A 
Angiotensin-Converting Enzyme lnhibitors Restore 
Hepatocyte Growth Factor Production in 
Patients With Congestive Heart Failure 856-6, 
207A 
Asymmetric Dimethylarginine Inhibits Basic 
Fibroblast Growth Factor Induced Angiogenesis 
1041-31,232A 
Basic Fibroblast Growth Factor ls Produced From 
the lschemic Myocardium of Patients With 
Stable Effort Angina 1186-141 *378A 
Cardiac Effects of Growth Hormone in Short 
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Expression of Aden•virus Receptors CAR and avb3 
Integrin in Different Organs and Species Does 
Not Correlate With Aden•viral Vector Targeting 
In Vivo Indicating Anatomical Vector Barriers 
894-2 • 215A 
Hypothermia: A New Indicator of Imminent Death 
in Congestive Heart Failure 1228-7°212A 
Improvement of Cardiac Neuronal Function Using 
123I-MIBG Scintigraphy in Dilated 
Cardiomyopathy After Carvedilol Therapy 
1091-107.425A 
Influence of Fetal Cardiomyoeyte Transplantation  
the Progression of Heart Failure 894-1.215A 
Intermittent Large Dose Nitrates Added to Standard 
Therapy, Improves Left Ventricular Function 
and Exercise Capacity in Patients With Chronic 
Heart Failure g25-I • 188A 
Long-Term Beneficial Hem•dynamic and 
Neurohormonal Effects of Vasopeptidase 
Inhibition With Omapatrilat in Heart Failure 
1110-18o 185A 
Long-Term Effects of Heart Rate Reduction in 
Patients With Heart Failure: Comparison With 
Chronic b-Adrenergic Blockade 825-6-189A 
Long-Term Results of Permanent Biventricular 
Pacing in Refractory Heart Failure: Comparison 
of Patients With Stable Sinus Rhythm and 
Chronic Atrial Fibrillation 1 115-152 • 124A 
Long-Term Survival of Patients With Severe Left 
Ventricular Dysfunction and Multivessel Artery 
Disease: Five-Year Results of the High Risk 
Myocardial Ischemia Trial 1049-9 •176A 
Nesiritide (Human B-Type Natriuretic Peptide) 
Improves Symptoms and Hem•dynamics n 
NYHA Class IIl and IV Heart Failure 825-2o 
188A 
Nonangiotensin Converting Enzyme Dependent 
Angiotensin lI Generation i  Resistance Arteries 
From Patients With Chronic Heart Failure 
881-2.214A 
Outcome in Intention to Treat With a Biventricular 
Pacing for Severe Heart Failure: Comparison 
Monoventric ular/Biventricular Pacing 
1115-156.125A 
Passive Ventricular Constraint With the Acorn 
Prosthetic Jacket Prevents Progressive Left 
Ventricular Dilation and Improves Ejection 
Fraction in Dogs With Moderate Heart Failure 
870-1 o207A 
Potentiation of the B-Adrenergic Responsiveness in 
Failing Human Myocardium by Dantrolene 
Sodium 1227-15 • 209A 
Predictors of Oral Anticoagulant Utilization in 
Congestive Heart Failure: A Survey on 6428 
Outpatients of The: Italian Network-Congestive 
Heart Failure (IN-CHF) 1199-12•201A 
Prospective Clinical Evaluation of Transvenous 
Biventricular DDD Pacing in Refractory Heart 
Failure: Preliminary Results of the Insync 
Multicenter Study 1115-153 °124A 
Quantitative Fatty Acid Myocardial Scintigraphy 
Predicts Responders for b-Blockade Therapy in 
Patients With Dilated Cardiomyopathy 
1209-124 • 468A 
Recovery-Directed Left Ventricular Assist Device: A 
New Concept 1200-7. 204A 
Removal of Cardiodepressant Factor(s) in Dilated 
Cardiomyopathy b  lmmunoadsorption 
1018-19° 170A 
Resting Myocardial Blood Flow and Metabolism 
Predicts Improved Native Cardiac Output and 
the Ability to Exercise With Weaning in Patients 
With the TCI Heartmate L ft Ventricular Assist 
Device 909-3 °219A 
Results of a Multidose Phase I Trial With Tumor 
Necrosis Factor Receptor (p75) Fusion Protein 
(Etanercept) in Patients With Heart Failure 
1110-14-184A 
Reversal of Myocyte Injury With Chelation Therapy 
in Patients With Thalassemia 1240-143o536A 
Save Me the Money: A Cost Comparison of 
Inpatient Versus Outpatient Care of Left 
Ventricular Assist Device Patients 1200-6o 
204A 
Sequential Evaluation of Big Endothelin Plasma 
Concentration i Patients With Advanced Heart 
Failure: Effects of Therapy 1199-19o202A 
Serum Profiles of Cytnkine Antagonists During the 
Acute Decompensation f Advanced Heart 
Failure 1018-17 .169A 
Survival Benefit of Revascularization in lschemic 
Cardiomyopathy With Viability Demonstrated 
by Low-Dose Dobutamine Echocardiography 
1149-84 •445A 
The Detrimental Effect of Combined Aspirin and 
Angiotensin Converting Enzyme Inhibitor 
Therapy on Readmission Rates in Heart Failure 
881-3 • 214A 
The Effect of Chronic Nocturnal Oxygen on Sleep 
Disordered Breathing Associated With 
Congestive Heart Failure (CHF) 1199-18• 
202A 
The Effect on Heart Rate of Immediate and 
Slow-Release Metoprolol in Patients With 
Chronic Heart Failure 1110-10• 183A 
The Effects of Hydralazine on the Prevention of 
Nitrate Tolerance in Patients With Chronic Heart 
Failure 1110-16*185A 
The Resting Electrocardiogram Provides a Sensitive 
and Inexpensive Marker of Prognosis in Patients 
With Chronic Congestive Heart Failure 847-4* 
145A 
Time Course of Functional Changes in Long-Term 
Survivors With Idiopathic Dilated 
Cardiomyopathy: Effects of Metoprnlol 
1083-100.497A 
U-74, A 2 l Aminosteroid-Lazaroid Selectively 
Inhibits the Transcription of iNOS in Cultured 
End•- and Myocardial Cells 894-6.,216A 
Unexpected Intracardiac Abrasion of Implantable 
Silicone Rubber Atria] Defibrillation Leads 
848-2,, 146A 
Unique Renal and Systemic Hemedynamic A tions 
of a New Natriuretic Peptide in Experimental 
Heart Failure 1199-17•202A 
Withdrawal of Chronic Beta Blockade in Heart 
Failure Patients Does Not Influence Exercise 
Hemodynamics 1199-9o200A 
Heart function tests 
A New Digital Method for Estimating Left 
Ventricular Volume Using Real-Time 
Three-Dimensional Echocardiography: A 
Comparison With Magnetic Resonance Imaging 
829-4*441A 
Accurate Measurement of Left Ventricular Stroke 
Volumes Using Real-Time, Three-Dimensional 
Echo During Nonischemic and Ischemic 
Conditions 9144°486A 
Constitutive Properties of Cardiac Muscle Cells 
Measured Under Physiologic Conditions Which 
Parallel In Vivo Cell Lengthening 1082-87- 
496A 
Evaluation of Left Ventricular Diastolic Function by 
Color M-Mode Echocardiography: Is it Preload 
Dependent? 1120-106•432A 
Exercise Stress Echocardiography Enhances 
Detection of Anthracycline Cardiotoxicity 
1 t78-109¢455A 
Functional Outcome of Patients Operated for 
Transposition of the Great Arteries With the 
Mustard Procedure 885-5.539A 
Improved Accuracy for a Semiautomated Method 
for Computing Right Ventricle Cavity Volumes 
From Real-Time Three-Dimensional Echo: 
Comparison Studies to Ultrasonic Crystals in an 
Open Chest Animal Model 914-2•486A 
Improved Echo Diagnosis of Left Ventricular 
End-Diastolic Stiffness in Patients With 
Transplant Rejection 1169-14• 198A 
ls Blood Pressure Response to the Valsalva 
Maneuver Related to Neurohormones, Exercise 
Capacity, and Clinical Findings in Heart 
Failure? 1019-13.173A 
Myocardial Beta Natriuretic Peptide Release After 
Acute Ischemia in Patients Undergoing Beating 
Heart Coronary Surge D' 1019-12• 172A 
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Noninvasive Assessment of Left Ventricular 
lsovolumic Contraction and Relaxation Using 
Continuous Wave Doppler Aortic Regurgitant 
Velocity Signals: An In Vivo Validation Study 
1150-107.446A 
Normal Parameters of Left Ventricular Volume and 
Ejection Fraction Measured by Gated 
Myocardial Perfusion SPECT 1029-35,.409A 
Potential Role of Brain Natriuretic Peptide as a 
Screening Test for Cardiac Remodeling in 
Hypertensive Patients 1076-112" 246A 
Reliability of the Six-Minute Walk Test in CHF 
Patients 1228-11 •213A 
The Effect of Reactive Airways Disease on Peak 
Oxygen Consumption i  Congestive Heart 
Failure 1019-11 °172A 
Time Course of Left Ventricular Mass Regression 
Following Left Ventricular Assist Device 
Implantation 870~* 208A 
Using Fructose-1,6-Diphosphate to Enhance Heart 
Preservation 1124-167"357A 
Heart rate 
Alterations of Heart Rate Variability After 
Radiofrequency Catheter Ablation of Focal 
Atrial Fibrillation 1175 - 187 • 144A 
Altered Force Frequency Relationship of Human 
Myocardium in Mitral Valve Incompetence 
852-5"558A 
Autonomic Modulation of Heart Rate and Blood 
Pressure in Offspring of Hypertensive Subjects 
1045-120o 237A 
Barureflex Sensitivity and Heart Rate Variability in 
Patients With and Without Sustained T-Wave 
Altemans After an Acute Myocardial Infarction 
1086-187 " 121A 
Beat-by-Beat QT Variability Is Markedly Sensitive 
to Respiration in Patients With Heart Failure 
1228-13,,213A 
Chronic Hyperinsulinemia Impairs Heart Rate 
Variability in Obese and Hypertensive Subjects 
851-3 • 287A 
Chronotropic Incompetence Predicts Long-Term 
Mortality Better Than Coronary Angiography 
862-1 • 561A 
Differences in Heart Rate Variability Between 
African-Americans and Whites With Coronary 
Artery Disease and lschemia 1086-188" 121A 
Do We Really Need Expensive Tests to Accurately 
Predict Prognosis in Patients With Heart 
Failure? 1140-4*190A 
Early Morning Sympathovagal Balance Is Improved 
by Aldosterooe Blockade in Chronic Heart 
Failure 1110-13 " 184A 
Evolutionary Pattern of Heart Rate Variability Early 
After Acute Myocardial Infarction 1117-184" 
350A 
Heart Rate Variability and Ischemic Responses to 
Mental Stress: Results From the 
Psych•physiological Investigations of
Myocardial Ischemia (PIMI) Study 1086-185,, 
120A 
Heart Rate Variability Immediately Following 
Exercise Testing Predicts Mortality Independent 
of Thallium Per'fusion Defects 862~1o561A 
Is QT Dispersion Altered by Changes in Heart Rate? 
830-4" 129A 
ls QT Dispersion Heart Rate Dependent? What Are 
the Values of Correction Formulas for QT 
Interval? 1055-187° l13A 
Long-Term Effects of Heart Rate Reduction in 
Patients With Heart Failure: Comparison With 
Chronic b-Adrenergic Blockade 825-6" 189A 
New Insights Into Calcium Cycling Using 
Post-Extrasystolic Potentiation i  
Phospholamban Overexpression 891-2 - 515A 
New Technique for Vagal Nerve Stimulation 
1232-157 • 158A 
Night Heart Rate Trends Correlate With Changes in 
Heart Failure 1228-6- 211A 
Pronouced HR Variability After Exercise in Inferior 
Ischemia: Exercise-Induced Inferior Ischemia 
Invokes the Cardioinhibitory Reflex I 186-137 ° 
377A 
Rate-Related Changes in Cardiac Repolarization: 
QT Interval Versus Monophasic Action 
Potential Duration 1146-187,. 135A 
RR Intervals and Heart Rate Variability Rise 
Gradually. Then Decfine Rapidly, Before the 
Onset of Sustained Ventricular 
Tachyarrbythmias 1085-155,, l18A 
Sympathetic Activation Leads to Higher Correlation 
Between Mean Heart Rate and Heart Rate 
Variability in Patients With More Severe Heart 
Failure 1117-185.350A 
The Effect on Heart Rate of Immediate and 
Slow-Release Metoprolol in Patients With 
Chronic Heart Failure 1110-10.183A 
The Functional Significance of Chronotropic 
Incompetence During Dobutamine Stress Test 
1056-34•411A 
The Influence of Cigarette Smoking on Time 
Domain Measures of Heart Rate Variability in 
Healthy Volunteers 1146-189.136A 
Ventilatory and Chronotropic Responses to Exercise: 
Better Predictors of Heart Failure Mortality and 
Peak V02 1140-3" 190A 
Heart septal defects 
Amplatzer Septal Occluder for Catheter Closure of 
Large (>_20 ram) Secundum Atrial Septal 
Defects (ASD): Results of Interuational]US 
Multicenter Clinical qrial 1181-144"531A 
Calculation of Shunt Flow Volume Through Atrial 
Septat Defect by a Newly Developed Digital 
Doppler Color Flow Mapping Method Using 
Transesophageal Echo in Patients 1090-84" 
424A 
Delivery of Amplatzer Septal Occluder Devices in 
Patients With Multiple Atrial Septal Defects and 
in Complex Patients Via Right Internal Jugular 
Vein 1181-145"532A 
The Impact of Isolated Secundum Atrial Septal 
Defect Closure on Growth in Undersized 
Children 1092-161 ,.524A 
Transcatheter Closure of Atrial Septal Defect Using 
Self-Expandable Septal Occluder 1030-145" 
519A 
Transcatheter Correction of Heart Defects by 
Detachable Balloon Buttoned Devices: A 
Feasibility Study 827-4" 528A 
Transcatheter C eation of Atrial Septal Defect and 
Fontan Fenestration With "Butterfly" Stent 
Technique 827-6" 529A 
Heart surgery 
Comparison of Stress Hemodyamics Between 
Nonstented Aortic Bioprostheses, Mechanical 
Valves, and Normal Native Aortic Valves 
1197-191 " 560A 
Costs Over Eight Years in the Emory Angioplasty 
Versus Surgery Trial 1015-118.228A 
Early Calcification and Degeneration ofMitral Valve 
Reconstruction i Patients Undergoing Chronic 
Dialysis 1225-190"565A 
Factors Associated With Age at Operation for 
Children With Congenital Heart Disease 
1092-160" 524A 
Grafting Strategies in Minimally lnvasive CABG 
With EndoCPB 1138-173"551A 
Impact of Minimally lnvasive Approach on Valvular 
Heart Surgery: A Case Controlled Study 842-6 
• 554A 
Improved Clinical Outcomes in Patients Undergoing 
Coronary Artery Bypass Grafting With 
Coronary Endarterectomy 879-6" 567A 
Influence of Preoperative Internal Mammary Artery 
Flow Reserve and Postoperative Flow at Rest on 
Functional Graft-Assessment After Minimal 
lnvasive Bypass Surgery 1025-62"403A 
Initial Experience W~th Real-Time 
Three-Dimensiooal Echocardiography for the 
Mitral Valve Apparatus 1026-80"404A 
lntraoperative Echocardiography in Coronary Artery 
Bypass Graft Surgery Without Cardiopulmonary 
Bypass 866-6 °471A 
Minimally [nvasive Coronary Artery Bypass Surgery 
as a Treatment fur Restenosis 1138-174,,551A 
Multivessel Stenting Reduces In-Hospital 
Complication Compared With Repeat 
Aortocoronary Bypass Surgery 1099-55 ° 51A 
Prediction of Coronary Artery Disease in Patients 
Undergoing Mitrat Valve Prolapse Surgery 
842-4 *554A 
Prognosis by Measures of Intraoperative 
Transesophageal Echocardiography in Patients 
Undergoing Cardiac Surgery 1148-61.442A 
Rate Control Versus Conversion Strategy in Post 
Operative Atrial Fibrillation: A Prospective, 
Randomized Pilot Study 1022-150-103A 
Short- and Long-Term Follow-Up in 771 Patients 
Undergoing Reoperative Heart Valve Surgery 
1078-177°548A 
The Role of Intraoperative Transesophageal 
Echocardiography in the Assessment of Mitral 
Regurgitation Among Patients Undergoing 
Aortic Valve Replacement for Aortic Stenosis 
866-5 • 471A 
Three-Dimensional Echocardiography in 
Hypoplastic Left Heart Syndrome: 
Delermination of Right Ventrieular Size and 
Function 1061-158.521A 
Using Three-Dimensional MR Velocity 
Reconstruction toStudy the Energetics of the 
Total Cavopulmonary Connection In Vivo 
1061-161.522A 
World's Largest Registry of Minimally lnvasive 
CABG With EndoCBP Demonstrates Excellent 
Results With Minimal Morbidity and Mortality 
879-5 ,, 567A 
Heart valve prosthesis 
A Prospective Observation of Patients Starting Oral 
Anticoagulation Following Heart Valve 
Replacement 1046-174.544A 
Comparison of Stress Hemodyamics Between 
Nonstented Aortic Bioprostheses, Mechanical 
Valves, and Normal Native Aortic Valves 
1197-19t .560A 
Effective Orifice Areas for Pediatric-Sized Bileaflet 
Mechanical Valves: In Vitro Studies Using Flow 
Visualization and Doppler 1235-34.474A 
Hemodynamic Performance During Maximal 
Exercise: A Comparison Between Stenfess and 
Stented Aortic Bioprostheses 1197-174-559A 
Routine Fonow-Up of Prosthetic Cardiac Valves by 
Echocardiography: How Often? 867-4.472A 
The Effects of Heparin Administration i  
Thrombosis of Mechanical Mitral Prosthesis 
Assess by Echocardiography 1148-63.443A 
Heart valves 
ACE Genotype Predicts Valve Damage in Acute 
Rheumatic Fever 1225-177" ~5A 
An Echocardiographic S oring Algorithm for 
"Carcinoid-Like" Valvular Heart Disease in 
Patients Treated With Anorectic Drugs 
1079-191 " 549A 
Contrasting Effects of Similar Regurgitant Orifices 
in Mitral and Tricuspid Regurgitation 852-3" 
557A 
Detection of Chlamydia Pneumoniae in Human 
Nonrbeumatic Sclerotic Heart Valves by 
lmmunhistochemical Analysis and Polymerase 
Chain Reaction 1139-191 ,. 552A 
Early Calcification and Degeneration ofMitral Valve 
Reconstruction i Patients Undergoing Chronic 
Dialysis 1225-190o565A 
Impact of Minimally Invasive Approach on Valvular 
Heart Surgery: A Case Controlled Study 842-6 
.554A 
Improved Assessment of Mitral Valve Stenosis by 
Transthoracic Real-Time 3-D Echocardiography 
1026-79 " 404A 
Increased Apparent Valve Thickness With Tissue 
Harmonic Imaging: The Effect on Mitral Valve 
Leaflets 828-5"439A 
Long-Term (13-Year) Results After Pulmonary 
Balloon Valvuloplasty in Adolescent and Adult 
Patients 1181-160.532A 
Role of Mitral Valve Chordal Distribution in Mitral 
Valve Function: An In Vitro Study 1016-174" 
541A 
The Prevalence of Significant Valvular Regurgitation 
and Pulmonary Hypertension i 753 Patients 
Who Took Eenfluramine and Phentermine in a 
Community Setting t 079-190. 549A 
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Tricuspid Valve Balloon Dilation in Children 
1181-158,,532A 
Heart, artificial 
Hypertension During Support With Ventricular 
Assist Devices: Incidence, Risk Factors, and 
Management 909-1 •219A 
Recovery-Directed Left Ventricular Assist Device: A 
New Concept 1200-7 •204A 
Hem•dynamics 
A Model-Based Expert System for Improving 
Assessment of Patients With Cardiovascular 
Diseases in Intensive Care Units 865-305A 
Adranomedullin: A Unique In•dilator In Vivo 
893-1 * 314A 
Are Diastolic Velocities of the Mitral Annulus 
Load-Dependent? A Tissue-Doppler Study in 
Hem•dialysis Patients 815-5 •429A 
Cardiogenic Shock Complicating Right Vantricular 
Myocardial Infarction: Outcome After 
Pereutaneous Revascularization 1155-168,, 
367A 
Carotid Arterial Wave Intensity Measured 
Noninvasively in Humans 1237-82.477A 
Changes in Left Ventricular Diastolic Function Six 
Months After Nonsurgical Septal Reduction 
Therapy for Hypertrophic Obstructive 
Cardiomyopathy 837-4¢ 449A 
Contrast-Enhanced Doppler Echocardiography 
Allows a Complete Hem•dynamic Assessment 
in Patients With Congestive Heart Failure 
1179-126•456A 
Direct Comparison of Intracoronary Pressure and 
Doppler-Derived Parameters of Intermediate 
Lesions in Multivessel Disease 1071-50*46A 
Does Transoperative Right Heart Catheterization 
Reduce Cardiac Complications After 
Noncardiac Surgery? 1015-120•229A 
Doppler Echocardiographic Parameters in Patients 
With Left Ventricular Hypertrophy: 
Physiological Versus Pathological Hypertrophy 
1112-85 • 498A 
Earlier Pressure Wave Reflection as a Marker of 
Atherosclerosis: Assessment byPortable 
Applanation Tonometry 1073-27 •241A 
Early, Long-Term Therapy With Bosentan Prevents 
Progressive Left Ventricular Dysfunction and 
Dilation in Dogs With Moderate Heart Failure 
1080-15 • 178A 
Effect of Active and Passive Smoking on Wave 
Reflection as Measured From the High-Fidelity 
Aortic Pressure Waveform 1073-31o242A 
Effect of Sildenafil (Viagra) on Coronary Blood 
Flow and Hem•dynamics During Exercise 
1221-113,,303A 
Effects of Hyperoxia on Flow-Related Endothelial 
Function and Hem•dynamics n Patients With 
Heart Failure 1013-70,,225A 
Estrogen Receptor-Mediated Gender-Specific 
Vascular Effects of 17b-Estradiol 1107-119• 
259A 
Fractional Flow Reserve, Absolute and Relative 
Coronary Blood Flow Velocity Reserve in 
Relation to 99mTc-MIB1 Spect Scintigraphy in 
Intermediate Coronary Lesions 1219-46.99A 
Hem•dynamic Performance During Maximal 
Exercise: A Comparison Between Stantless and 
Stented Aortic Bioprostheses 1197-174•559A 
Hem•dynamic, Functional, Echocardiographic, and 
Survival Benefits of Long-Term Continuous 
Intravenous Prostacyclin Infusions in Primary 
Pulmonary Hypertension 877-1 •308A 
High Dose Vitamin E Decreases Arterial Wave 
Reflection and Improves Ventricular/Vascular 
Coupling 1040-200229A 
Identification of Circulatory Parameters by Use of a 
Computer Model Coupled With a Nonlinear 
Optimization Algorithm 1505-2 •9A 
Is Continuous Intravenous Prostacyclin Infusion 
Effective in Secondary Pulmonary 
Hypertension? 1134-310270A 
Is Normotensive Type II DM Associated With Left 
Ventricular Hypertrophy Independent of
Hem•dynamic Stimuli? 888-5•514A 
Mortality Is Not Increased With Pulmonary Artery 
Catheterization in Acute Coronary Syndromes: 
The GUSTO Trials 889-3 o395A 
Noninvasive Evaluation of Pulmonary Capillary 
Wedge Pressure in Patients With Acute 
Myocardial Infarction by Deceleration Time of 
Pulmonary Venous Velocities in Diastole 837-3 
•449A 
Postprocedural Hypotension After Carotid Stent 
Implantation: Incidence and Clinical Sequelae 
1008-96 • 16A 
Radial Artery Pulse Wave Analysis for Assessment 
of Left Ventricular Failure 1228-5,,211A 
Right and Left Ventricular Interaction in Chronic 
Heart Failure: Contribution of External Forces to 
Determine Hem•dynamic Response During 
Nitroprusside Infusion 1168-5• 196A 
Right Ventricular Ejection Fraction in Idiopathic 
Dilated Cardiomyopathy Compare to Ischemic 
Left Ventricular Dysfunction: Data From an 
Angiographic Study 1168-2• 196A 
Role of Mitral Valve Chordal Distribution in Mitral 
Valve Function: An In Vitro Study 1016-174• 
541A 
The Change in Aortic Valve Area During a Cardiac 
Cycle Can Be Used to Predict he Rate of 
Hem•dynamic Progression of Aortic Stenosis 
812-2.427A 
The Effectiveness of Prostacyclin as a Therapy for 
Secondary Pulmonary Hypertension 877-2 • 
308A 
Withdrawal of Chronic Beta Blockade in Heart 
Failure Patients Does Not Influence Exercise 
Hem•dynamics 1199-9 m 200A 
Hemostasis 
Abnormalities of Hypercoagulability in Atrial 
Fibrillation: Relationship to Asymptomatic 
Embolization Detected by Transcranial Doppler 
1022-156* 105A 
Antioxidant Therapy With Vitamin E Does Not 
Improve Fibrinolysis in Postmenopansal Women 
831-3o265A 
Arterial Access Site Closure With a Novel Sealing 
Device: Duett 1216-38,,92A 
Both Atenolol and Propanolol Blunt the Fibrinolytic 
Response to Exercise but Not Resting 
Fibrinolytic Potential 1220-31 • 302A 
Both PEG-Hirudin and Enoxaparin Blunt the Rise of 
Von Willebrand Factor in Patients With Unstable 
Angina 819-2•351A 
Does Abciximab inhibit the Expression of PAC- I on 
Newly Released GP llb/llIa Receptors? 
I 102-24 • 252A 
Elimination of Excess Vascular Access Site Bleeding 
During Coronary Intervention With Abciximab 
1157-60•73A 
Enoxaparin Versus Unfractionated Heparin as 
Adjunctive Therapy to rt-PA in Acute 
Myocardial Infarction: Results of the Heparins 
and Reperfusion Trial lI (HART II) Pilot Study 
869-5•383A 
Hypercoagulable States in Patients With Recurrent 
Thrombosis of Mechanical Heart Valves 
I046-173 •543A 
Incidence of lntracranial Hemorrhage in Trials of 
Glycoprotein llb/Iila Receptor Inhibitor Drugs 
1068-92•41A 
Incidence of Thrombocytopenia Complicating 
Treatment With Glycoprotein llb/llla Receptor 
lnhibitors 1104-72•255A 
Investigation of the Novel P2T Receptor Antagonist 
AR-C69931MX on Ex Vivo Adenosine 
Diphosphate-Induced Platelet Aggregation and 
Bleeding Time in Healthy Volunteers 1104-73. 
255A 
Polymorphism of Angiotensin Converting Enzyme 
Gene Is Associated With Hem•static Parameters 
Disturbances in Patients With Essential 
Hypertension t165-121-285A 
Hormones 
Adrenomedullin: A Unique In•dilator In Vivo 
893-1.314A 
Augmented Ventricular Gene Expression and 
Secretion of Adrenomedullin Experimental 
Congestive Heart Failure 1227-17•209A 
Can Ultrasonic Myocardial Textural Analysis Help 
to Detect a Possible Cardiac Damage Due to 
Anabotic-Androgenic Steroids Abuse in 
Athletes? 901-6*484A 
Chronic Transdermal Estradiol-17b Therapy Lowers 
Blood Pressure in Newly Diagnosed 
Hypertensive Postmenopausal Women 877-4,, 
309A 
Determination ofMenopausal Status in Women: The 
NHLBI-Sponsored WISE Study 835-4,,266A 
Effect of Different Estrogen-Progestin Replacement 
Therapy Schemes Upon Exereise-lnduced 
Myocardial Ischemia in Female Menopausal 
Patients With Coronary Artery Disease 
1005-139 ° 327A 
Effect of Estrogen + Progestin on Progression of 
Carotid Atherosclerosis in Postmenopausal 
Women With Documented Heart Disease: 
HERS B-Mode Substudy 831-5*265A 
Effects of Estrogen Versus Droloxifene on Adhesion 
Molecules and Cytokines in Healthy 
Postmenopausal Women 911-2.318A 
Initiation of Hormone Replacement Therapy After 
Acute Myocardial Infarction ls Associated With 
More Angina but Less Death/Myocardial 
Infarction During Follow-Up 893-6,,315A 
lntracoronary 17b-Estradiol Reduces Plasma 
Endothelin-I Levels in Postmenopausal Women 
With Coronary Artery Disease 899-2*316A 
PET Assessment of Myocardial Blood Flow Before 
and After Hormone Replacement Therapy in 
Postmenopausal Women 1221-115¢303A 
Plasma Leptin Levels Are Related to Fatigue in 
Patients With Chronic Heart Failure 844-2. 
194A 
Raloxifene Acutely Relaxes Rabbit and Human 
Coronary Arteries In Vitro by an 
Endothelium-Dependent Mechanism 1041-30* 
231A 
Relation Between Plasma Leptin and Insulin 
Metabolism 1164-71*283A 
Superiority of Brain Natriuretic Pep•ire in Assessing 
Efficacy of Therapy to Improve Symptoms of 
Congestive Heart Failure in the Outpatient 
Setting 1140-15•193A 
Surgical Oophorectomy With and Without 
Hysterectomy. Hormone Therapy, and CAD in 
Women: The NHLBI-Sponsored WISE Study 
1 I07-120•259A 
Tamoxifen's Versus Estrogen's Effect on the 
Microvasculature ofPostmenopausal Women 
899-6°317A 
Testosterone Causes Dilatation of Rat Coronary 
Arteries by a Novel Non-Genomic Mechanism 
1132-25 •268A 
Testosterone Enhances Brachial Artery Reactivity in 
Men With Coronary Artery Disease 1013-74,, 
226A 
Testosterone Relaxes Male and Female Rat 
Coronary Arteries In Vitro Via an Endothelium 
lndependem Mechanisms 1132-24,.268A 
Triiodothyronine Treatment inChildren After 
Cardiac Surgery: A Placebo-Controlled, Double 
Blind Clinical Study 859-3 •535A 
Hyperlipoproteinemia 
Biphasic Pattern of Cell Turnover During 
Atherogenesis in Man and APOE*3 Leiden 
Mice 1011-310223A 
Chronic Endotbelia Receptor Antagonism Preserves 
Coronary Endothelial Function In Vivo in 
Experimental Hypercholesterolemia 1041-27 ,* 
231A 
Contribution of Vasoactive Prostanoids to Vascular 
Tone in Healthy Subjects, Hypertensive Patients, 
and Hypercholesterolemic Patients 1162-23,, 
280A 
Dietary Treatment in Dyslipidemia: Do Dietitians 
Do It Better? A Prospective, Randomized 
Clinical Trial 860-4,.297A 
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With Tirofiban +Heparin but Not With Heparin 
Alone in Patients With Unstable 
Angina/Non-Q-Wave Myocardial Infarction 
1032-t3l .330A 
Role of Inflammatory Mediators in Oxygen-Free 
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(AS): Implications for Secondary Prevention 
1139-192•553A 
Use of Lipid Lowering Medications in Patients With 
Coronary Disease 1990-1996: The National 
Ambulatory Medical Care Survey 860-6o298A 
Prognosis 
A Composite Score Derived From Dobutamine 
Stress Echocardiography Improves the Ability 
of a Clinical-Angiographic Model to Predict 
Cardiac Events in Patients With Coronary 
Artery Disease 1178-104•454A 
A New Prognostic Marker for Unstable Angina and 
Subendocardial Myocardial Infarction 
1127-1630362A 
A Novel Polymorphism in the Gene Coding for the 
bl-Receptor Associated With Survival in 
Patients With Heart Failure 818-2•261A 
A Rapid Bedside Assay for Myoglobin Predicts 
Mortality in ST Elevation Myocardial Infarction: 
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Rats 1223-67•305A 
The Effectiveness of Prostacyclin as a Therapy for 
Secondary' Pulmonary" Hypertension 877-2 •
308A 
Prostaglandins 
Analysis of Efficacy and Cost of Severe Intermittent 
Claudication Treatment With PGE1 i.v. 
Infusion: A Short-Term Versus Long-Term 
Protocol 840-4. 277A 
Aspirin 325mg, Single-dose. Increases 
Venoconstriction to Norepinephrine in Normal 
Subjects 1104-67,254A 
Effects of lloprost Inhalation on Exercise Capacity 
and Gas Exchange in Patients With Primary 
Pulmonary Hypertension 1134-30 • 270A 
Prosthetic valves 
Diastolic LV Dysfunction Is a Major Predictor of 
Symptom Persistence Nine Years After Aortic 
Valve Replacement 805-5 • 547A 
Erroneous Echocardiographic Diagnoses in Patients 
With Mechanical P~sthetic Valve Dysfunction: 
Correlation With Surgical Findings 1235-33• 
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Hypercoagulable States in Patients With Recurrent 
Thrombosis of Mechanical Heart Valves 
1046-173 -543A 
Long-Term Follow-Up of Conservatively Treated 
Prosthetic Valve Endocarditis: Low Rate of 
Reinfection or Death 871-60563A 
Prediction of Long-Term Survival After Valve 
Replacement in Chronic Aortic Regurgitation: ls 
Angiography Superior to Echocardiography? 
871-3 •563A 
Routine Follow-Up of Prosthetic Cardiac Valves by 
Echocardiography: How Often? 867-40472A 
Pulmonary artery 
Catheter Fragmentation a d Prolonged Pulmonary 
Arterial Thrombolysis n Massive Pulmonary 
Embolism 1222-78 •304A 
Complex Pulmonary Atresia: Outcome of Hospital 
Surviw~rs After Radical Repair 885-4•538A 
Cotransfection t FosB and JunB Genes Induces 
Hypertrophy in Cultured Pulmonary Arterial 
Smooth Muscle Cells 1012-77•224A 
lntravascular Ultrasound Assessment of Pulmonary 
Valve Ring and Pulmonary Artery Wall 
Stiffness, Distensibility, and Compliance in 
Pediatric Patients With Pulmonary Stenosis 
1219-48•99A 
Noninvasive Differentiation of Primary Pulmonary 
Hypertension and Chronic Pulmonary 
Thromboembolism Using Transthoracic 
Echocardiography 1222-75 •304A 
Pulmonary circulation 
Deceleration Time Prolongation i Atrial 
Fibrillation: Insights From a Numerical Model 
837-6.449A 
Effects of Iloprost Inhalation on Exercise Capacity 
and Gas Exchange in Patients With Primary 
Pulmonary Hypertension 1134-30-270A 
Implantation and Follow-Up of End•vascular Stents 
in Pulmonary Vein Stenosis 827-1-527A 
lntrapulmonary Artery Lesions in Chronic 
Obstructive Pulmonary Disease: Evidence by 
Transesophageal Echocardiography 1222-77 *
304A 
Noninvasive Differentiation of Primary Pulmonary 
ttypertension a d Chronic Pulmonary 
Thromboembolism Using Transthoracic 
Echocardiography 1222-75 • 304A 
Pulmonary l-laemodynamics and Exercise Gas 
Exchange in Secondary Pulmonary 
Hypertension Due to Chronic Heart Failure or 
Connective Tissue Disease 1168-6• 196A 
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Pulmonary Venous Flow Patterns in a Large Normal 
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and Transesophageal Echocardiography 
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The Combination of Blood and Agitated Saline 
Contrast Enhances the Doppler 
Echoeardiographic Assessment ofTricuspid 
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The ETA Receptor Antagonist LU 135252 Prevents 
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Noninvasive Differentiation of Primary Pulmonary 
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Arrest: Role of Transesophageal 
Echocardiography 1148-66*444A 
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Decreasing Functional Capacity 1228-90212A 
The Effect of Reactive Airways Disease on Peak 
Oxygen Consumption i Congestive Heart 
Failure 1019-11 *172A 
Pulmonary heart disease 
A Prospective Study of Echocardiographic Features 
in 51 Patients With Systemic Sclerosis (SSc) 
1205-34-462A 
Continuous Administration of Prostacycin Analogue 
Improves Vascular Remodeling and Survial in 
Pulmonary Hypertensive Rats 1199-15-201A 
Nouinvasive Differentiation of Primary Pulmonary 
Hypertension a d Chronic Pulmonary 
Thromboembolism Using Transthoracic 
Echocardiography 1222-75 *304A 
The Effect of Chronic Nocturnal Oxygen on Sleep 
Disordered Breathing Associated With 
Congestive Heart Failure (CHF) 1199-18, 
202A 
The Effectiveness of Prostacyclin as a Therapy for 
Secondary Pulmonary Hypertension 877-2• 
308A 
The ETA Receptor Antagonist LU 135252 Prevents 
the Progression of Established Pulmonary' 
Hypertension I duced by Monocrotaline in Rats 
1041-28-231A 
Pulmonary valve 
Echocardiographic Predictors of Coronary Artery 
Pathology in Pulmonary Atresia With Intact 
Ventricular Septum 814-1 o524A 
Long-Term (13-Year) Results After Pulmonary 
Balloon Valvuloplasty in Adolescent and Adult 
Patients 1181-160.532A 
Mid-Term Clinical and Echocardiographic 
Follow-Up Afler Ross Procedure 842-2-554A 
Progression of Mild and Moderate Valvar Pulmonary 
Stenosis in the Adult: Assessment by Serial 
Doppler Echocardiography 885-6• 539A 
Pulmonary Outflow Tract Reconstruction With 
Autolotgous Tissue During the Ross Procedure: 
Right Ventricular Characteristics n Mid-Term 
Follow-Up 1152-161•531A 
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QT interval 
A Computer Program for Automatic Noninvasive 
Analysis of Multiple Ventricular Repolarization 
Abnormalities 1506-1 o9A 
Acute Effects of Selective and Nonselective 
Beta-Receptor Antagonism and Potassium on 
QT Interval in LQT1 Type of Long QT 
Syndrome 1204-189• 152A 
Age and Gender Related Changes of Beat-to-Beat 
Variability in Amplitude of the Repolarization 
Segmentin Healthy Subjects 1055-186o113A 
Assessment of QT Interval and QT Dispersion for 
Prediction of All-Cause and Cardiovascular 
Mortality in American Indians: The Strong 
Heart Study 830-3 o 129A 
Athletic Left Ventricular Hypertrophy Is Associated 
With Increased QT Dispersion: An 
Observational Study 1230-98•510A 
Beat-by-Beat QT Variability Is Markedly Sensitive 
to Respiration in Patients With Heart Failure 
1228-13•213A 
Carvedilol Reduces QT Interval Dispersion in 
Patients With Chronic Heart Failure 1199-8• 
200A 
Cost Implications of Routine Statewide Neonatal 
ECG Screening for Sudden Infant Death 
Syndrome and QT Prolongation 1210-159- 
534A 
Differential Response of QT and QU Intervals to 
Adrenergic Stimulation in Long QT Patients 
With lks Defects 839-3o138A 
Dynamics of the QT Interval in Response to Sudden 
Vagal-Induced Lengthening of the RR Interval 
830-5 • 130A 
Effect of Acute Myocardial Infarction on QT 
Dispersion: A Longitudinal Study 1024-187- 
108A 
Effects of Beta-Adrenergic Blockade on 24-Hour 
QT Interval Variability in Newborn Infants With 
Prolonged Ventricalar Repolarization 1024-189 
• 108A 
Exercise-lnduced QT-lnterval Changes for 
Predicting Improvement i  Regional Myocardial 
Blood Flow and Cardiac Output After Coronary 
Angioplasty in Patients With Right Bundle 
Branch Block 1146-186"135A 
Gender-Dependent Relation Between QT Interval 
and Its Components and Cardiac Cycle Length 
in Apparently Normal Population 1146-184- 
134A 
Induction of Early Aflerdepolarisations and Torsade 
De Pointes by Macrolid-Antibiotics in the 
Isolated Rabbit Heart 104-3-75 • 234A 
Involvement ofCardiac Sympathetic Nerve 
Dysfunction in Increased QT Dispersion in 
Patients With Chronic Heart Failure 1234-188• 
161A 
lrbesartan Reduces QT Dispersion in Hypertensives 
872-4 • 299A 
Is QT Dispersion Altered by Changes in Heart Rate? 
830-4* 129A 
ls QT Dispersion Heart Rate Dependent? What Are 
the Values of Correction Formulas for QT 
Interval? 1055-187" I13A 
New Technique for Quantifying Spatial Dispersion 
of Ventricutar Repolarization Morphology in 
Digitized ECGs 1117-188•351A 
Patients With Longer QT (QTc) Interval Are More 
Likely to Remain in Sinus Rhythm After 
One-Year Treatment on Dofetilide: The 
EMERALD (European and Australian 
Multicenter Evaluative Research on Atrial 
Fibrillation Dofetilide) Study 1144-153• 132A 
Poor Correlation of Automated and Manual QT 
Dispersion Measurements in Patients and 
Normal Subjects 1 117-186•350A 
Principal Component Analysis of Spatial Dispersion 
of Repolarization i LQT1 and LQT3 Gene 
Carriers 1055-189-114A 
Prognostic Significance of Increased QT Dispersion 
in Ventrieular Extrasystoles and in Sinus Beats 
After Myocardial Infarction 1204-181 ° 151A 
Prognostic Value of QT-Interval and -Dispersion in 
Apparently Healthy Individuals: Results From 
the Munster Heart Study (PROCAM) 1034-164 
• 333A 
QT Abnormalities in Genetically Affected Subjects 
Without Left Ventricalar Hypertrophy: A Study 
on 201 Subjects With Familial Hypertrophic 
Cardiomyopathy 1230-101 •511A 
QT Dispersion Should Be Adjusted for Age: 
Observations From 1,f)96 Normal Subjects 
830-2 • 129A 
QT Interval and Cardiac Cycle Length in Normal 
Subjects, Myocardial Infarction, and 
Hypertrophic Cardiomyopathy: New Insight 
Into Mechanisms of Arrhythmogenesis? 
1024-186• 107A 
QT Interval Dynamieity for Risk Stratification i
Idiopathic Dilated Cardiomyopathy 1228-12• 
213A 
Rate-Related Changes in Cardiac Repolarization: 
QT Interval Versus Mort,phasic Action 
Potential Duration I I46-187 • 135A 
Repolarization Characteristics and Sudden Death 
After Myocardial Infarction: A Case Control 
Study 847-6.146A 
Use of the lmplantable Cardioverter Defibrillator in 
the Long QT Syndrome 1145-178•!33A 
QT syndrome-inherited 
Acute Effects of Selective and Nonselective 
Beta-Receptor Antagonism and Potassium on 
QT Interval in LQTI Type of Long QT 
Syndrome 1204-189 • 152A 
Differential Response of QT and QU Intervals to 
Adrenergic Stimulation in Long QT Patients 
With Iks Defects 839-3*138A 
Do Congenital and Acquired Long QT Syndromes 
With Torsades De Pointes Have Different 
Clinical and Genetical Patterns? 839-6•139A 
Efficacy and Limitations of Beta-Blocker Therapy in 
Long QT Syndrome 839-1 • 138A 
Induction of Early Afterdepolarisations and Torsade 
De Pointes by Macro]id-Antibiotics in the 
lsolated Rabbit tteart 1043-75 •234A 
Microvolt Level T Wave Alternans ls Prevalent in 
Subjects With Congenital Long QT Syndrome 
830-6•130A 
Principal Component Analysis of Spatial Dispersion 
of RepoIarization i LQT1 and LQT3 Gene 
Carriers 1055-189 • 114A 
Spontaneous Sequences of Onset and Offset During 
Recording of Torsades De Pointes in Patients 
With Congenital Long QT Syndrome 839-5, 
139A 
Use of the lmplantable Cardioverter Defibrillator in 
the Long QT Syndrome 1145-178•133A 
Quality improvement 
A View of the Bridge: The Effectiveness of 
Interventions to Improve Cardiovascular Care 
1015-117 •228A 
Acute Myocardial Infarction (AMI) Statewide 
Outcomes for Urban[Rural Admissions: 
Experience From the Pennsylvania Health Care 
Cost Containment Cnuncil (PHC4) 892-2 ° 
313A 
Can Emergency Room Nurses Perform a Screening 
Cardiac Ultras*trod Exam? Assessment of 
Quality and Diagnostic Impact 867-3 •472A 
Determinants ofSatisfaction Across Managed Care 
Plans 1077-121 •248A 
First Experiences With DICOM Images and 
Waveforms lntergration 1504-2•8A 
Impact of Atrial Fibrillation on Quality of Life: A 
Prospective, Multicenter Study 1022-151 • 
104A 
Improvement i  Treatment Quality Indicators for 
Elderly Patients With Acute Myocardial 
lnfarctkm: The Cooporative Cardiovascular 
Project in Maryland and the District of 
Columbia 835-5 •266A 
Interoperabithy of DICOM Implementations Can Be 
Enhanced Significantly by a QC Approach 
Using Automated Validation Tools 1504-1-8A 
Is a Patient Care Facilitated or Impeded by 
Participation i  an Acute Myocardial lnfarctinn 
Research Trial? I095-195 •346A 
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Patterns of Cardiac Rehabilitation Referral and 
Attendance in a Northern Canadian Setting 
1224-116.307A 
Problems With Casual Blood Pressure Measurement 
in a University Hospital Cardiovascular Clinic 
804-4 • 238A 
Queuing for Coronary Angiography During Severe 
Supply-Demand Mismatch in a US Public 
Hospital: Analysis of a Waiting List Registry 
1166-77 • 286A 
Reducing Costs and Improving Outcomes of 
Pereutaneous Transluminal Coronary 
Interventions 8084- 249A 
Risk Adjustment Models for Adverse Outcomes and 
Benchmarking in lnterventional Cardiology: A 
Report From the Blue Cross Blue Shield of 
Michigan Cardiovascular Consortium (BCM2) 
I 166-74 • 285A 
Shorter Hospital Stays for Angioplasty Patients Who 
Receive Abciximab 1166-111-286A 
The Kansas City Cardiomyopathy Questionnaire: A 
New Quality of Life Measure for Heart Failure 
Is Reliable and Responsive to Clinical Change 
1077-116-247A 
The Profile of Patients in Whom Thrombolytic 
Therapy ls Delayed and Its Impact on Mortality 
1213-196*390A 
Utilization of an Artificial Neural Network for 
Mortality Risk Adjustment in The Cooperative 
Cardiovascular P oject 1501-1 o6A 
Variability in Quality of Care for Elderly Patients 
Admitted With Unstable Angina in Connecticut 
1063-1310337A 
Quality of life 
A New Composite Outcome Measure for Coronary 
Intervention 1166-760286A 
Analysis of Congestive Heart Failure Patient 
Preferences for Treatment Outcomes: Symptoms 
Versus Survival I081-13•181A 
Angina, Normal Coronary Arteries, Normal and 
Abnormal Coronary Sinus Lactates: 20-Year 
Follow-Up 1186-1390378A 
Depressed Coronary Disease Patients Derive More 
Improvement i  Quality of Life From Coronary 
Revaseularization 1015-116•228A 
Disparate Effects of Improving Exercise Capacity 
and Quality of Life Following Cardiac 
Rehabilitation i  Young and Elderly Coronary 
Patients 1171-100•505A 
Effect of Gender on Transradial and Transfemoral 
Access for Coronary Procedures 1187-60•83A 
Functional Outcome of Patients Operated for 
Transposition of the Great Arteries With the 
Mustard Procedure 885-5 •539A 
Gender Differences in "Quality of Life" in Atrial 
Fibrillation 1022-152• 104A 
Impact of Atrial Fibrillation on Quality of Life: A 
Prospective, Multicenter Study 1022-151 • 
104A 
Long-Term Adaption of Cardiac Arrest Survivors 
905-2 • 402A 
Long-Term Effects of Ventricular Septal Defects 
With a Moderate Left to Right Shunt, With and 
Without Operation 885-3 • 538A 
Quality of Life Comparisons in Non-Q-Wave 
Myocardial Infarction Patients Randomized to 
an Early lnvasive Versus Conservative Strategy: 
Results of the Veterans Administration 
Non-Q-Wave Infarction Strategies In-Hospital 
~VANQWISH) Trial 896-4• 397A 
Quality of Life in Heart Failure and Other 
Conditions 1228-3 •211A 
Results of the Multieenter Enhanced External 
Counterpulsation (MUST-EECP) Outcomes 
Study: Quality of Life Benefits Sustained 12 
Months After Treatment 1065-162-339A 
Safety of Cellular Telephones on lmplantable 
Cardioverter Defibrillators 1145-179• 133A 
The Kansas City Cardiomyopathy Questionnaire: A 
New Quality of Life Measure for Heart Failure 
ls Reliable and Responsive to Clinical Change 
1077-116 • 247A 
Treadmill Exercise Test Performance Predicts 
Perceived Quality of Life Seven Years Later 
862-2•561A 
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Usefulness of Short Course Exercise Training on 
Cardiovascular Status and Quality of Life After 
Acute Myocardial Infarction 1213-197-390A 
Radioisotopes 
Acute and Six-Month Follow-Up Results of 32P 
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Patients With CAD: The Milan BX 
Dose-Response Study 77-6o 20A 
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Catheter for End.vascular Irradiation to Prevent 
Restenosis: Safety and Efficacy Preclinical 
Studies 1070-57.43A 
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Pig Coronary Arteries 1070-60.44A 
Effects of Low Dose-Rate b-Irradiation on Smooth 
Muscle Cells: Comparison With High 
Dose-Rate Exposure 1101-135o55A 
Follow-Up Angiographic Comparison of the 
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Radioactive Isostent: Results From Expanded 
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Functional Significance of Coronary Artery Stenosis 
Evaluated by Intravascular Ultrasound: Relation 
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Overstretch Model 1101-96.54A 
Improved Washout Profiles With an 
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Myocardial Perfusion Imaging 1029-36*410A 
Improvement ofCardiac Neuronal Function Using 
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Cardiomyopathy After Carvedilol Therapy 
1091-107 •425A 
Initial Results of the CURE Safety Trial: Coronary 
Brachytherapy With Radioactive Liquid-Filled 
Balloons 1216-59.94A 
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Resolution 1098-40*48A 
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Intracoronary Gamma Radiation Reduces Intimal 
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Intracoronary Gamma Radiation to Reduce In Stent 
Restenosis: The Multicenter Gamma 1
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Thrombus Area 1220-22.300A 
Intracoronary Radiation Using a b-Particle-Emitting 
Gold Stent Increases Neointima Formation in a 
Porcine Coronary Restenosis Model 77-8.21A 
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Therapy? 77-3,, 20A 
Localization of Target Tissue and the Minimum 
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Therapy 1070-59 • 44A 
Low Body Exposure in Case of Radioactive Balloon 
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Study of 188 Rhenium in Pigs 1070-58.44A 
Radioactive 133-Xenon Gas-Filled Balloon to 
Prevent Restenosis: Efficacy, Dosimetry, and 
Safety Considerations 1101-97.55A 
Results From the ARTISTIC Feasibility Study of 
192-Iridium Gamma Radiation to Prevent 
Recurrence of In Stent Restenosis 823-3.56A 
Segmental Left Ventricular Function by Myocardial 
Perfusion Gated-SPECT: A Comparison With 
Two-Dimensional Echocardiography 1122-123 
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The Importance of Centering for lntracoronary 
Radiation Therapy in Stented Arteries: An 
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1009-60 * 17A 
Three-Year Clinical and Angiographic Follow-Up 
After Catheter-Based Intracoronary 
Radiotherapy 823-2.56A 
Validation of a Dual Isotope Approach for Early 
Assessment ofMyocardial Viability and 
Residual Ischemia Following Coronary 
Reperfusion 1060-125.416A 
Yttrium-90 Delivered via a Centering Catheter and 
Afterloader, Given Both Before and After Stent 
Implantation, Completely Inhibits Neointima 
Formation in Swine Coronary Arteries 77-4• 
20A 
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"preconditioning" Against Left Ventricular 
Dystunction Follows Exercise-Induced lschemia 
in Multivessel Coronary Disease 1186-140• 
378A 
16-Interval Gating Improves Thallium-201 Gated 
SPECT LVEF Measurement i  Patients With 
Large Myocardial Infarction 1122-127*436A 
A Normal Exercise Thallium-201 Image Is 
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of Medical Resources 1151-124.447A 
Accuracy of Gated-SPECT Imaging in Diagnosing 
Individual Coronary Artery Stenosis: A
Comparison Between Ungated, Gated 
End-Systolic, and Gated End-Diastolic Images 
1029-34 • 409A 
Assessment of Myocardial Perfusion With 
Intravenous Infusion of Microbubbles Using 
Intermittent Harmonic Imaging in Patients With 
Acute Myocardial Infarction: Comparison With 
99mTc-Sestamibi Single-Photon Emission 
Computed Tomography and Myocardial Contra 
1236-61 *475A 
Attenuation Corrected Thallium Scintigraphy 
Accurately Predicts the lnvasively Measured 
Fractional Flow Reserve 802-2.417A 
Automatic Quantitation ofWall Motion and 
Thickening by Gated SPECT: Validation and 
Application in Identifying Severe Coronary 
Artery Disease 802-6•418A 
Clinical Evaluation of a Novel Dual-Simultaneous 
SPECT Myocardial Perfusion Protocol: Blinded 
Comparison to Dual-Sequential Images 802-5• 
418A 
Clinical Impact of Gating Errors on Visual 
Assessment of Myocardial Perfusion and 
Ventricular }"unction From SPECT Data 
1122-122.435A 
Comparability of Myocardial Perfusion Imaging and 
Echocardiography for Identifying Myocardial 
Infarction in Emergency Department Patients 
With Chest Pain 1147-32.441A 
Defect Extent and Severity Are Underestimated 
With Dobutamine Stress Using Technetium-99m 
Tetrofosmin SingLe-Photun Emission Computed 
Tom.graphic Myocardial Perfusion Imaging 
802-3 • 418A 
Detecting Viable Myocardium and Predicting 
Functional Improvement: Comparison of 
Positron Emission Tomography, 
Rest-Redistribution Thallium-201 SPECT, 
Thallium-201 Re injection SPEC~. l-123 BMIPP 
SPECT, and Dobatamine Stress 
Echocardiography 821-5.438A 
Diagnostic and Prognostic Value of Combined 
Dobutamine Stress Echocardiography and 
Myocardial Scintigraphy After Heart 
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Transplantation: Comparison With Intravascular 
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Images 1239-124.479A 
Fractional Flow Reserve, Absolute and Relative 
Coronary Blood Flow Velocity Reserve in 
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Free Fatty Acid Imaging Besides Sestamibi 
Scintigraphy for Predicting Resting and 
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1122-124,,436A 
Improvement of Cardiac Neuronal Function Using 
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Increased Myocardial Glucose Uptake After 
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Revascularization n Patients With End-Stage 
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Incremental Prognostic Value of 
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Cardiomyopathy 803-6* 495A 
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Cardiovascular Events 1215-140o393A 
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Outcome of Dilated Cardiomyopathy 1170-102 
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Referred for SPECT Myocardial Perfusion 
Scintigraphy 1151-127.448A 
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Myocardial Contrast Echocardiography in Acute 
Myocardial Infarction and Unstable Angina: 
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Study 1236-63 -475A 
Myocardial Doppler Velocity Responses to Exercise 
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Ischemia by Dual Isotope SPECT 1088-64• 
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Myocardial Kinetics of 99mTc-Sestamibi, 
99mTc-Tetrofosmin, and 99mTc-Q12 in a 
Severe Model of Ischemia With Reperfusion 
Injury 1239-126.480A 
Myocardial Perfusion Imaging and Coronary 
Angiography in Children With Homozygous 
Familial Hypercholesterolemia 1240-158 • 
537A 
Myocardial Viability Assessment by 
Nonfluoroscopic Catheter-Based 
Electroanatomical Mapping: Validation of a 
New Method by Radionuclide Imaging 
1186-138.378A 
Noninvasive Cardiac Assessment of Diabetic 
Nephropathy Renal Transplant Candidates 
1062-166.335A 
Noninvasive Risk Stratification of Elderly and 
Young Patients With Nuclear Cardiac Imaging 
1021-86. 490A 
Optimal Viability Criteria on Thallium-201 
Reinjection SPECT to Predict Improvement of 
Funcfion After Revascularization t060-123. 
416A 
Outcome of Patients With Vasodilator-Induced ST
Depression and Normal SPECT Perfusion 
Imaging 1151-126,448A 
Physiologic Doses of Intravenous Testosterone 
Improve Exercise and Adenosine-Induced 
Myocardial Perfusion Defects in Elderly Men 
With Coronary Artery Disease 1091-108,426A 
Poststress Drop in Ejection Fraction on ECG Gated 
SPECT Thallium-201 Scintigraphy Predicts 
Poor Prognosis 857-3.469A 
Prediction of Death and Nonfatal Myocardial 
Infarction by Combined Myocardial Perfusion 
and Radionuclide Ventricular Function (RNA) 
Studies During Pharmacologic Stress Testing 
857-5-470A 
Prediction of Long-Term Outcome With 
Simultaneous Stress Tc-99m-Sestamibi SPECT 
and First-Pass Radionuclide Angiography 
857-4 • 469A 
Predictors of Outcome in Hypertensive Subjects 
With Coronary Artery Disease 1239-123 • 479A 
Prognostic Significance of Normal Exercise 
Myocardial Perfusion Imaging in Conjunction 
With Suboptimal Workload 857-2°469A 
Prognostic Value of Resting TI-201 Lung Uptake in 
Patients With Severe Postischemic LV 
Dysfunction 1209-127•468A 
Quantitative Estimation of Myocardial Salvage After 
Primary Coronary Angioplasty in Patients With 
Angiographic No Reflow 1067-42.39A 
Quantitative Fatty Acid Myocardial Scintigraphy 
Predicts Responders for b-Blockade Therapy in 
Patients With Dilated Cardiomyopathy 
1209-124 • 468A 
Quantitative Thallium SPECT (QTI-S) at One-Year 
Postrevascularization Helps to Predict Outcome 
in Diabetic Patients: Results From the Emory 
Angioplasty Versus Surgery Trial (EAST) 
857-6.470A 
Reduced Early Diastolic Coronary Flow and 
Coronary Flow Reserve in Patients With Left 
Bundle Branch Block, Exercise Thallium-201 
Perfusion Defect, and Normal Coronary Arteries 
802-4•418A 
Regional and Global Hypoperfusion of the Left 
Ventricle in Congesfive Heart Failure 1049-12• 
177A 
Relation Between QT Dispersion and Myocardial 
Perfusion to Survival in Patients With Life 
Threatening Ventricular Arrhythmias. 1239-127 
• 480A 
Reproducibility of Dual Isotope Myocardial 
Perfusion SPECT Using a New Quantitative 
Perfusion SPECT (QPS) Approach 897-6• 
483A 
Reproducibility of Myocardial Blood Flow and Flow 
Reserve Measurement With Positron Emission 
Tomography 1121-66,~435A 
Segmental Left Ventricular Function by Myocardial 
Perfusion Gated-SPECT: A Comparison With 
Two-Dimensional Echocardiography 1122-123 
• 436A 
Spatial Distribution and Clearance of VEGF-CDNA 
Following lntramyocardial Injection 826-I • 
354A 
Specificity of the Stress Electrocardiogram During 
Adenosine Myocardial Perfusion Imaging in 
Patients Taking Digoxin 1017-1900542A 
The Acute Administration of 17 b-Estradiol 
Decreases the Size of Aden•sine-Induced 
Myocardial Perfusion Defects in 
Postmenopausal Women With Coronary Disease 
1091-1060425A 
The Acute Use of Technetium-99 Sestamibi Imaging 
in the Emergency Department for Early 
Discharge of Patients With Potential Acute 
Myocardial lschemic Events 1212-129 ° 388A 
The Impact of Time From Coronary Angioplasty on 
the Detection of Restenosis by Exercise 
Perfusion Imaging: An Incremental Analysis 
897-1 • 482A 
The Incremental Value of Thallium Tom•graphic 
Imaging Over Clinical and Exercise Variables 
for the Detection of Restenosis Following 
Coronary Angioplasty 897-2•482A 
The Prediction of Severe Coronary Artery Disease in 
Patients Undergoing Pharmacologic 
Thallium-201 Imaging 1151-123.447A 
The Prognostic Impact of lschemia s a Function of 
Ejection Fraction on Gated Myocardial 
Perfusion SPECT 857-10469A 
Validation of a Dual Isotope Approach for Early 
Assessment of Myocardial Viability and 
Residual lschemia Following Coronary 
Reperfusion 1060-125•416A 
Validation of SPECT Models in Predicting Outcome 
in Medically Treated Patients With Coronary 
Artery Disease 1239-122 • 479A 
Ventricular Volumes Compared Among Three Gated 
SPECT Methods and Echocardiography 
1029-32 • 409A 
Viability Threshold Determination by Collateral 
Flow Estimation Using Tc 99m Sestamibi 
Imaging During Acute lnfarcfion 1060-126• 
417A 
Vitamin C Improves the Coronary Vasodilator 
Reser',es in Asymptomatic Smokers 1013-68o 
225A 
Worsening Clinical Status, During Follow-Up 
Predicts Future Evenls Better Than Serial 
Exercise Thallium-201 Testing 1215-139. 
392A 
Receptors, B-adrenergic 
A Novel Polymorphism in the Gene Coding for the 
b 1-Receptor Associated With Survival in 
Patients With Heart Failure 818-2•261A 
b-Adrenergic Subsertsitivity and Decreased Cardiac 
Function After Prolonged Cardioselective 
Norepinephrine Stimulation in Transgenic Mice 
Overexpressing Nerve Growth Factor 893-3- 
314A 
Repeated Stunning Precedes Myocardial 
Hibernation in Progressive Multiple Coronary 
Artery Obstruction 849-1.370A 
Receptors, endogenous ubstances 
Activation of the Jak/STAT Signaling Pathway by 
Blocking G Protein-Coupled Receptor Kinases 
in Cardiomyocytes 1195-110°295A 
Atorvastatin Downregula~es AT1-Receptor Gene 
Expression in Cell Proliferation in Vascular 
Smooth Muscle Cells 1011-28.222A 
Chronic Moxonidine Therapy Produces Sustained 
Reduction of Plasma Norepinephrine inPatients 
With Heart Failure I 110-12•184A 
Estrogen Receptor-Mediated Gender-Specific 
Vascular Effects of ] 7b-Estradiol I 107-119 • 
259A 
Functional Evaluation of Novel Amino-Acid 
Altering Angiotensin 1I Type I Receptor Gene 
Variants in Essential Hypertension ]106-110. 
257A 
Lack of Increase in Angiotensin II Type I Receptor 
Protein After Acute Ischemia-Reperfusion in 
lsolated Working Rat Hearts 1011-22.221A 
Phosphatidylinositot 3-Kinase-Dependent Activation 
of Akt by the Endothelial Receptor Tyrosine 
Kinase Tie I 893-5 *315A 
Platelet GPIIIa Receptor PLA Polymorphism and 
Cardiovascular Disease: The Framingham Heart 
Study 818-5 • 262A 
The F (ab') 2 Fragment of 7E3, the Parent Antibody 
of Abciximab, Blocks GPllb/llla-Mediated 
Thrombosis in Rats 1133-77°269A 
Reentry 
Arrangement of the Atrial Muscle Fibers in the 
Inferior Right Atrial Isthmus: Its Role in Atrial 
Flutter 1202-153•147A 
Dofetilide Decreases Functional Reentry During 
Ventricular Fibrillation 1204-187 • 152A 
New Insights Into Atrial Flutter: Studies in a Canine 
Model 1202-152-147A 
Progressive Isthmus Delay During Atrial Flutter 
Ablation: The Critical Importance of 
Isthmus-Spanning Electrodes for Distinguishing 
Conduction Delay From Block 1084-149, 
116A 
Quantitative Effects of Functional Bundle Branch 
Block in Patients With A-V Reentry 1231-151 • 
157A 
Reflexes, cardiovascular 
Brain Death Associated Neural and Hum•rat 
Changes Are Not Responsible for Cardiac 
Dysfunction in the Potential Organ Donor 
1169-11 o198A 
Sinus Node Behavior During Stable and Unstable 
Ventricular Tachycardia With Ventriculo-Atrial 
Dissociation 1204-185.151A 
The Impact of Cachexia on Cardiorespiratory Reflex 
Control in Cfironic Heart Failure 1019-2° 170A 
Rehabilitation 
A Comparison of Outcomes in African American 
and White Patients Undergoing Cardiac 
Rehabilitation 1226-194. 566A 
Almost Half of Patients With Acute Myocardial 
Infarction Can Be Safely Discharged on Day 
Three After Successful Reperfusion With 
Transradial Coronary Intervention 1213-198. 
390A 
Dyspnea Threshold Is Related to Ventilatory 
Thrcshold During Exercise in Patients With 
Chronic Heart Failure 1019-90172A 
Effect of a Heart Failure Program on Hospitalization 
Rates and Morbidity Rates 1081-12.181A 
Exercise Training Reduces the Expression of 
Inducible Nitric Oxide Synthase in Skeletal 
Muscle Biopsies of Patients With Chronic Heart 
Failure 844-3 • 194A 
Patterns of Cardiac Rehabilitation Referral and 
Attendance in a Northern Canadian Setting 
1224-116*307A 
Prediction of Predischarge Cognitive Deficits in 
Cardiac Arrest Survivors Using Serum Protein 
S-100 and Neuron Specific Enolase 905-1 • 
401A 
Usefulness of Short Course Exercise Training on 
Cardiovascular Status and Quality of Life After 
Acute Myocardial Infarction 1213-197o390A 
Reimbursement 
The Importance of Payer Case Mix on Hospital Cost: 
Don't Contract Without It 1077-120•248A 
Renal circulation 
Effects of Carveditol on Renal Function in Patients 
With Heart Failure I I 10-8 • 183A 
Malignant Hypertension Associated With Renal 
Artery Stenosis: Successful Treatment by 
Percutaneous Stenting (FI'RAS) I 130-49.66A 
Renal Artery Stenfing Improves Renal Function in 
Patients With Atherosclerotic Renovascular 
Disease 1193-68°291A 
Renal Artery Stents: Characteristics and Outcomes 
After 363 Procedures 78-3-22A 
Renal function 
Comparison of Coronary Bypass Surgery' Versus 
Coronary Angioplasty in Patients With Chronic 
Renal Failure 1187-39•81A 
Do We Really Need Expensive Tests In Accurately 
Predict Prognosis in Patients With Heart 
Failure? 1140-4• 190A 
KEY: Abstract itle, Session-abstract number •page number 
700A SUBJECT INDEX JACC February 1999 
Malignant Hypertension Associated With Renal 
Artery Stenosis: Successful Treatment by 
Percutaneous Stenting (PTRAS) 1130-49°66A 
Palmaz Stenting Reverses Progressive Renal 
Dysfunction i Patients With Global Renal 
lschemia Due to Atherosclerotic Renal Artery 
Stenosis 1069-97 •42A 
Progression of Coronary Artery Disease in Patients 
With Chronic Renal Failure 1065-164.340A 
Prostacyclin Synthase Gene Transfer Protects Renal 
Function and Attenuates the Development of
Hypertension i  Spontaneously H pertensive 
Rats 1223-67,, 30SA 
Renal Artery Stenting Improves Renal Function in 
Patients With Atherosclerotic Renovascular 
Disease 1193-68 o291A 
Renal Artery Stents: Characteristics and Outcomes 
After 363 Procedures 78-3,,22A 
Stents Do Not Improve Acute and Long-Term 
Clinical Outcomes in Patients With Chronic 
Renal Failure and Coronary Disease 1037-91 •
28A 
Unique Renal and Systemic Hem•dynamic A tions 
of a New Natriuretic Peptide in Experimental 
Heart Failure 1199-17*202A 
Renin 
Genetic Potymorphism ofthe Renin Angiotensin 
Aldosteron System May Determine the Clinical 
Phenotype inGene Carriers in a Family With 
Hypertrophic Cardiomyopathy I020-I01 * 
489A 
Omapatrilat, a Novel Vasopeptidase Inhibitor, 
Reduces Blood Pressure in Normotensive 
Subjects 877-3 o309A 
Reperfusion 
ABC (Aspirin, Beta Blocker, Clot Buster: 
Thrombolytic or PTCA) for Day One of Acute 
Myocardial Infarction in Medicare Patients 
1064-197o338A 
Abciximab Decreases "Slow Flow" During Direct 
Angioplasty for Acute Anterior Myocardial 
Infarction: A Randomized Study 1099-93,, 52A 
Almost Half of Patients With Acute Myocardial 
Infarction Can Be Safely Discharged on Day 
Three After Successful Reperfusion With 
Transradial Coronary Intervention 1213-198. 
390A 
Beneficial Effects of Adenosine Adjunct o Primary 
Angioplasty in Acute Myocardial Infarction 
1184-171 °376A 
Differential Effects of Stenting and Angioplasty in 
Women Versus Men Undergoing a Primary 
Mechanical Reperfusion Strategy in Acute 
Myocardial Infarction: The PAMI Stent 
Randomized Trial 832-6o357A 
Does Stent-Like Primary PTCA in Acute 
Myocardial Infarction Confer Long-Term 
Freedom From Restenosis Similar to Primary 
Stenting? Analysis From the PAMI Stent 
Randomized Trial 869-1 • 382A 
Enhanced Speed and Stability of Reperfusion With 
High Dose Hirulog Versus Heparin as Adjuncts 
to Thrombolytic Therapy for Acute Myocardial 
Infarction: Continuous ST Segment Recovery in 
The HERO-1 Study 1184-165,,375A 
Final Procedural Diameter Stenosis and Its Influence 
on the Six-Month Outcome After Primary 
PTCA: Results From the Stent PAMI Trial 
873-6 •92A 
Histologic and Echocardiographic Features of 
Reperfused Versus Nonreperfused Chronic 
Hibernating Myocardium 849-2 °371A 
Importance ofTime to Reperfusion on Outcomes 
After Primary PTCA for Acute Myocardial 
Infarction: Results From Stent PAMI 822-3. 
353A 
Increased Myocardial Perfusion in Patients With 
Acute Myocardial Infarction and Recent 
Angina: An Acute Myocardial Contrast 
Echocardiography Study 882-3,, 481A 
Interinstitutional Variability in Detecting Myocardial 
Perfusion Abnormalities With Accelerated 
Intermittent Harmonic Imaging 1057-62.412A 
Myocardial Platelet Accumulation After 
Reperfusion Depends on Local Aggregation 
More Than on Embolization From the Unstable 
Coronary Lesion, and ls Not Prevented by 
Aspirin 904-4.401A 
Outcomes of Bail-Out Stenting After Failed Primary 
Angioplasty inAcute Myocardial Infarction: 
Analysis From the PAMI Stent Trial 1126-198 • 
361A 
Prediction of Functional Recovery in Patients With 
Acute Myocardial Infarction as Assessed by 
Myocardial Contrast Echocardiography and 
Coronary Flow Reserve Measurement 882-1 • 
480A 
Predictors of Six-Month Event-Free Survival After 
Mechanical Reperfusion i Acute Myocardial 
Infarction: The PAMI Stent Randomized Trial 
858-3-379A 
Primary Angioplasty for Acute Myocardial 
Infarction With No Surgery on Site: Outcomes, 
Core Angiographic Analysis, and Six-Month 
Follow-Up in the 500 Patient Prospective 
PAMI/No S.O.S. Registry 822-1.352A 
Routine Stent Implantation Reduces Restenosis 
After Primary Angioplasty in Acute Myocardial 
Infarction: Results From the PAMI Stent 
Randomized Trial 1126-199.361A 
Serial Changes in Wall Motion Abnormality, 
Glucose Utilization, and Free Fatty Acid 
Utilization in Successfully Reperfused 
Myocardium 1209-122 -467A 
Stent PAMI Six-Month Angiographic Follow-Up: 
Incidence and Predictors of Reocclusion 
Following Primary [rfCA or Stenting 896-3* 
397A 
Subselective lntracoronary Aqueous Oxygen 
Hyperoxemic Reperfusion After One Hour 
Coronary Occlusion in Swine Restores Left 
Ventricular Function 1124-165 o357A 
The Influence of Race and Gender on Reperfusion 
Therapy Use Among Medicare Beneficiaries 
With Myocardial Infarction 832-4 •356A 
Time-to-Thrombolysis and Time-to-Reperfusion: 
Relation With Final Myocardial Damage 
1003-128•324A 
Ventricular Function After Mechanical Reperfusion 
Therapy: Observations From the Stent PAMI 
Trial 898-4.398A 
Viability Threshold Determination byCollateral 
Flow Estimation Using Tc 99m Sestamibi 
Imaging During Acute Infarction 1060-126o 
417A 
Repolarization 
Barnreflex Sensitivity and Heart Rate Variability in 
Patients With and Without Sustained T-Wave 
Altemans After an Acute Myocardial Infarction 
1086-187 • 121A 
Dose-Dependent Protection of Atrial 
Tachycardia-Induced Electrical Remodeling by 
Mibefradil t143-147.130A 
Effects of Beta-Adrenergic Blockade on 24-Hour 
QT Interval Variability in Newborn Infants With 
Prolonged Ventricular Repolarization 1024-189 
• 108A 
Efficacy and Limitations of Beta-Blocker Therapy in 
Long QT Syndrome 839-1,,138A 
Factors Associated With an Invasive Strategy in 
Patients With Unstable Angina 1063-129• 
337A 
Is QT Dispersion Altered by Changes in Heart Rate? 
830-4 •129A 
Is QT Dispersion Heart Rate Dependent? What Are 
the Values of Correction Formulas for QT 
Interval? 1055-187-113A 
Is T Wave Altemans Related to Delayed Myocardial 
Activation or Inhomogeneity of Ventficular 
Repolarization? 1055-185° 113A 
Predictive Value of QT Dispersion for Sudden 
Cardiac Death in Patients With Arrhythmogenic 
Right Ventricular Dysplasia 1055-184• II3A 
Prognostic Value of QT-lnterval and -Dispersion in 
Apparently Healthy Individuals: Results From 
the Munster Heart Study (PROCAM) 1034-164 
• 333A 
QT Abnormalities in Genetically Affected Subjects 
Without Left Ventricular Hypertrophy: A Study 
on 201 Subjects With Familial Hypertrophic 
Cardiomyopathy 1230-101-511A 
Rate-Related Changes in Cardiac Repolarization: 
QT Interval Versus Monophasic Action 
Pntential Duration 1146-187 • 135A 
Relation Between the Cellular Repolarizafion 
Characteristics and the Critical Mass for Human 
Ventricular Fibrillation 1204-179 * 151A 
Relationship Between Left Ventricular Function and 
Recovery Time Dispersion in Patients With 
Previous Myocardial Infarction 1234-186* 
160A 
Right Bundle Branch Block and ST Segment 
Elevation in Lead VI-V3: Prevalence in an 
Apparently Healthy Population g39-4*138A 
Resource utilization 
"Expanded" Cardiac All•graft Transplantation Can 
Help Maximize Donor Resoures 1169-8.197A 
A Normal Exercise Thallium-201 Image ls 
Associated With Lower Subsequent U ilization 
of Medical Resources 1151-124o447A 
Can Emergency Room Nurses Perform a Screening 
Cardiac Ultrasound Exam? Assessment of
Quality and Diagnostic Impact 867-3.472A 
Clinical Risk Assessment and Stress Echo Safely 
Identifies Chest Pain Patients Appropriate for 
Early Discharge 853-3.,459A 
Cost-Effective Implications of a Cardiac Ultrasound 
Screening Strategy in Evaluation of Mitral Valve 
Prolapse 867-1 ,.472A 
Do the "100-Top Hospitals" Differ in Clinical and 
Financial Performance for the Treatment of 
Acute Myocardial Infarction? 1021-88"491A 
Estimation of Operating Room Costs for Coronary 
Artery Bypass Graft Surgery 1015-121 •229A 
Length of Stay Predictors Following Coronary 
Artery Stenting 1158-97 e75A 
Mortality ls Not Increased With Pulmonary Artery 
Catheterization in Acute Coronary Syndromes: 
The GUSTO Trials 889-3*395A 
Multivessel Stenting Reduces In-Hospital 
Complication Compared With Repeat 
Aortocoronary Bypass Surgery 1099-55•51A 
Self-Management Practices, Quality of Life, and 
Healthcare Resource Utilization in Patients With 
Chronic Heart Failure 1081-6.180A 
Shorter Hospital Stays for Angioplasty Patients Who 
Receive Abciximab 1166-111 o286A 
Should All Patients With Acute Myocardial 
Infarction be Treated at Tertiary Hospitals 
Rather Than at Community Hospitals? 
1096-163 •348A 
The Importance of Payer Case Mix on Hospital Cost: 
Don't Contract Without It 1077-120.248A 
Transfer From Community Hospitals to Tertiary 
Hospitals After Thrombolytic Therapy for Acute 
Myocardial Infarction: Insights From GUSTO-I 
1096-162.348A 
Restenosis 
"Optimal" Instead of "High" Balloon Pressure 
Dilatation During Coronary Stent Placement 
833-3.58A 
2.5-Year Follow-Up of the CLOUT Study: 
Long-Term Implications for an Aggressive 
IVUS Guided Balloon Angioplasty Strategy 
1187-38•81A 
A Comparison of Diabetics With Restenosis to 
Diabetics Without Restenosis 1187-42•82A 
A Rat Carotid Artery Model of In Stent Restenosis 
1101-136o55A 
Abciximab Reduces Vascular Lesion Formation in 
Nonhuman Primates 845-1o69A 
Acute and Six-Month Follow-Up Results of 32P 
Radioactive b-Emitting Stent Implantation i
Patients With CAD: The Milan BX 
Dose-Response Study 77-6- 20A 
Aden•viral Mediated NOS3 Gene Transfer in 
Porcine Coronary Arteries Reduces In Stent 
Restenosis 834-3 o59A 
Angiographic Patterns of ln-Stent Restenosis 
Lesions That Failed Radiation Therapy 
1129-94 • 63A 
Assessment of the Biological Effects of Retinoic 
Acid in Cell Cultures In Vitro and In Vivo After 
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Local Delivery in the Rabbit Carotid Artery 
1133-75 •268A 
avb3 Receptor Blockade Reduces Restenosis 
Following Balloon Angioplasty in the 
Atherosclerotic Rabbit 1039-60• 31A 
b-Emitting 186 Rhenium Liquid Filled Balloon 
Catheter for End.vascular Ir adiation to Prevent 
Restenosis: Safety and Efficacy Preclinical 
Studies 1070-57.43A 
b-Energy to Prevent Restenosis: The Rotterdam 
Contribution to the BERT 1.5 Trial 1098-57. 
49A 
b-Irradiation for Treatment of Recurrent In Stent 
Restenosis 1098-59 • 50A 
b-Particle Emitting Radioactive Stent o Prevent 
Restenosis 77-7•21A 
Balloon Dilatation Guided by Intravascular 
Ultrasound: Acute and Long-Term Results of 
the UPSIZE Pilot Trial 810-1 •46A 
Can Debulking Prior to Stenting Be Justified as 
Standard Treatment for Right Coronary Artery 
Ostial Lesions? 1037-56•27A 
Can lntracoronary Ultrasound (ICUS) Guided 
Stent-Like Balloon Angioplasty Convey a 
Stent-Like Six-month Angiographic and ICUS 
Outcome? 1189-46 • 86A 
Chlamydia Pneumoniae Seropositivity Predicts the 
Risk of Restenosis After Percutaneous 
Transluminal Coronary Angioplasty 846-3° 
80A 
Clinical and Angiographic Outcomes of Patients 
With In Stent Restenosis Crossing Over From 
Placebo to Radiation Therapy 823-5*57A 
Clinical Evaluation of a Biocompatible 
Phosphorylcholine-Coated Coronary Stent 82-5 
.34A 
Clinical Presentation of Restenosis I  Associated 
With the Extent of Atherosclerotic Inflammation 
of the lnitial Coronary Lesions 1039-59-31A 
Clinical, Angiographic, and Physiologic Predictors 
of Major Adverse Cardiac Events (MACE) After 
Stetu Implatuation 1007-51 * 12A 
Comparison of Cilostazol and Ticlopidine After 
Coronary Artery Stetuing: Immediate and 
Long-Term Results 1068-56.40A 
Coronary Stent Implantation i Patients With 
Nooinsulin-Dependetu Diabetes Mellitus 
1218-135•98A 
Coronary Stetu Placement in Two or More Vessels: 
One-Year Clinical and Angiographic Outcome 
and Comparison With Single Vessel Stenting 
1007-54 • 13A 
Cross-Sectional Measurements After Treatment of In 
Stent Restenosis: An lntravascular Ultrasound 
Guide for lntracoronary Radiation Dosimetry 
1100-45• 53A 
Cutting Balloon Angioplasty for Small Size Vessels 
1098-39 °48A 
Cutting Balloon Angioplasty Prior to Stenting Is a 
Useful Strategy for the Reduction of Stem 
Restenosis 1188-53¢83A 
Cutting Balloon Versus Conventional Balloon 
Angioplasty: Subgroup Analysis of a 
Prospective and Randomized Trial 1098-41 • 
48A 
Cyclic Adenosine Monophosphate Is a More Potent 
Inhibitor of Human Vascular Smooth Muscle 
Cells Than Cylcic Guanosine Monophosphate: 
An In Vitro Comparison of Antiproliferative 
Signal Transduction 1040-24• 230A 
Differing Coronary Arterial Responses to Balloon 
Angioplasty Between Stable and Unstable 
Lesions: A Combined Study of Intravascular 
Ultrasound and Angioscopy 1216-41.93A 
Distribution of Neointimal Proliferation in Human 
Coronary Arteries Treated With 
Polytetrafluorethylene St tu-Grafts 1009-59. 
17A 
Doppler and QCA Guided Aggressive PTCA Has 
the Same Target Lesion Revascularization f 
Stem Implantation: Six-Month Results of the 
DEST1NI Study 810-2•47A 
Dose Rate and Cumulative Dose Effects of P-32 
Radioactive Stents 77-5• 20A 
Dose Rate Mediated Vascular Remodeling of 
Porcine Coronary Arteries Following 
lntrac oronary b-Radiation 845-2.70A 
Early Lumen Loss After Repeat Angioplasty for 
In-Stent Restenosis 1129-59-62A 
Effect of Covered Stents by Autologous Vascular 
Graft on Endothelialization, I timal 
Hyperplasia, nd Vascular Injury in Porcine 
Coronary Arteries 1099-92.52A 
Effect of Residual Dissection After Coronary Stem 
Implantation on Early and Late Results 
1188-56 •84A 
Effect of y-Irradiation on the Cell Cycle of Rat 
Smooth Muscle Cells 1101-134•55A 
Effects of Low Dose-Rate b-lrradiation on Smooth 
Muscle Cells: Comparison With High 
Dose-Rate Exposure 1101-135•55A 
End*vascular I radiation of Coronary Arteries 
Inhibits Lumen Loss and Neointima Formation 
in Stent Grafts 823-4.56A 
Evolution of Primary PTCA for Acute Myocardial 
Infarction: Changes in 30-Day Mortality, 
Reinfarction, and Urgent Target Vessel 
Revasculafization From 1984-1997 1033-197. 
331A 
Excimer Laser Coronary Angioplasty in In-Stent 
Restenosis: Acute and Long-Term Clinical 
Outcomes 1129-92.63A 
Excimer Laser Versus Rotational Atherectomy for 
the Treatment of Diffuse ln-Stent Restenosis: 
Acute and Long-Term Results 1129-91 •62A 
External Beam Irradiation Reduces Neointima 
Formation and Augments Lumen Size After 
Coronary Stenting in Pigs 823-6•57A 
Final Results of a Prospective Comparison of 
Angiography-Guided Stent Implantation With 
High Versus Very High Balloon Inflation 
Pressure 1188-55,.84A 
Follow-Up Angiographic Comparison of the 
Low-Dose Versus High-Dose Phospborus-32 
Radioactive lsoslent: Results From Expanded 
IRIS andMilan Dose-A Studies 1009-57~,17A 
Full Lesion Stent Coverage Reduces Subsequent 
Target Lesion Revascularization: An
Intravascular Ultras*and Study 1129-53.61A 
Gallium-68 Positron Radiation Effectively Reduces 
Neointima Proliferation in the Porcine Coronary 
Overstretch Model 1101-96•54A 
How Safe and Effective Is Percutaneous Treatment 
of ln-Stent Restenosis? 1129-58.62A 
HPA-3 Polymorphism of the Platelet Fibrinogen 
Receptor ls Not Associated With an Increased 
Risk of Thrombosis or Restenosis After 
Coronary Stent Placement 1068-93•41A 
Humanized Platelet-Derived Growth Factor-b 
Receptor Antibodies Decrease Neointima 
Formation at 30 Days in Baboon Stented 
Carotids 1039-57 •30A 
Immediate and Long-Terra Results: "T" Stenting in 
Bifurcational Coronary Lesions 873-4.91A 
Impact of Cilostazol on Restenosis Following 
Percutaneous Coronary Angioplasty for 
Diabetics 833-1 •57A 
In Vivo Intravascular Ultrasound Measured Stent 
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Transthoracic E hocardiographic V sualization 
of Left Atrial Chamber and Appendage Thrombi 
828-6 •4zlOA 
Predictors of Oral Anticoagulant U ilization in 
Congestive Heart Failure: A Survey on 6428 
Outpatients ofThe Italian Network-Congestive 
Heart Failure (IN-CHF) 1199-12.201A 
Safety and Efficacy of Eptifibatide Therapy in 
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Amyloid Myocardium Based on Measurement 
of Myocardial Bulk Modulus 888-4•514A 
Evolution of Right Pulmonary Vein Lumen 
Narrowing After Right Atrial Linear 
Radiofrequency Ablation 838-6 •137A 
Feasibility Study of Percutaneous Transmyocardiat 
Revascularization With Forward-Looking 
A-Mode Ultrasound for Real-Time Wall 
Thickness Measurements 886-60101A 
Harmonic Power Doppler Imaging in Conjunction 
With Contrast Agent SHU 563A Allows 
Recognition of Viable Myocardium: 
Experimental Contrast Echocardiographic 
Studies of Reperfused Myocardium 1058-109• 
414A 
Hypoperfused Myocardial Mass Estimated From 
Three-Dimensional Contrast Echocardiography 
Using a Novel Contrast Agent, AI-700, Aids in 
Accurate Quantitation of Infarct Mass 
1208-108 •467A 
Improved Accuracy for a Semiautomated Method 
for Computing Right Ventricle Cavity Volumes 
From Real-Time Three-Dimensional Echo: 
Comparison Studies to Ultrasonic Crystals in an 
Open Chest Animal Model 914-2.486A 
Improved Structure Identification by Tissue Doppler 
Echocardiography: An Experimental nd 
Clinical Classification of Motion Patterns 901-5 
• 484A 
Inferior Vena Caval Masses: A Series of 62 Cases 
Diagnosed by Echocardiography 1087-33. 
419A 
Integrated Backscatter ofLeft Atrial Spontaneous 
Echo Contrast in Mitral Stenosis Correlates 
With Left Atrial Fibrinogen Level but Not 
Coagulation Activity 901-4.484A 
Intracardiac Echocardiographic Quantification f
Changes in Wall Thickness and Ventricular 
Function Associated With Radiofrequency 
Ablation in Chronic Myocardial Infarction 
1172-150o 140A 
lntravascular Ultrasound Assessment of Pulmonary 
Valve Ring and Pulmonary Arter5, Wall 
Stiffness, Distensibility, and Compliance in 
Pediatric Patients With Pulmonary. Stenosis 
12t9-48o99A 
ls There a Benefit o Lowering Low-Density 
Lipoprotein Below 100 mg/dl in Patients With 
Coronary Artery Disease? 1135-690271A 
Left Ventticular Energetics in Transgenic Mice With 
Dilated Cardiomyopathy 891-3°515A 
Local Deliver 5, of Low Weight Molecular Heparin 
After Stent Implantation toPrevent Nor lntimal 
Proliferation: Results of the lntravascular 
Ultrasound Substudy 1188-94•85A 
Nonperfused Versus Perfused Myocardium: Feature 
Extraction of Digital Myocardial Contrast 
Echocardiographic Images 841-2o450A 
Normal Values of Regional Left Ventricular Systolic 
and Diastolic Endocardial Motion: Multicenter 
Color Kinesis Study 1180-32°457A 
Optimal lntravascular Ultrasound Criteria for Stent 
Deployment: Comparison of Different 
Ultrasound Criteria on the Six-Month 
Restenosis Rate 886-5 • 101A 
Peripheral Vascular Endothelial Function ls 
Abnormal After Cardiac Transplant in Iscbemic 
but Not in Nonischemie Cardiomyopathy 
1049-8 • 176A 
Quantitative Analysis of Mitra[ Regurgitation Jet 
Eccentricity by Color Flow Doppler Identifies 
Patients With Flail Leaflets 1016-1750541A 
Quantitative Three-Dimemsional Contrast 
Echocardiography Can Estimate Myocardial 
Mass at Risk, Infarct Mass, and Efficacy of 
Reperfusion: Experimental Canine Studies With 
a Transvenous Contrast Agent, NC 100100 
1235-32 • 473A 
Real-Time Three-Dimensional Echocardiography 
Using Sequential Data Acquisition With 
Ultrafast Rotating Transthoracic S anner: First 
Experience in Pafients 1026-83..405A 
Right Atrial Mural Swelling and Its Effect on 
Adjacent Great Vessels From Linear 
Radiofrequency Ablation for Atrial Fibrillation 
838-5 • 137A 
Safety of lntracoronary Doppler Measurement Using 
lntracoronary FIoWire: Experience With 892 
Cases 1071-49* 46A 
Studies of Brachial Artery Flow-Mediated 
Vasodilation Using a Continuous Echo-Tracking 
Ultrasound Technique 1042-69 • 232A 
Test-Retest Reliability of Measurements of Left 
Ventricular Mass in Single Patients: The 
Reproducibility Echocardiographic Study (RES) 
1014-I 10• 226A 
Transesophageal Echocardiography Could Evaluate 
the Stage of Takayasu's Arteritis With Aortic 
Aneurysm 1074-71.243A 
Treatment of Pseudoaneurysm of the Femoral Artery 
by Direct Thrombin Injection: Acute Results 
and Follow-Up 1193-69.291A 
Validation of Endocardial Ultrasonic Crystal Array 
Methods for RV and LV Cavity and Stroke 
Volume Determinations Compared to 
Electromagnetic Flow Probe and Conductance 
Catheter Methods in a Study of Sheep With 
Chronic Aortic Regurgitation 891-5 •515A 
Various Responses of Vessel Remodeling in a 
Saphenous Vein Graft After Coronary Artery 
Bypass Grafting Demonstrated byIntravascular 
Ultrasound 1010-49.19A 
Unstable angina 
A New Prognostic Marker for Unstable Angina and 
Subendocardial Myocardial Infarction 
L 127-163•362A 
A Novel Intravascular Catheter for the In Vivo 
Thermography of Coronary Arteries 1131-97• 
67A 
An lschemia-Guided Strategy of Cardiac 
Catheterization in Patients With NonST 
Segment Elevation Acute Coronary Syndromes 
May Be Associated With Improved Outcomes 
1214-162•391A 
Analysis of Angiographic Plaque Burden in Stable 
and Unstable Coronary Syndromes 1002-197 • 
323A 
Are We Under-Anticoagulating OurPatients With 
Unstable Angina? 889-6 *396A 
Bedside Evaluation of New Onset Chest Pain by 
Transthoracic Stress Echocardiography Using 
Transesophageal Atrial Pacing Is Comparable to
Nuclear Perfusion Stress Imaging 1212-130• 
389A 
Black Patients Presenting With Acute Coronary 
Syndromes Have Better Outcomes Due to Less 
Extent of Disease 1154-129•365A 
Both PEG-Hirudin and Enoxaparin Blunt the Rise of 
Von Willebrand Factor in Patients With Unstable 
Angina 819-2•351A 
C Reactive Protein in Unstable Angina: Marker or 
Culprit? 875-2• 385A 
C-Reactive Protein and Troponin T Independently 
Predict Mortality in Patients With Unstable 
Angina: Results From the CAPTURE Trial 
896-6 °397A 
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C-Reactive Protein Levels in Acute Coronary 
Syndromes Are Unrelated to the Extension of 
Coronary Atherosclerosis 1183-133,374A 
Cardiac Troponin I Levels and Clinical Outcomes in 
Patients With Acute Coronary Syndromes: The 
Role of Early Percutaneous Revascularization 
1094-132 ° 346A 
Changing Outcome of Percutaneous Intervention i
Patients With Unstable Angina 81-1 *31A 
Chlamydia Pneumoniae and Helicobacter Pylori in 
Human Coronary Atherosclerosis 817-5,260A 
Comparability of Myocardial Perfusion Imaging and 
Echocardiography for Identifying Myocardial 
Infarction in Emergency Department Patients 
With Chest Pain l t47-32°441A 
Continuous 12-Lead ST Segment Monitoring Is 
Superior to Early Echocardiography for 
Identifying Low-Risk Chest Pain Patients With a 
Worse In-Hospital Outcome 1212-132 ° 389A 
Decreasing Thrombin Activity During Thrombin 
Inhibition Improves Clinical Outcome in 
Unstable Coronary Disease 1183-131,373A 
Do Multiple Infections Have a Rote in the 
Path•genesis ofAcute Coronary Syndromes? 
1002-200 •324A 
Does Culprit Lesion Morphology lmprove 
Prognostic Assessment inAcute Coronary 
Syndromes? 903-1,399A 
Does the Diagnosis of Unstable Angina Require the 
Presence ofIschemic ECGChanges? 876-2° 
393A 
Enoxaparin for Unstable Angina/Noo-Q Wave 
Myocardial Infarction: Meta-Analysis of T1MI 
1 l B and ESSENCE 819-1 *351A 
Enoxaparin Is Superior to Unfractionated Heparin 
Regardless of aPTT Range Achieved: A TIMI 
11B Substudy 819-3°352A 
Episodic Activation of Cyclooxygenase 2 in Patients 
with Unstable Angina 1068-52 *39A 
Eptifibatide During Immediate Percutaneous 
Coronary Intervention (PCI) in the Acute 
Coronary Syndromes (ACS): Findings From the 
PURSUIT Study 1157-57*72A 
Eptifibatide Protects Against Adverse Cardiac 
Complications Both Before and During 
Percutaneous Intervention i Patients With 
Acute Coronary Syndromes Without ST 
Elevation 1068-53 °40A 
Eptifibatide Reduces the Size and Incidence of 
Myocardial Infarction in Patients With 
Non-ST-Elevation Acute Coronary Syndromes 
1032-133"331A 
Even Minor Elevations of Creatine Kinase Predict 
Increased Risk of Cardiac Events in Acute 
Coronary Syndromes Without ST-Segment 
Elevation 1094-133 - 46A 
F Vlla and FI+2 in Unstable Angina Pectoris: 
Heparin Therapy, Haemostatic Activation, and 
Recurrent lschemia 1191-23-289A 
Factors Associated With an lnvasive Strategy in 
Patients With Unstable Angina 1063-129* 
337A 
Heparin Weaning Attenuates but Does Not Prevent 
Rebound Thrombin Generation in Acute 
Coronary Syndromes: Results From a 
Randomized Pilot Study 904-1 •400A 
Impact of BMIPP SPECT in the Diagnosis of 
Unstable Coronary Artery Disease: A 
Comparison With ECG Changes and Troponin T 
Levels 1209-123 •467A 
Impact of Smoking on Outcomes With Unstable 
Angina/Non Q Myocardial Infarction: Report 
From the T1MI-3 Registry 1154-133°366A 
In Vitro Hyper-Responsivity to Lypopolisaccharyde 
in Patients With History of Unstable Angina Is 
Not Associated to Seropositivity for 
Citomegalovims, Helicobacter Pylori, and 
Chlamydia Pneumoniae 875-5.385A 
In Vivo Local Thermography of Human Coronary 
Arteries: Implications for the Path•physiology 
of Acute Ischemic Syndromes 903-2,.399A 
Increased Prevalence of Prothrombin Mutated Allele 
G20210A in Patients With Familial Acute 
Coronary Syndromes 1073-28°241A 
Initiation of Hormone Replacement Therapy After 
Acute Myocardial lnfitrction ts Associated With 
More Angina but Less Death/Myocardial 
Infarction During Follow-Up 893-6,315A 
Long-Term Prognosis of Patients With Unstable 
Angina Undergoing Coronary Stenting 
1214-163•391A 
Myocardial Contrast Echocardiography in Acute 
Myocardial Infarction and Unstable Angina: 
Correlation With Nuclear Medicine Preliminary 
Study 1236-63..475A 
No Evidence for the Direct Involvement of 
Chlamydia Pneumoniae in the Path•genesis of
Acute Coronary Syndromes 876-4,394A 
Pathological Findings and Clinical Correlates From 
Suction Thrombectomy Specimens in Acute 
Coronary Syndromes 903-3,400A 
Plasma Troponin T Level in Patients With Unstable 
Angina Pectoris: Association With Myocardial 
Perfusion and Functional Abnormalities on 
Gated SPECT imaging and Angiographic 
Morphology 1094-130,345A 
Platelet Activating Factor Concentration as a 
Diagnostic Test for Unstable Angina 1212-128 
• 388A 
Platelet-Dependent Thrombin Generation in Patients 
With Unstable Angina Pectoris 1183-1300 
373A 
Prognostic [mportance of ST-Segment Monitoring 
With Continuous 12-Lead ECG in Patients With 
Chest Pain and Nondiagnostic ECG 1212-133° 
389A 
Prognostic Significance of Abnormal Creatine 
Kinase MB Fraction With Normal Total 
Creatine Kinase in Patients With Acute 
Coronary Ischemic Syndrome 876-6,394A 
Prognostic Value of Admission Electrocardiogram of 
1.072 Patients With Unstable Angina and 
Non-Q-Wave Myocardial Infarction 1125-129o 
359A 
Prospective Evaluation of Clinical Practice 
Guidelines Regarding the Likelihood of 
Coronary Artery Disease 889-1,395A 
Putative Antigens for T Cell Response in Unstable 
Angina 1002-198 -323A 
Randomized Trial of Oral Anticoagulation Therapy 
in Patients With Acute lschemic Syndromes 
Without ST Elevation: Importance of Good 
Compliance 896-2 o396A 
Recidivism Rates Among Patients Presenting With 
Chest Pain and the Impact on Resource 
Utilization 1154-130•365A 
Reduced Antioxidant Capacity Is Associated With 
Elevated Levels of Ceruloplasmin and 
C-Reactive Protein and With Prognosis in 
Unstable Angina 876-3,394A 
Rise in C-Reactive Protein Levels Is Suppressed 
With Tirofiban +Heparin but Not With Heparin 
Alone in Patients With Unstable 
Angina/Non-Q-Wave Myocardial Infarction 
1032-131 °330A 
Role of Inflammatory Mediators in Oxygen-Free 
Species Production by Polymorphonuclear 
Leukocytes in Unstabte Angina 875-3 ° 385A 
Safety and Efficacy of Eptifibatide Therapy in 
Patients With Previous Stroke or Transient 
Ischemic Attack 1032-129 * 330A 
Sensitivity lor the Prediction of Events in Patients 
With Unstable Coronary Artery Disease Is 
Better for C-Reactive Protein Than for Troponin 
I 1094-129.345A 
Soluble Adhesion Molecule Expression in Acute 
lschemic Syndromes 875-4° 385A 
Stents Versus Conventional PTCA in Unstable 
Angina 1038-95 °29A 
Substantial Number of Patients With Acute 
Coronary Syndromes at Risk for Stroke Each 
Year: Results From the PURSUIT Trial 
1154-132*366A 
Success and Complication Rates During Diagnostic 
Angiography and Coronary Interventions in
Octogenarians: A Single Center Experience in 
Preselected High-Risk Patients 1021-87 • 491A 
Superiority of Enoxaparin Over Unfractionated 
Heparin in Unstable Angina Occurs Early in 
Treatment: Results From TIMI I 1B 819-6o 
352A 
The Acute Coronary Syndrome Paradox: Patients 
Who Stand to Derive Maximal Benefit Are 
Least Likely to Have Catheterization r
Revascularization 1063-133 o338A 
The Acute Use of Technetium-99 Sestamibi Imaging 
in the Emergency Department for Early 
Discharge of Patients With Potential Acute 
Myocardial lschemic Events 1212-129.388A 
The Agency for Health Care Policy and Research 
Guidelines Predict Subsequent lschemic Events 
but Not Extent of Disease or Culprit Lesion 
Morphology in Patients With Unstable Angina 
1063-132 * 337A 
The Utility of a Clinical Algorithm and Influences in 
Its Use to Triage Chest Pain Patients in the 
Emergency Department 892-I .313A 
Thrombin Generation After Heparin Discontinuation 
Is Related to Low Antithrombin Activity 889-5 
o396A 
Treatment Benefit With Enoxaparin in Unstable 
Angina Is Greatest in Patients at Highest Risk: 
A Multivariate Analysis From TIMI 11B 8194 
• 352A 
Variability in Quality of Care for Elderly Patients 
Admitted With Unstable Angina in Connecticut 
1063-131,337A 
Vasodilator Capacity of the Culprit Lesion in 
Patients With Unstable Angina 1183-128o 
373A 
Valvular disease 
A Digital Three-Dimensional Doppler Is•velocity 
Surface Derived Flow Quantification Method. a 
Robust Control Surface Geometry-Independent 
Solution for Quantifying Vulvar Regurgitation: 
In Vitro Studies I090-83.424A 
A Prospective Study of Echocardiographic Features 
in 51 Patients With Systemic Sclerosis (SSc) 
1205-34- 462A 
An Automated Three-Dimensional Digital Color 
Doppler Stroke Volume Method Yields Accurate 
Effective Orifice Areas in an In Vitro Model of 
Aortic Stenosis 1090-80o423A 
An Echocardiographic S oring Algorithm for 
"Carciooid-Like" Valvular Heart Disease in 
Patients Treated With Anorectic Drugs 
1079-191 •549A 
Aortic Regurgitant Volume Measurement by 
Automated Cardiac Output Validation by 
Magnetic Resonance Imaging 1090-81 * 424A 
Arterial Norepinephrine Levels Underestimate 
Sympathetic Nervous System Activity in 
Patients With Chronic Mitral Regurgitation 
1047-193,545A 
Chronic Aortic Regurgitation Causes Fibrosis 
Featuring Hyperproduction fNoncollagen, 
Glucosamine-Containing Matrix Elements 
871-1.562A 
Complete Four-Dimensional Color Doppler Flow 
Integration: A Rapid and Accurate Tool for 
Qumltitation of Cardiac Flows 1090-104.425A 
Detection of Chlamydia Pneumoniae in Human 
Nonrheumatic Sclerotic Heart Valves by 
]mmunhistochemical Analysis and Polymerase 
Chain Reaction 1139-191.552A 
Diastolic LV Dysfunction ls a Major Predictor of 
Symptom Persistence Nine Years After Aortic 
Valve Replacement 805-5•547A 
Direct Semiautomated Computation of Multiple 
Three-Dimensional Flow Convergence 
Is•velocities From Digital Reconstruction of
Color Doppler Data of the Flow Convergence 
Region: An In Vitro Study With Differently 
Shaped Orifices 1090-79. 423A 
Double Balloon Versus Inoue Balloon for Mitral 
Commissurotomy: Long-Term Results of a 
Prospecrive Randomized Trial 1167-191-556A 
Early Effect of Valve Replacement for Severe Aortic 
Regurgitation on Left Ventricular Dysfunction 
1197-177,559A 
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Echocardiographic Predictors of Sympathetic 
Nervous System Activation in Patients With 
Chronic Mitral Regurgitation 1225-175q,564A 
Effective Orifice Areas for Pediatric-Sized Bileaflet 
Mechanical Valves: In Vitro Studies Using Flow 
Visualization and Doppler 1235-34-474A 
Effects of Blood Viscosity on Proximal Flow 
Convergence Calculations of Regurgitant Flow 
Rate and Jet Dimensions as Evaluated by Color 
Doppler Flow Mapping: An In Vitro Study 
1150-108-446A 
Elevated Serum Tumor Necrosis Faetor-a in Patients 
With Severe Aortic Stenosis and Mitral 
Regurgitation 1225-173 o564A 
Exercise Echocardiography After the Pulmonary 
Autograft (Ross) Operation for Patients With 
Aortic Valve Disease 1197-190o559A 
Five-Year Follow-Up After Percutaneous Balloon 
Mitral Valvuloplasty inChildren and 
Adolescents 1167-192 •556A 
Impact of Minimally Invasive Approach on Valvular 
Heart Surgery: A Case Controlled Study 842-6 
• 554A 
Importance of Temporal Variation in Quantifying 
Functional Mitral Regurgitation: Minimum 
Flow Rate at Mid-Systole Rather Than 
Maximum Flow Rate Best Predict Overall 
Severity 1016-173-541A 
Improvement in Walking Distance and Quality of 
Life in Peripheral Arterial Disease by a 
Nutritional Product Designed to Enhance Nitric 
Oxide Activity 840-1,277A 
Incidence and Mechanism of Aortic Stenosis in 
Familial Hypercholesterolemia 1139-193- 
553A 
Is Myocardial Na+Ca2+ Exchanger Gene 
Expression Altered in Chronic Heart Failure? 
1048-18-174A 
Left and Right Ventricular Function After 
Percutaneous Balloon Valvuloplasty or Open 
Commissurotomy in Rheumatic Mitral Stenosis 
1167-194•557A 
Left Ventricular Hypertrophy in Mitral Regurgitation 
Is Not Driven by Abnormal Myocardial Protein 
Synthesis Rates 1225-176• 564A 
Long-Term Follow-Up of Conservatively Treated 
Prosthetic Valve Endocarditis: Low Rate of 
Reinfection or Death 871-6,563A 
Noninvasive Quantification f the Aortic Valve Area 
in Patients With Calcified Aortic Valve Stenosis 
by Magnetic Resonance Imaging 805-3- 546A 
Percutaneous Balloon Versus Surgical Closed Mitral 
Commissurotomy: 10-Year Follow-Up of a 
Randomized Trial 1167-175o555A 
Percutaneous Mitral Balloon Valvuloplasty in
Pregnant Women With Mitral Stenosis 
1167-174-555A 
Predicting Mortality for Aortic Valve Surgery? 
1046-177 • 544A 
Prediction of Coronary Artery Disease in Patients 
Undergoing Mitral Valve Prolapse Surgery 
842-4 *554A 
Predictors of Restenosis Following Percutaneous 
Balloon Mitral Commissurotomy: A Long-Term 
Echocardiographic Evaluation 1167-193•556A 
Preoperative Prediction of 30-Day Mortality After 
Cardiac Surgery: Registry of the ALKK 
1097-139-349A 
Progression of Left Ventricular Remodeling in 
Mitral Regurgitation: A Prospective Quantitative 
Echocardiographic Study 852-4,558A 
Prosthetic Mitral Regurgitation Can Be Mimicked 
by Color Flow Mapping: Avoiding Misdiagnosis 
1150-105-446A 
Pulmonary Outflow Tract Reconstruction With 
Autololgous Tissue During the Ross Procedure: 
Right Ventricular Characteristics in Mid-Term 
Follow-Up 1 t52-161*531A 
Quantitative Analysis of Mitral Regurgitation Jet 
Eccentricity by Color Flow Doppler Identifies 
Patients With Flail Leaflets 1016-t750541A 
Real-Time Interactive Cardiac Magnetic Resonance 
Imaging System With Color Flow Mapping 
1238-105 • 478A 
Regression of Myocardial Hypertrophy in
Concentric and Eccentric Remodeling 805-6 •
547A 
Relative Prolapse in Apically Tethered Mitral 
Valves: An Important Mechanism of Moderate 
to Severe Mitral Regurgitation 852-2,,557A 
Role of Endothelial Adhesion Molecules in the 
Path•genesis of Degenerative Aortic Valve 
Disease l 139-190.552A 
Serotonin-lnduced Proliferation i  Cardiac Valve 
Tissue 1079-194-550A 
Short- and Long-Term FollOw-Up in 771 Patients 
Undergoing Reoperative Heart Valve Surgery 
1078-177 • 548A 
Short-Term Estrogen Treatment Prior to and 
Following Balloon Injury of Rat Carotid Artery 
Effectively Blunts the Vascular Injury Response 
1132-21 •267A 
Should Cardiac Auscultation Be Completely 
Replaced by Echocardiography? A Prospective, 
Direct Comparison i 100 Patients With a 
Systolic Murmur of Unknown Etiology 805-1• 
546A 
Simple Method for Estimating Regurgitant Volume 
Using a Single Radius for Measuring Proximal 
Is•velocity Surface Area: An In Vitro Study of 
Simulated Mitral Regurgitation 1090-82-424A 
Stentless Bioprosthesis Are Perfect for the Small 
Aortic Root 842-1-553A 
Surgical Treatment of Valvular Heart Disease in 
Patients With Acromegaly and Cardiomyopathy 
1047-194,545A 
The Different Strata of Left Ventricular Remodeling 
After Aortic Valve Replacement With a 
Stentless Valve 1197-176-559A 
The Importance of the Interval Between Preoperative 
Neurologic Events and Valve Operation in 
Patients With Acute Infective Endocarditis 
842-5 • 554A 
Transesophageal Echocardiography in 
Phentermine-Fenfluramine Users Suggests 
Frequent Misdiagnosis of Valvular Heart 
Disease by Transthoracic E hocardiography 
1079-192 • 549A 
Tumor Necrosis Factor-Alpha Levels in Mitral 
Regurgitation Are Associated With Sympathetic 
Nervous System Activation 1225-174-564A 
Validation Studies for Real-Time Three-Dimensional 
Echocardiographic Determination f Left 
Ventricular Diastolic and Systolic Cavity and 
Stroke Volumes: Comparisons ofDigital 
Sonomicrometric Arrays. Conductance Catheter, 
and EM Flow Meter Measurements 1090-105o 
425A 
Valvular Heart Disease. in Patients With Chinese 
Herbs Nephropathy 1079-193,549A 
Valvular Hem•dynamics at Rest and Exercise 
Following Pulmonary Autograft Replacement of 
the Aortic Valve (Ross Procedure) 1197-175, 
559A 
Why Do Only Some Patients With Inferior Infarction 
Have Mitral Regurgitation? Insights From 
Three-Dimensiomd Echocardiography 1026-8t 
• 405A 
Va lvu lop las ty  
10-Year Experience With Retrograde Nontransseptal 
Balloon Mitral Valvuloplasty at Its Center of 
Origin: Immediate Results and Long-Term 
Follow-Up 1167-1900556A 
Double Balloon Versus Inoue Balloon for Mitral 
Commissurotomy: Long-Term Results of a 
Prospective Randomized Trial 1167-191 o556A 
Echocardiographic Features of Early Procedural 
Failure Following Percutaneous Balloon Mitral 
Valvotomy 1167-1760555A 
Five-Year Follow-Up After Percutaneous Balloon 
Mitral Va]vuloplasty in Children and 
Adolescents 1167-192•556A 
Left and Right Ventricular Function After 
Percutaneous Balloon Valvuloplasty or Open 
Commissurotomy in Rheumatic Mitral Stenosis 
1167-1940557A 
Long-Term (I 3-Year) Results After Pulmonary 
Balloon Valvuloplasty in Adolescent and Adult 
Patients 1181-160•532A 
LV Systolic Dysfunction i Mitral Stenosis: Preload 
Effect or Depressed Contractility? I 167-173 • 
555A 
Mitral Balloon Valvotomy in 450 Patients Using 
lnoue Balloon Technique Long-Term (8.7 Year) 
Results and Predictors of Restenosis 1167-177 • 
556A 
Percutaneous Balloon Versus Surgical Closed Mitral 
Commissurotomy: 10-Year Follow-Up of a 
Randomized Trial 1167-175,,555A 
Percutaneous Mitral Balloon Valvuloplasty in
Pregnant Women With Mitral Stenosis 
1167-174.555A 
Platelet Activation in Patients With Mitral Stenosis 
With Chronic Atrial Fibrillation Undergoing 
Balloon Mitral Valvuloplasty 1047-192-545A 
Predictors of Restenosis Following Pereutaneous 
Balloon Mitral Commissurotomy: A Long-Term 
Echocardiographic Evaluation 1167-1930556A 
Reparative Approach of Atrioventricular Valves 
Following Severe Blunt Cardiac Trauma 
1046-1760544A 
Role of Coumadin in Patients After Mitral Valve 
Repair: Analysis of 202 Patients Followed Up to 
12 Years After Surge D' 1046-1750544A 
Role of Mitral Valve Chordal Distribution in Mitral 
Valve Function: An In Vitro Study 1016-174, 
541A 
Tricuspid Valve Balloon Dilation in Children 
1181-158o532A 
Vascular biology 
A New Prognostic Marker for Unstable Angina and 
Subendocardial Myocardial Infarction 
1127-1630362A 
Adaptive Coronary Remodeling Is Evident in Later 
Stages of Transplant Vasculopathy: A Serial 
Intravascular Ultrasound Study 864-6"90A 
Advanced Glycation End Products Inhibit the 
Stimulation of Nitric Oxide Synthase by 
Histamine in a Human Endothelial Cell Model 
1041-29 *231A 
Apoptolysis: A NoveL Mechanism for Plaque 
Ulceration and Rupture 1161-112,278A 
Asymmetric Dimethylarginine Inhibits Basic 
Fibroblast Growth Factor Induced Angiogenesis 
1041-31 •232A 
Atorvastatin Downregulates AT1 -Receptor Gene 
Expression i  Cell Proliferation i  Vascular 
Smooth Muscle Cells 10I 1-28,,222A 
Bacterial Lipopolysaccharide Induces Alkaline 
Phosphatase Activity in Bovine Calcifying 
Vascular Cells: Possible Role in Vascular 
Calcification 809-3 • 250A 
Biphasic Pattern of Cell Turnover During 
Atherogenesis in Man and APOE*3 Leiden 
Mice 1011-31"223A 
Circulating Vascular Endothelial Growth Factor 
(VEGF) Levels Are Elevated in Patients With 
Peripheral Vascular Disease and Increase 
Further After Exercise 899-3,,316A 
Cotransfection f FosB and JunB Genes Induces 
Hypertrophy inCultured Pulmonary Arterial 
Smooth Muscle Cells 1012-77 •224A 
Cyclic Adenosine Moo•phosphate Is a More Potent 
Inhibitor of Human Vascular Smooth Muscle 
Cells Than Cylcic Guanosine Moo•phosphate: 
An In Vitro Comparison of Antiproliferative 
Signal Transduction 1040-24• 230A 
Cytotoxic Effect of Adherent Monocytes on Aortic 
Smooth Muscle Cells: An In Vitro Model of the 
Medial Degeneration in Vasculopathies 
1161-113-278A 
Dendroaspis Natriuretic Peptide Relaxes Isolated 
Human Arteries and Veins 1192-26o290A 
Developmentally Regulated Endothelial Cell Locus: 
A Novel Angiogenic Protein 809-4•250A 
Do Serum Urate Levels in Heart Failure Reflect 
Chronic Vascular Inflammation? 895-2,,217A 
Effect of y-Irradiation on the Cell Cycle of Rat 
Smooth Muscle Cells 1101-134o55A 
Effects of End•vascular Ir adiation on Platelet 
Recruitment a Sites of Balloon Angioplasty in 
Pig Coronary Arteries 1070-60,44A 
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High Dose Vitamin E Decreases Arterial Wave 
Reflection and Improves Ventricular/Vascular 
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Inhibition of Platelet Adhesion by Thrombostatin, a 
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Myocardial Vascular Responsiveness in Familial 
Hypercholesterolemia 1194-113*293A 
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Vascular surgery 
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in Peripheral Arteries 78-4*22A 
Flow Characteristics ofthe Internal Mammary 
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1191-24•289A 
ICAM-I Up-Regulation Precedes the Remodelling 
of Collateral Arteries (Arteriogenesis) 
1161-114•278A 
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Dissection 880-5 •311A 
Recanalization of Chronic Total Occlusions of the 
Abdominal Aorta and the Iliac Arteries 
1130-44.65A 
Treatment ofPseudoaneurysm of the Femoral Artery 
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and Follow-Up 1193-69,,291A 
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Disease 1044- 115.236A 
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Endothelin Response 1169-9• 197A 
Aspirin 325mg, Single-dose, Increases 
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Subjects 1104-67•254A 
Intravenous Administration of Vitamin C Acutely 
Improves Endotheliurn-Dependent Dilation in 
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• 224A 
Serum Cholesterol Level and Vasomotor Responses 
of Coronary St•noses to Acetylcholine in 
Patients With Stable Angina 1191-25•289A 
Vasodilator Capacity of the Culprit Lesion in 
Pafients With Unstable Angina 1183-128• 
373A 
Vasodilation 
Chronic Endothelia Receptor Antagonism Preserves 
Coronary Endothelial Function In Vivo in 
Experimental Hyperel~tole st rolemia 1041-27• 
231A 
Clinical Determinants ofCoronaly Steal Induced by 
lntravanous Dipyridamole 897-3 • 482A 
Coronary Vascular Dysunction Associated With 
Direct Current Shock lnjury 1192-28•290A 
Dandroaspis Natriuretic Peptide Relaxes Isolated 
Human Arteries and ~ins 1192-26* 290A 
Digoxin Impairs Endotheli urn-Dependent and 
-Independent Relaxations in Isolated Arteries 
1044-114*236A 
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lnduced by Angiotensin Converting Enzyme 
lnhibitors? 1072-22 • 240A 
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t062-165 •334A 
Endothelial Function and Vitamin C 836-1*275A 
Omapatrilat, a Novel Vasopeptidase Inhibitor, 
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Subjects 877-3 •309A 
Relation of Inflammation to Vascular Function in 
Patients With Coronary Heart Disease 836-5• 
276A 
Studies of Brachial Artery Flow-Mediated 
Vasodilation Using a Continuous Echo-Tracking 
Ultrasound Technique 1042-69 •232A 
The Effects of Short-Term Passive Smoke Exposure 
on Endothelium-Dependent a d Independent 
Vasodilation 1042-67.232A 
Vasodilator Capacity of the Culprit Lesion in 
Patients With Unstable Angina 1183-128• 
373A 
Vasodilator agents 
Coronary Vasomotion and Stenting 1042-700233A 
Endothelial Function and Vitamin C 836-1.275A 
Impaired Detection of Coronary Disease Due to 
Inconsistent Vasodilator Response to 
Dipyridamole in The NHLBI Women's I chemia 
Syndrome Evaluation (WISE) Study 854-3• 
460A 
Improved Washout Profiles With an 
Adenosine/Exercise Protocol in Thallium-201 
Myocardial Perfusion Imaging 1029-360410A 
Phase 2 Trial of a Novel Prostaeyclin Analogue, 
UT-15, in Patients With Severe Intermittent 
Claudication 840-3 • 277A 
Testosterone Causes Dilatation of Rat Coronary 
Arteries by a Novel Non-Genomic Mechanism 
I t 32-25,, 268A 
Testosterone Relaxes Male and Female Rat 
Coronary Arteries In Vitro Via an Endothefium 
[ndependent Mechanisms 1132-24*268A 
The Effects of Hydralazine on the Prevention of 
Nitrate Tolerance in Patients With Chronic Heart 
Failure 1 t 10-16*185A 
Vasopressin 
Vasopressin Modulates Sympathetic Nerve Activity 
in Various Models of Hypertension 1107-121 • 
259A 
Ventilation 
Pulmonary Ha.re•dynamics and Exercise Gas 
Exchange in Secondary Pulmonary 
Hypertension Due to Chronic Heart Failure or 
Connective Tissue Disease 1168-6¢ 196A 
Routine Follow-Up of Prosthetic Cardiac Valves by 
Echocardiography: How Often? 867-4•472A 
Ventilatory and Chronotropic Responses to Exercise: 
Better Predictors of Heart Failure Mortality and 
Peak V02 1140-3.190A 
Ventrieular arrhythmia 
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ICD Systems in the Acute Human Clinical 
Evalution 1054-179* 112A 
Adverse Cardiovascular Events Associated With 
Nutritional Supplements Containing Ma Huang 
(Ephedra) 1085-154-117A 
Analysis of Repolarization Changes in a 
Double-Blind Crossover Study on Dofetilide 
Versus Sotalol for Ventricular Tachycardia 
1085-179•119A 
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High Risk Patients? 824-5•264A 
Are There Differential Effects of the New lks 
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Bar•reflex Sensitivity and Heart Rate Variability in 
Patients With and Without Sustained T-Wave 
Altemans After an Acute Myocardial Infarction 
1086-187 • 121A 
Carvedilol Reduces QT Interval Dispersion in 
Patients With Chronic Heart Failure 1199-8• 
200A 
Comparison of 8-ram Tip and Irrigated Tip Catheters 
for Radiofrequency Ablation of Ventricular 
Myocardium 1172-149.140A 
Do Nonischemic Hypertensive Patients With Left 
Vemricular Hypertrophy Have Late Potentials or 
Complex Vemricular Arrhythmias? The LIFE 
Study 1045-12l *237A 
Duration and Circadian Variation of Paroxysmal 
Atrial Tachyarrhythmias n Patients With Dual 
Chamber lmplantable Defibrillator: Implications 
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Relationship With Clinical Variables and 
Arrhythmic Events After Acute Myocardial 
Infarction 1024-185" 107A 
Effect of a Novel a Na+/H+ Exchange Inhibitor. 
KB-R9032. on Myocardial 
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Lead System 1054-180,112A 
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Repeatability of Activation Patterns on the 
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Spatiotemporal Organization of Ventricular 
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Ventricular Arrhythmias Are Closely Related to Left 
Ventricular Size and Mass in Patients 
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Implications to Design of the Optimal 
Defibrillation Waveform 1023-180o 106A 
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Reduced My•filament Ca2+ Responsiveness 
Underlies Postfibrillatory Contractile 
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Reduced Risk of Death With Safety Balls in an 
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Spatiotemporal Organization ofVentricular 
Fibrillation Increases During Global Ischemia in 
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Reduce the Defibrillation Threshold 1054-178• 
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Dysfunction hy Three-Dimensional 
Echocardiography: Direct In Vivo Validation 
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Assessment of "Pseudonormal" LV Relaxation 
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Early Postoperative Changes in Regional Systolic 
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Following Transmyocardial Laser 
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Sensitive Tool for the Detection and 
Localization of Microvascular Injury 1236-65• 
476A 
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Heart 1019-7•171A 
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